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Hospital Episode Statistics (HES) is the main hospital administrative dataset in 
England. Since the early 1990s HES has been used for research.  The aim of the thesis 
is to evaluate the use of HES data to measure surgical outcomes. 
 
Objectives:  
1. Can HES data be used to measure rare surgical complications when there is a 
code? 
2. Can HES data be used to measure rare surgical complications when there is no 
code? 
3. Can HES data be used to compare different types of surgery for the same 
condition? 
4. Can HES data be used to measure changing trends in surgical practice? 
5. Can HES data be used as a national audit tool? 
6.  
Methods: Hospital Episode Statistics from @1, @2, @3. @4 and @5 were used to 
address each individual objective. HES data were obtained from the National Health 
Service (NHS) Information Centre and stored into Microsoft SQL server for analysis. 
HES data were cleaned and converted into clinical database. Patients' data were 
identified using operative and diagnostic codes. All duplicates were removed and 
patients were followed across time and place to identify complication. For each study a 







Objective 1: Venous Thromboembolism (VTE) following colorectal resection was used 
to answer this objective.  A total of 35,997 underwent colorectal resection during the 
period of study. The VTE rate was 2.3%. Two hundred and one (0.56%) patients 
developed VTE during the index admission and 571 (1.72%) were readmitted with 
VTE. Following discharge from the index admission, the risk of VTE in patients with 
cancer remained elevated for six months compared with two months in patients with 
benign disease. Age, postoperative stay, cancer, emergency admission, and emergency 
surgery for patients with inflammatory bowel disease (IBD) were all independent risk 
factors associated with an increased risk of VTE. Patients with ischaemic heart disease 
and those having elective Minimal Access Surgery (MAS) appear to have lower levels 
of VTE.  
 
Objective 2: Bile duct reconstruction following Laparoscopic Cholecystectomy (LC) in 
England was used for this objective. Five hundred seventy-two thousand two hundred 
and twenty-three LC and attempted LC were performed in England between April 2001 
and March 2013. Five hundred (0.09%) of these patients underwent Bile Duct 
Reconstruction (BDR). The risk of BDR for Admission with other causes is 
significantly lower than acute cholecystitis (Odds ratio OR0.48 (95%CI 0.30—0.76). 
The regular use of On Table Cholangiogram (OTC) (OR 0.69 (0.54—0.88) and high 
consultant caseload >80 LC/year (OR 0.56 (0.39—0.54) reduced the risk of BDR. 
Patients who underwent BDR were 10 times more likely to die within a year than those 






Objective 3: Laparoscopic versus open repair of inguinal hernia: a longitudinal cohort 
study was used for this objective. Between April 2002 and April 2004 125,342 patients 
who underwent inguinal hernia repair were included in the analysis and they were 
followed until April 2009. There were no differences in postoperative stay between the 
laparoscopic and open groups except for the laparoscopic bilateral hernia repair patients 
who had a shorter stay than the open group. Infection and bleeding were more common 
following open repair, whilst urinary retention and injury to an organ were more 
frequent after laparoscopic repair. Reoperation for another inguinal hernia was more 
common after laparoscopic (4.0%) than after open repair of primary inguinal hernia 
(2.1%). There was no difference in reoperation rate following repair of a recurrent 
inguinal hernia. Consultant caseload was strongly inversely correlated with reoperation 
following laparoscopic but not open repair of primary inguinal hernia. 
 
Objective 4: Epidemiological trends in surgery for rectal prolapse in England was used 
for this objective. During the study period, a total of 25,238 adults underwent a total of 
29,379 operations for rectal prolapse [median age 73 years (IQR 58-83) years; female to 
male ratio: 7:1]. Median LOS was 3 days (IQR 1-7) with an overall in-hospital 
mortality rate of 0.9%. Numbers of total admissions (2001: 4,950 vs. 2012: 8,927) and 
of patients undergoing prolapse surgery (2001: 2,230 vs. 2012: 2,808) significantly 
increased (P < 0.001 for trends) throughout the study period. The overall increase in 
surgery (up about 1/3rd overall and 44% for elective) was dwarfed by an increase in 
popularity of laparoscopic surgery (increased 15-fold during the period). Overall 
prolapse reoperation rate (as a surrogate of recurrence) was 12.7%. The lowest 
recurrence rate was observed for elective open resection (9.1%) but this had the highest 





reoperation rates (<11%) but lower mortality rates of approx. 0.3% for elective surgery. 
The data refute a trend toward subspecialisation (by surgeon or hospital) during the 
study period. 
Objective 5: Definitive management of Gallstone pancreatitis in England was used for 
this objective. A total of 5,454 patients were admitted with GSP between April 2007 
and April 2008, of whom 1,866 (34.2%) underwent definitive treatment according to 
BSG guidelines, 1,471 on the index admission. Patients who underwent a 
cholecystectomy during the index admission were less likely to be readmitted with a 
further bout of GSP (1.7%) than those who underwent endoscopic sphincterotomy alone 
(5.3%) or those who did not undergo any form of definitive treatment (13.2%). Of those 
patients who did not undergo definitive treatment before discharge, 2,239 received 
definitive treatment following discharge but only 395 (17.6%) of these had this within 2 
weeks. Of the 505 patients who did not undergo definitive treatment on the index 
admission and who were readmitted as an emergency with GSP, 154 (30.5%) were 
admitted during the 2 weeks immediately following discharge. 
 
Conclusion 
Hospital Episode Statistics can be used to measure surgical outcome in a number of 
useful and reproducible ways. HES can be used to measure mortality, complications, 
compare different surgical approaches, assess the effect of changes in practice, and 
assess caseload outcome association. Those metrics can be used to inform health care 
planners, develop guidelines, inform patients, and reward hospitals for improved 
outcome. The use of HES, however, has weaknesses which to a certain extent could be 
overcome easily with minor alteration in the way that diagnostic, consultant/operator 






1. Venous Thromboembolism following colorectal resection 
Yesar El-Dhuwaib, C. Selvasekar, D. Corless, M. Deakin, J. SLavin 
Colorectal Disease Journal 2017 Apr;19(4):385-394. doi: 10.1111/codi.13529 
Presented at 
• the European Association for Endoscopic Surgeon (EAES) in Brussels 2012 
 
2. Bile duct reconstruction following laparoscopic cholecystectomy in England 
Yesar El-Dhuwaib, J. Slavin, D. Corless, I. Begaj, D. Durkin, M. Deakin  
Surgical Endoscopy August 2016, Volume 30, Issue 8, pp 3516–3525 
Presented at  
• The European Association for Endoscopic Surgeon in Brussels 2013 and it was 
nominated for Karl Storz Award at EAES in Brussels 2013. 
3. Laparoscopic versus open repair of inguinal hernia: a longitudinal cohort study.  
Yesar El-Dhuwaib, D. Corless, C. Emmett, M. Deakin, J. Slavin 
Surgical Endoscopy March 2013, Volume 27, Issue 3, pp 936–945 
Presented at 
• The British Hernia Society, Glasgow 2008 and was awarded Brenden Devlin 
Prize 
• The Association of Laparoscopic surgeon of Great Britain and Ireland 
(ALSGBI), Colchester 2009 and it was awarded top 4 abstracts. 







4. Epidemiological trends in surgery for rectal prolapse in England 2001-2012; an 
adult hospital population‐based study 
Yesar El-Dhuwaib, A. Pandyan, C. Knowles 
Colorectal Dis. 2020 Oct;22(10):1359-1366. 
Presented at  
• The Association of Coloproctology of Great Britain and Ireland, Edinburgh, 
2016. 
 
5. Definitive management of Gallstone pancreatitis in England 
Yesar El-Dhuwaib, M. Deakin, G. David, D. Durkin, D. Corless, J. Slavin 
Annals of Royal College of Surgeon of England: 94 Issue: 6, May 2012, pp. 402-
406 
Presented at  
• The Annual Pancreatic Society of Great Britain and Ireland (PSGBI), 





Table of Contents 
Acknowledgement .......................................................................................................... iii 
Published papers ........................................................................................................... viii 
Table of Contents .............................................................................................................. x 
1 Introduction ............................................................................................................... 1 
1.1 Evidence based medicine ................................................................................... 1 
1.2 Traditional research and data ............................................................................. 3 
1.2.1 Meta-analysis and Systematic Review........................................................ 4 
1.2.2 Randomised Control Trial........................................................................... 5 
1.2.3 Cohort Study ............................................................................................... 8 
1.2.4 Cross-sectional Study.................................................................................. 8 
1.2.5 Case Control Studies ................................................................................... 8 
1.3 Non-conventional large datasets ........................................................................ 9 
1.3.1 Cancer Registry Data .................................................................................. 9 
1.3.2 National Dataset .......................................................................................... 9 
1.3.3 Administrative Data .................................................................................. 10 
1.3.3.5.1 Hospital Dataset (Hospital Episode Statistics) .......................................... 12 
1.3.3.5.2 Office of National Statistics Mortality Dataset ......................................... 13 
1.3.3.5.3 GP Dataset ................................................................................................ 13 
1.3.3.5.3.1 The General Practice Research Database (GPRD) ................................. 13 
1.4 Benefit and drawback of non-conventional data .............................................. 15 
1.5 Hospital Episode Statistic (HES) ..................................................................... 17 
1.6 Measurement of Surgical Outcomes using HES Data ..................................... 18 
1.7 HES reliability .................................................................................................. 22 
1.8 General Surgery................................................................................................ 26 
1.9 Surgical outcomes ............................................................................................ 29 
1.9.1 Mortality ................................................................................................... 29 
1.9.2 Morbidity and Complications ................................................................... 31 
1.9.3 Length of stay ........................................................................................... 31 
1.9.4 Readmission rate ....................................................................................... 32 
1.9.5 Patient satisfaction, reported outcome, and quality of life........................ 32 
1.10 Aim and Objectives .......................................................................................... 34 
2 Literature review ...................................................................................................... 36 
2.1 Literature review .............................................................................................. 37 
2.1.1 Inguinal hernia .......................................................................................... 38 





2.1.3 Bowel pathology ....................................................................................... 48 
3 Data and Methodology ............................................................................................ 64 
3.1 Hospital Episode Statistics ............................................................................... 64 
3.1.1 Types of available HES data ..................................................................... 65 
3.1.2 Level of approval ...................................................................................... 66 
3.2 Apply, store and install HES data into a computer .......................................... 66 
3.2.1 Applying for HES data ............................................................................. 66 
3.2.2 Data security ............................................................................................. 67 
3.2.3 Accessing the data .................................................................................... 67 
3.3 validation of Clinical codes. ............................................................................. 68 
3.3.1 Pilot audit of general surgery clinical codes. ............................................ 68 
3.3.2 Participant: ................................................................................................ 68 
3.3.3 Methods .................................................................................................... 69 
3.3.4 Data analysis ............................................................................................. 69 
3.3.5 Results ....................................................................................................... 69 
3.4 How to convert HES data into clinical data (inguinal hernia) ......................... 70 
3.4.1 Background for inguinal hernia ................................................................ 70 
3.4.2 Aims of this study ..................................................................................... 72 
3.4.3 Method ...................................................................................................... 72 
3.4.4 Technical Points ........................................................................................ 74 
4 Can HES data be used to measure rare complications when there is a code? ......... 82 
4.1 Venous thromboembolism following colorectal resection .............................. 82 
4.1.1 Abstract ..................................................................................................... 82 
4.1.2 Introduction ............................................................................................... 84 
4.1.3 Method ...................................................................................................... 86 
4.1.4 Results ....................................................................................................... 89 
4.1.5 Discussion ................................................................................................. 98 
5 Can HES data be used to identify rare complications of surgery when there is no 
code available for this complication? ........................................................................... 103 
5.1 Bile duct reconstruction following laparoscopic cholecystectomy in England.
 104 
5.1.1 Abstract ................................................................................................... 104 
5.1.2 Introduction ............................................................................................. 106 
5.1.3 Methods .................................................................................................. 107 
5.1.4 Results ..................................................................................................... 113 
5.1.5 Discussion ............................................................................................... 121 
6 Can HES data be used to compare different types of surgery for the same 





6.1 Laparoscopic versus open repair of inguinal hernia: a longitudinal cohort 
study. 127 
6.1.1 Abstract ................................................................................................... 127 
6.1.2 Introduction ............................................................................................. 129 
6.1.3 Methods................................................................................................... 131 
6.1.4 Statistics .................................................................................................. 133 
6.1.5 Results ..................................................................................................... 134 
6.1.6 Discussion ............................................................................................... 145 
7 Can HES data be used to measure changing trends in surgical practice? ............. 150 
7.1 Epidemiological trends in surgery for rectal prolapse in England 2001-2012
 151 
7.1.1 Abstract ................................................................................................... 151 
7.1.2 Introduction ............................................................................................. 153 
7.1.3 Methods................................................................................................... 155 
7.1.4 Results ..................................................................................................... 157 
7.1.5 Discussion ............................................................................................... 163 
8 Can HES data be used to measure adherence to national guidelines? ................... 165 
8.1 Definitive management of Gallstone pancreatitis in England ........................ 166 
8.1.1 ABSTRACT ............................................................................................ 166 
8.1.2 Introduction ............................................................................................. 168 
8.1.3 Method .................................................................................................... 169 
8.1.4 Results ..................................................................................................... 170 
8.1.5 Discussion and Conclusion ..................................................................... 176 
9 Discussion .............................................................................................................. 180 
9.1 Can meaningful clinical recommendations be made from research using HES 
data? 181 
9.2 Strength and weaknesses of HES data. .......................................................... 189 
9.2.1 Strength of HES data .............................................................................. 189 
9.2.2 Weaknesses of HES data ........................................................................ 190 
9.2.3 Suggestions for HES data analysis ......................................................... 194 
9.3 Proposed changes to HES data ....................................................................... 197 
9.4 Conclusion ...................................................................................................... 201 
10 References .......................................................................................................... 202 
11 Appendix ............................................................................................................ 216 
11.1 Appendix 1 ..................................................................................................... 216 






One of the aims of all doctors is to inform patients about the nature of their disease and 
the best modality of treatment. Doctors should explain all treatment options and present 
an unbiased summary of the pros and cons of each option. They should also inform 
patients about the risk of harm associated with each option, in particular, the one 
selected. Such discussions normally occur during the consultation between the doctor 
and patient[1]. Doctors are required, where possible, to support their advice with 
appropriate evidence and data. This thesis discussion is limited to general surgery only. 
1.1 Evidence based medicine 
The concept of Evidence Based Medicine was first introduced in mid-19th Century[2]. 
But it was not practiced in the way it is known today until 1990 where Gordon Guyatt 
from McMasters University Internal Medicine, introduced a new concept in medicine 
he called “Scientific Medicine”[3]. The term described a novel method of teaching 
medicine at the bedside. It was built on groundwork laid by his mentor David Sackett 
drawing on a combination of best experience and best evidence. Although the term was 
received well, some of his colleagues made some suggestions that made Guyatt 
returned with a new title that described the core curriculum of the residency program: 
“Evidence-Based Medicine” (EBM)[4].  
 
The current definition of EBM is the conscientious, explicit and judicious use of current 
best evidence in making decisions about the care of individual patient and, in practice, 
it requires the explicit integration of an individual’s clinical expertise with the best 
available external clinical evidence from systematic research. An individual’s clinical 





be under supervision), continuing professional development, and scholarly activity (i.e. 
reading research). This is consistent with the traditional models of EBM.  
 
It is often perceived that EBM is based on knowledge from traditional research. 
However, this does not imply that the knowledge gained from other sources of 
information such as audits, registry and other types of administrative/process control 
data. Traditional research is a slow process that takes a long time to generate important 
new knowledge. The results may not be published or it could take years to be published 
and it out of date at the time of publication. A survey of non-published and delayed 
publication of vaccine were published in the BMJ in 2014 analysed 384 trials (85% 
sponsored by industry)[5]. Of 355 trials (404,758 participants) that were completed, 176 
(n=151,379) had been published in peer reviewed journals. Another 42 trials (total 
sample 62,765) remained unpublished but reported results in ClinicalTrials.gov. The 
proportion of trials published 12, 24, 36, and 48 months after completion was 12%, 
29%, 53%, and 73%, respectively. Including results posted in ClinicalTrials.gov, 48 
months after study completion results were available for 82% of the trials and 90% of 
the participants. This shows the difficulty in conducting trials and publishing them. In 
addition to the trouble of conducting a trial and publishing it, it often takes few years to 
convert an idea into a trial. There is huge effort needed to design a trial and obtain 
ethical approval. Such delays are barriers to effective implementation of EBM. 
 
Research from other source of information may be as good as traditional research to 
obtain the relevant information and inform the medical community with current 
relevant information. For example, in 1995 there was a national outcry due to high 





College drew upon HES data to assess whether the mortality in Bristol had a high 
mortality when compared to other centres in UK and identified that this was the case. 
The lessons learnt from this use of HES data changed practice nationally.  
 
EBM has become well established and consistently embedded in the medical practice 
since the 2000s. Clinicians are no longer allowed to practice without their practice 
being routinely scrutinised [6]. Health Care Authorities tend to provide national 
guidelines based on the best evidence available to the medical and surgical 
communities. For example, National Institute of Clinical Excellence (NICE) oversees 
all service provision and new technology in the country and regularly reviews the best 
available evidence to support, or not, a new method of treatment [7]. Other relevant 
professional specific societies are also responsible for certain aspects of surgical 
practice, for example in general surgery other such responsible bodies are The 
Association of Coloproctology of Great Britain and Ireland (ACPGBI)[8], The 
Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland 
(AUGIS)[9], and British Society of Gastroenterology (BSG)[10]. 
 
In surgery, the main aspects of research are almost always focused on improving 
surgical outcomes. Randomised control trials or comparative studies to find the best 
method of practice are necessary to inform clinicians about the best types of practice or 
surgery. Guidelines are later developed based on these studies. However, such primary 
studies that inform these guidelines are difficult and expensive to conduct. 
1.2 Traditional research and data 
Conventional datasets are the traditional method of collecting data. These are normally 





analysed by the same team collecting them and the results will be published thereafter. 
Prospective data are often collected as part of randomised control trials or other types of 
studies such as cohort studies. The data are often complete and rigorously collected. 
There is a lot of effort made to design the study and what types of information are 
needed. They are collected for certain periods of time for a specific reason. Therefore, 
these datasets, although robust, are limited in breadth. 
 
Sometimes researchers decide to review the clinical data retrospectively to perform 
retrospective studies. They review patient case notes and review what happened to 
those patients. These studies, whilst useful, are likely to be broad but limited in 
robustness. 
1.2.1 Meta-analysis and Systematic Review 
Meta-analysis is regarded as the most powerful tool to inform practitioner about certain 
level of evidence. A good meta-analysis is always considered as level one in the 
evidence of Medicine tool kit. Some databases such as Cochrane, is regarded as the 
ultimate evidence-based medicine for any particular research[11]. 
 
A good systematic review can be given a similar level of evidence to meta-analysis. 
According to the centre for Evidence-Based Medicine, Systematic review of 
randomised control trials with good homogeneity is given level 1A. where is systematic 
review of cohort studies with good homogeneity is given level 2A, and systematic 
review of case control studies with good homogeneity is given level 3A[12].  
 
Although Cochrane reviews regarded as the ultimate level of evidence, it is not 





insufficient data. For example, Wake et al in 2005 attempted to assess Transabdominal 
Pre‐Peritoneal (TAPP) vs Totally Extraperitoneal (TEP) laparoscopic techniques for 
inguinal hernia repair. They found there are 8 studies but no randomised control trials. 
They concluded that there was insufficient data to allow conclusions to be drawn about 
the relative effectiveness of TEP compared with TAPP. Efforts should be made to start 
and complete adequately powered RCTs, which compare the different methods of 
laparoscopic repair[13]. However, such a study is yet to be conducted (last checked in 
Jan 2020). 
 
Meta-analyses are not without their weaknesses. Selection bias is one of the quoted 
weaknesses of them. It has been suggested by Dickersin et al in 1994 that a small 
modification in search criteria, may results in a significant effect  on the number of 
studies selected[14]. Another weakness is publication bias. Positive results are more 
likely to be published than negative ones. Turner et al in 2008 showed 97% of studies 
with positive results are published compared to only 12% where the results were 
negative when they analysed  antidepressant[15]. This will lead to biased results when 
conducting meta-analysis. Heterogeneity of data is another weakness of meta-analysis. 
Despite best effort of researchers to produce well designed meta-analysis, there are 
factors that they found very difficult to adjust for such as heterogeneity of the data and 
availability of the data[16, 17]. Finally, if the methodology used for meta-analysis is not 
robust enough, it can produce confounded results that can be detrimental to patient care 
[18]. 
1.2.2 Randomised Control Trial 
Randomised Control Trials (RCTs) are the second most important level of evidence. A 





is a study in which people are allocated at random to receive one of several clinical 
interventions. One of these interventions is the standard of care. The control may be a 
standard practice, a placebo, or no intervention at all. It measures and compares the 
outcomes after the participants receive the interventions. 
 
RCTs are difficult to conduct and requires a lot of collaborations, funding, and 
commitments from many centres for a long period of time. For example, ROSSINI 2 
trial is currently recruiting patients[19]. The trial aim is to recruit 6610 patients from 64 
centres over a 2-year period. Although the trial is up to date with the recruitment 
process (Jan 2020), the commitment from these centres are crucial to complete the 
trials. Sometimes trial fails to recruit and has to be closed in the middle due to difficulty 
in recruiting patients such as PROSPER trial[20].  
 
Solheim in 2019 wrote an invited article about RCT in surgery. He stated “surgical 
RCTs are usually not done in stages and choosing the most appropriate endpoints and 
estimations about effect sizes and statistical power can therefore be difficult. As a 
result, most surgical RCTs are comparable with phase II drug trials and are therefore 
small and sometimes more explorative in nature. Second, recruitment may be 
problematic. Patients are often more reluctant towards invasive, risky, and non-
reversible interventions if the treating physician has no clear treatment 
recommendation. Also, operative treatments are usually not as common as drug 
treatments, and this affects recruitment. Third, pre-inclusion bias may be problematic, 
not at least in studies comparing surgery with non-operative treatment. Often, patients 





introduce expectation bias and reduce the likelihood of demonstrating an effect of 
further non-operative management”[21]. 
 
Although the above may be true for some surgical trials, there are a number of very 
good well-designed trials such as controlled trial of arthroscopic surgery for 
osteoarthritis. The researchers designed phase 2 trial and analysed the results to 
calculate the number of participants and then conducted phase three trial[22]. 
 
Practice in the real world is different from trials. The outcome in the real world may not 
reflect the results from RCT or be similar. Often these trials performed in certain 
centres which have better resources and different level of skills. These are often not 
available to the rest of the healthcare providers and therefore, transferring the 
experience may not be possible. In fact, even a surgeon who participates in RCT may 
not follow the results later, once the trials are finished[23]. 
 
Finally, RCTs are based on randomising patients but not surgeon. Surgical outcome 
varies considerably among healthcare providers and surgeons.  Therefore, performing 
multicentre RCT to compare surgical outcome may end up with biased results. For 
example, looking at the NBOCA[24] the 90 days mortality varies between zero and 
6%.. In pancreatic surgery the quoted mortality figure is between 1 and 3 % in tertiary 
centres of excellence. However, in non-academic centres the mortality figures could be 
as high as 11.4%[25]. This variability may skew the end results of any RCT. 
 
With the development of National Institute for Health Research (NIHR) and its huge 





significantly. It produced a framework for all patient and clinicians in the NHS to 
participate in multicentre trials. All clinicians have the ability to join national trials by 
registering their centre and themselves as principle investigator for their centre. This 
has resulted in many well-designed multicentre trials[26]. 
1.2.3 Cohort Study 
Cohort Study is conducted by following one or more samples (cohorts) prospectively to 
determine and evaluate the outcome of a specific intervention or disease and to identify 
what are the risk factors associated with it. As the study is conducted, outcomes from 
participants in each cohort are measured and relationships with specific characteristics 
determined. These studies are cheaper and easier to conduct than randomised control 
trials. Cohort study can also be standardized and matched to a control group[27]. 
1.2.4 Cross-sectional Study 
Cross-sectional Study is performed by collecting data on the whole population at a 
single point in time to examine the relationship between a health-related disease or 
intervention and other variables of interest[28]. 
 
Cross-sectional studies therefore provide a snapshot of the frequency of a disease or 
other health related characteristics in a population at a given point in time. This 
methodology can be used to assess the burden of disease or health needs of a population 
and is therefore useful in informing the planning and allocation of health resources 
1.2.5 Case Control Studies 
Case Control Studies compare patients who have a disease with patients who do not 
have the disease (controls) and look back retrospectively to compare how frequently the 
exposure to a risk factor is present in each group to determine the relationship between 






Case control studies are observational because no intervention is attempted and no 
attempt is made to alter the course of the disease. The goal is to retrospectively 
determine the exposure to the risk factor of interest from each of the two groups of 
individuals: cases and controls. 
1.3 Non-conventional large datasets 
These data are collected for a number of reasons. They are divided into three main 
categories. Cancer Registry Data which are collected by cancer network for auditing 
purposes. National Audits which are collected to audit national data and Administrative 
Data which are collected for non-clinical purposes. 
1.3.1 Cancer Registry Data 
In the UK, National Cancer Intelligence Network collects data on all cancer patients on 
a national level. The network is divided on a geographical basis and all hospitals within 
the area should follow that network. The data collected are mainly about cancer staging 
and other patient demography. While the aim is to have 100% accurate and complete 
data, the cancer network set a goal of 70% complete cancer staging record by 2013. 
They managed to achieve 76% but they admitted there are huge variations in data entry 
among health care providers and clinical commissioning groups[29]. 
1.3.2 National Dataset 
These are either national audits or national registry. They are often collected for certain 
periods of time and they require a great deal of collaboration and dedication on a 
national level. They can be performed on the good will of people such as Chole S study 
which is evaluation of cholecystectomy surgery over a two month period in over a 100 
hospitals[30]. Or they can be mandatory such as The National Emergency Laparotomy 
Audit NELA[31]. In order to perform such a massive audit, the group has to secure 





on the audit mandatory through the Healthcare Quality Improvement Partner (HQIP). 
Hospitals record their data regularly but the case assignment remains a problem to the 
auditor. Case assignment varies between 50 and 95%[31]. Similar problems occur in 
other national databases, such as National Bowel Cancer Audit Programme NBOCAP. 
Despite the fact they are mandatory and published per hospital and surgeon, they are 
incomplete. A simple look at the data will show the case ascertainment varies between 
different hospitals somewhere between 70 and 110%[24] .  
 
Another national Audit was established in the last couple of years called “Perioperative 
Quality Improvement Programme (PQIP)”.  Although, it is not mandatory, many 
hospitals are signing up to it. It is also organised and funded by The Royal College of 
Anaesthetists[32]. At the moment, the data are produced for audit purposes but they 
started working on research outcomes as well. In all these audits, one can expect the 
data to be accurate and complete but they are not validated by external audit.  
1.3.3 Administrative Data 
Health care administrative data are generated at every encounter with the health care 
system, whether through a visit to a physician’s office, a diagnostic procedure, an 
admission to hospital, or receipt of a prescription at a community pharmacy. The terms 
“Health Care Utilization Data”[33], “Administrative Health Care Billing Records”[34], 
“Administrative Claims Data”[35], or simply “Claims Data” are synonymous with 
“health care administrative data”. These data are collected for administrative or billing 
purposes, yet may be leveraged to study health care delivery, benefits, harms, and 
costs[35]. They are often collected for administrative purposes by non-clinical staff 
such as clinical coders. There are many data available in the UK and internationally. 





1.3.3.1 International Dataset 
Most developed countries have some sort of administrative data that has the potential to 
inform research. 
1.3.3.2 American Dataset 
The National (Nationwide) Inpatient Sample (NIS)[36] is the largest publicly available 
all-payer inpatient care database in the United States. It contains data from 
approximately 8 million hospital’s admissions each year. Restricted access data files are 
available with data use agreement and brief online security training. The 2012 NIS was 
redesigned. The new NIS is a sample of discharges from all hospitals participating in 
Healthcare Cost and Utilization Project (HCUP). For prior years, the NIS was a sample 
of hospitals. The NIS allows for weighted national estimates to identify, track, and 
analyse national trends in health care utilization, access, charges, quality, and outcomes. 
The NIS is drawn from States participating in HCUP. NIS data are available since 1988, 
allowing analysis of trends over time. The NIS includes charge information for all 
patients, regardless of payer, including persons covered by Medicare, Medicaid, private 
insurance, and the uninsured. 
1.3.3.3 Danish Dataset 
There have been several studies from Denmark using the national administrative 
database or a combination of both administrative and clinical databases by linking both 
datasets. There are four different nationwide registers: The Danish National Patient 
Register, The Danish Civil Registration System, The Danish Register of Medicinal 
Product Statistics, and The Danish National Health Service Register for Primary Care. 
Each dataset has different criteria, which can be used for certain types of research. 





comparing different Danish Regions Regarding Demographic Characteristics, 
Healthcare Utilization, and Medication Use-A Descriptive Cross-Sectional Study[37]. 
1.3.3.4 Swedish Dataset 
The Swedish National Inpatient Register (IPR), also called the Hospital Discharge 
Register, is a principal source of data for numerous research projects. The IPR is part of 
the National Patient Register. The Swedish IPR was launched in 1964 (psychiatric 
diagnoses from 1973) but complete coverage did not begin until 1987. Currently, more 
than 99% of all patients including surgery and psychiatric hospital discharges are 
registered in the IPR. A previous validation of the IPR by the National Board of Health 
and Welfare showed that 85-95% of all diagnoses in the IPR are valid[38]. 
1.3.3.5 UK Dataset 
There are three main datasets. Hospital data, General practice data and the Office of 
National Statistics mortality data. 
1.3.3.5.1 Hospital Dataset (Hospital Episode Statistics) 
In England, all healthcare providers should convert their patient’s journey in the 
hospital into clinical codes. They use international classification of disease (ICD 
10)[39] codes for the diagnosis and Classification of Interventions and Procedures 
version 4 (OPCS 4) for the operative and intervention codes[40]. They have strict rules 
they should follow and all patients case notes should be translated into clinical codes 
within 30 days of discharge. Once this is completed, another code (Health Resource 







The data is then submitted to the NHS digital by each health care provider to get paid 
for the work they carried out in their hospital. This is called Payment by Results. The 
data is then collected by the NHS Information Centre and Hospital Episode Statistics 
(HES data) created. 
1.3.3.5.2 Office of National Statistics Mortality Dataset 
The Office of National Statistics (ONS) collects and keeps all records of death that 
occur in the UK[42]. ONS produce data on a monthly basis about all deaths, cause of 
death, place and date of death. These data are linked to HES data so researchers can 
access them to produce a better understanding of mortality in hospital and following 
discharge. 
1.3.3.5.3 GP Dataset 
There are 3 main types of data. 
1.3.3.5.3.1 The General Practice Research Database (GPRD) 
GPRD is the world's largest database of anonymised longitudinal medical records from 
primary care[43]. It contains comprehensive observational data from clinical practice; it 
is a valuable tool for academic research in a broad range of areas including clinical 
epidemiology, disease patterns, disease management, outcomes research, and drug 
utilisation. GPRD is a highly valued resource by Pharma and Biotech Companies 
because of its high-quality longitudinal person specific records that enable drug safety, 
outcomes and economic research. The ability to link data from hospital or disease 
registers adds to this capability. The data available are between 1987 and 2010. The 






1.3.3.5.3.2 Clinical Practice Research Datalink (CPRD) 
CPRD is primary care and linked data that offers a high-quality source of complete and 
representative healthcare information for investigating the nature and cause of 
disease[44]. CPRD collects fully-coded patient electronic health records from GP 
practices across the UK. Primary care data held by CPRD includes over 20 million 
patient lives, with over 5 million currently registered and active patients, representative 
of the UK population with respect to age, gender and ethnicity. All data are anonymised 
to protect the identity and confidentiality of patients. Access to CPRD is subject to 
protocol approval by and Independent Scientific Advisory Committee. 
1.3.3.5.3.3 The Health Improvement Network database (THIN) 
The Health Improvement Network (THIN) represents collaboration between two 
companies; In Practice Systems (INPS) - who developed Vision software used by 
General Practitioners (GPs) in the UK to manage patient data, and IMS Health who 
then provide access to the data for use in medical research[45]. THIN data are collected 
during routine practice and regularly delivered to THIN. Since THIN data collection 
began in 2003, over 500 Vision Practices have joined the scheme. 
 
Research studies for publication conducted using THIN data are approved by a 
nationally accredited ethics committee which has also approved the data collection 
scheme. The UCL Research Departments Primary Care & Population Health (PCPH) 
and Infection & Public Health (IPH) have acquired a full license to THIN for the 







THIN data currently contains the electronic medical records of 11.1 million patients 
(3.7 million active patients) equivalent to 75.6 million patient years of data collected 
from 562 general practices in the UK, covering 6.2% of the UK population. All data are 
fully anonymised, processed and validated by CSD Medical Research UK. 
1.4 Benefit and drawback of non-conventional data 
A meta-epidemiological survey of 337 Studies that use routinely collected health data 
shows that the most common reason why researchers use routine data are limited 
generalizability of trial results to the "real world" (37.6%), evaluation of specific 
outcomes (31.9%) or specific populations (23.5%), and inconclusive or inconsistent 
evidence from randomized trials (25.8%)[38]. 
 
Routine data are freely available and cheap. As the data is routinely collected by 
hospitals for administrative purposes, they do not cost a lot of money to use. In fact, in 
most cases they are available by non-profit government organisation for research 
purposes. They often charge administrative fees for data handling. Data analysis 
requires training and experience but it is not impossible or out of proportion. Routine 
administrative data can be used to assess all centres in the country and all patients. 
Therefore, it can give a true reflection on the current practice and can identify problems 
in the current practice among healthcare providers. 
 
It is very good at giving a broad view about the practice and changing practice for the 
coded procedures. By analysing several years, researchers can understand the shift in 






Large datasets are very good at investigating hospital volume and consultant caseload in 
association with surgical outcome[46, 47]. Such analysis is unique to those large 
datasets because of the size of the data and number of operations provided by each 
surgeon/ healthcare providers. Because large administrative data reflect the whole 
practice across the nation, these studies are population based and therefore do not 
require sampling power. Some of these studies assess hundreds of thousands of 
patients[48]. 
 
The drawbacks of these large routinely collected data are the following. There is a 
problem with large data sets that are collected due to the potential sources of error at the 
point of data entry. Miscoding is another weakness of these data. Data error could be 
produced because of typing error, poor documentation in the original patient notes, 
misinterpretation of the patients’ notes and when there is no specific code that describes 
the diagnosis or procedure.  
 
Research from large datasets give a very good global picture of the current problem 
such as recurrence of a hernia and the outcome can be assessed immediately. Whereas 
large multicentre trials can give a similar result but require years to design, develop and 
publish.   
 
Large data sets lack a lot of information such as the significance of comorbidity (e.g. 
grade of heart failure or COPD), significance of ischaemic heart disease. The sequence 
of comorbidity. For example, if a patient developed angina and he was treated by 
cardiac stent and now the patient is asymptomatic is completely different from a patient 





Research from large data sets is very good to give a global picture but struggle with 
details and therefore, it should act as complementary to traditional research and not as a 
replacement.  
1.5 Hospital Episode Statistic (HES) 
The history of HES dates back to 1982 when the government in the white paper 
“liberating the NHS” has established a system to collect and use hospital activity data to 
secure good quality outcome and inform patient’s choice. A steering group chaired by 
Dame Edith Körner published a report on the collection and use of hospital activity 
information in 1982[49]. A 10% sample collected nationally of patients admitted to the 
National Health Service (NHS) in England was established and it was mainly to give a 
rough idea about hospital activities. Later Körner report has resulted in the formation of 
Hospital Episode Statistics Data (HES) that was established during 1987. HES were 
published for the first time during the financial year 1989-90 and continued since then. 
Initially, the data collection was made by regional health authorities, and as a result of 
the changes in the NHS, these bodies were abolished and the NHS-Wide Clearing 
Service (NWCS) was established to collect and store HES data. In 2006 the National 
Programme for IT (NPfIT's) and Secondary Uses Service (SUS) took over this job. 
 
HES have evolved dramatically in the last 2 decades to reflect the changes in the NHS 
and the new requirement of the hospital policy changes. In addition, several systems of 
classifications were introduced. The data depends on 3 systems: The International 
Classification of Diseases (ICD) that represents diagnosis; the Office of Population, 
Censuses and Survey (OPCS) that represents operations and procedures; and Health 
resource Group (HRG) that is used for payment. In 1995, the ICD changed from 9th 





as an upgrade from the previous version of OPCS 4.3. Augmented data i.e. critical care 
data, was introduced during 1997. 
 
The data in its current form contain details about every single patient treated by the 
NHS Trusts in England, including acute hospitals, primary care trusts, mental health 
trusts, and the independent sector, such as treatment centres and care given to private 
patients in NHS hospitals. 
 
From 1989 HES contain all information about inpatients, whereas out-patients data 
were added from 2003 and Accident and Emergency data were added in 2008. During 
2007 over 16 million records of inpatients data were collected nationally. The data is 
collected by each NHS Trust, PCT, and Independent Treatment Centre and sent to the 
NHS Information Centre (NHSIC) each month. The data is managed by a private 
company “Northgate” that stores and cleans the data according to defined protocols. 
The data is then anonymised and provided to end users by “Northgate” under the 
supervision of the NHSIC. The NHSIC was recently demolished and NHS digital has 
taken over its role as well as many other activities. 
1.6 Measurement of Surgical Outcomes using HES Data 
Before embarking on the research, a question was raised question whether HES data 
can be used to measure surgical outcomes and what are the evidence for that. In 1995, 
there was a significant incidence at Bristol with high mortality of paediatric cardiac 
surgery. This led to a national public inquiry. The report of Bristol inquiry chaired by 
Ian Kennedy showed a need for changes to the NHS culture and management[50]. The 
inquiry was set up in 1998 to investigate the deaths of 29 babies undergoing heart 





provided a blueprint for wider reform of the NHS[51]”. The government published a 
new policy of first-class service for all NHS patients and quality in the new NHS in 
1998[52]. A definition of clinical governance was introduced and The clinical 
governance became a fundamental part of the NHS and it is directly report to the Trust 
board[6]. The NHS Plan: a plan for investment, a plan for reform (2000) pledged a 
significant increase in the NHS budget and significant cultural changes to the NHS[53]. 
 
A group from Imperial College investigated the mortality of paediatric cardiac surgery 
from HES and from Cardiac Surgical Registry (CSR). Their aim was to investigate 
whether Bristol mortality results can be identified from administrative data. Data from 
the CSR (January, 1984, to March, 1996) and HES (April, 1991, to December, 1995) 
were obtained for all 12 major centres in England in which paediatric cardiac surgery is 
done. Two age-groups were defined: children younger than 1 year and children aged 
between 1 and 15 years. Two different classifications of operative procedures were 
used: the first comprised broad classes of either open (requiring cardiopulmonary 
bypass) or closed operations, and the second consisted of 13 procedure groupings (11 
open, two closed). For the HES data, mortality rate was based on admissions for whom 
discharge status was known (discharge home, transfer to another hospital, or death in 
hospital). Admissions with unknown discharge status were excluded.  
 
Three stages of analysis were undertaken. First, overall mortality within each epoch was 
estimated with 95% CIs. Second, expected mortality in Bristol was estimated, allowing 
for between-centre variability. Specifically, within each procedure group they modelled 
between-centre variability using a variance-components (random-effect) model for the 





with Bristol level of activity was then predicted, and excess deaths in Bristol were 
estimated by subtracting these expected numbers from the observed numbers of deaths. 
The entire analysis was then repeated in turn for each of the remaining centres. And 
finally, traditional analysis to assess statistical significance and robustness. 
 
They showed for children younger than 1 year, in open operations, the mortality rate in 
Bristol was around double that of the other centres during 1991–95: within the CSR, 
there were 19.0 excess deaths (95% Confidence interval 2–32) among 43 deaths; and in 
HES, there were 24.1 excess deaths (12–34) among 41 deaths recorded. There was no 
strong evidence for excess mortality in Bristol for closed operations or for open 
operations in children older than 1 year[54].  This shows HES can be used to measure 
outliers in surgical mortality and it can be used to assess healthcare providers with a 
very good degree of confidence.  
 
The same group looked at HES data again and published their results in the British 
Medical Journal in 2004[55]. They investigated the trends in mortality of open cardiac 
surgery in children in Bristol and England between 1991 and 2002. They used similar 
methodology and selection criteria as previous mentioned. Their main outcome was 
Mortality in hospital within 30 days of a cardiac procedure.  
 
They identified 5221 open operations between April 1996 and March 2002 in children 
under 1 year and 6385 in children aged 1-15 years. Mortality for all centres combined 
fell from 12% in epoch 3 to 4% in epoch 6. Mortality in children under 1 year at Bristol 
fell from 29% (95% confidence interval 21% to 37%) in epoch 3 to 3% (1% to 6%) in 





to fewer high-risk procedures or an increase in the numbers of low risk cases (figure 1). 
Their work was a landmark in the use of HES data to measure mortality. The original 
work showed HES can be used to identify the problem and it can also be used to 
measure the effect of an intervention on patient outcome as in the second paper. 
  
Figure 1: Mortality (based on admissions with known outcome) for and number of open 
operations on children aged under 1 year from April 1991 to April 2002 in 11 English 
centres; data derived from hospital episode statistics[55].  
 
From this example, we can conclude with good confidence that HES can be used to 
measure mortality and the impact of any intervention. This raised the question whether 








1.7 HES reliability 
We have shown earlier HES can be used to measure mortality and the impact of 
intervention in the mortality. However, one cannot be sure how reliable administrative 
data.   
 
There are 2 systematic reviews of clinical coding accuracy in the literature. The first 
was published in 2001 by Campbell et al[56]. The systematic review search found 30 
papers. Only 21 papers were from the UK and were reviewed (12 from England and 
Wales and 9 from Scotland). Accuracy of coding varied between 53% and 100% over 
the 39 datasets, with a median of 90%. Procedures and operations were generally coded 
more accurately than diagnoses.  
 
In the 14 datasets concerned with OPCS codes (operative codes), accuracy ranged from 
53% to 100%, with a median of 97%.  The 25 ICD (diagnostic codes) datasets varied in 
accuracy from 53% to 98%, with a median of 84%. Overall accuracy rates were similar 
in Scotland to those in England and Wales. The median accuracy rates were 89 per cent 
(range 53–100 per cent) for the 22 Scottish datasets and 90% (range 53–100%) for 
those in England and Wales. Strong trends suggesting differences emerge when 
diagnostic and procedural codes are considered separately. The median accuracy rate 
for diagnostic codes in Scotland is 82% (range 53–98%; 14 datasets) compared with 
91% (range 74%–98%; 11 datasets) in England, Wales and Northern Ireland. For 
procedural codes, accuracy rates are higher in Scotland (median 98%, range 85–100%; 
eight datasets) than in England, Wales and Northern Ireland (median 69.5% (range 53-






The study concluded “Coding accuracy on average is high in the United Kingdom, 
especially for operations and procedures. However, policy-makers, planners and 
researchers need to recognize and account for the degree of inaccuracy in routine 
hospital information statistics. Further research is needed into methods of improving 
and maintaining coding accuracy”.  
 
Another systematic review was published in 2011 by Burns et al[57]. The authors 
concluded “Accuracy rates are improving. Current levels of reported accuracy suggest 
that routinely collected data are sufficiently robust to support their use for research and 
managerial decision-making”. The authors reviewed 32 articles which investigated the 
accuracy of clinical coding. 25 of them compared routinely collected data directly with 
patients’ case notes or operation notes. Only 14 studies were from England and the rest 
were from either Wales or Scotland. The authors also reviewed 7 other studies which 
compared routinely collected data with clinical registries. 5 of them were from England 
and 2 from Scotland. The overall median accuracy was 83.2% (IQR: 67.3–92.1%). The 
median diagnostic accuracy was 80.3% (IQR: 63.3–94.1%) with a median procedure 
accuracy of 84.2% (IQR: 68.7–88.7%). 
 
When the author compared those studies that included data prior to the introduction of 
Payment by Results (PBR) in 2004 and those afterwards, the accuracy improved from 
[pre-PbR 77.0% (IQR: 66.2–89.0%) to post-PbR 86.1% (IQR: 73.1–96.1%)]. The 
accuracy of the primary diagnosis also improved from [73.8% (IQR: 59.3–92.1%) to 
96.0% (IQR: 89.3–96.2%). There was no difference in overall accuracy between 
multiple hospital and single site data sets. When Scottish studies were compared with 





diagnosis accuracy. Those studies that used random sampling for case selection had 
lower median accuracy [random accuracy 83.1% (IQR: 68.0–88.2%) versus non-
random 93.7% (IQR: 90.3–95.0%).  
 
The author (Burns) also looked at studies that compare HES data to another database 
such as registry data. They found 7 studies (5 from England and 2 from Scotland). One 
of the studies is using data from the eighties, leaving only 4 from England. One study 
examined Clostridium difficile rates reported on HES database against those reported to 
the Health Protection Agency (HPA). This showed recording of C. difficile infection to 
be higher from HPA data than from HES data. In contrast, compared with HPA data for 
orthopaedic SSIs, there were many more SSIs and numbers of procedures recorded 
from HES data for all four orthopaedic procedures, although the infection rates 
themselves were broadly similar. These findings reflect the limitations of both methods 
used and the author suggested that there is a case for using both sources of 
information[58]. 
 
The second paper is to compare patient volume and outcomes in vascular surgery 
between an administrative data set (Hospital Episode Statistics) and a clinical database 
(National Vascular Database). HES data recorded twice as many procedures as the 
National Vascular Disease (NVD) registry (HES n= 16 923 and NVD n= 8462) with 
slightly higher death rates recorded on HES (HES, 18% and NVD, 15%). The study 
concluded that there are significant differences in total numbers between HES and the 
NVD. If the National Vascular Database is to become a credible source of information 





number of contributing surgeons and to increase the completeness of data 
submitted[59].  
 
A similar study compared HES and the Association of Coloproctology of Great Britain 
and Ireland (ACPGBI) colorectal cancer database. The study found a higher number of 
colorectal procedures reported on HES (HES n= 7516 and ACPGBI n= 6617) with 
comparable overall mortality at a national level [HES 418 (5.6%) versus ACPGBI 383 
(5.8%), P= 0.416][60]. This paper again showed HES data is superior to specialist data 
registry. 
 
The last paper compared HES data and Central Cardiac Audit Database (CCAD). The 
study found a higher number of reported infant cardiothoracic procedures on the CCAD 
than on the HES (HES, n= 1745 and CCAD, n= 2182). The reported mortality was 
lower on HES than on CCAD [HES n= 74 (4.2%) versus CCAD n= 139 (6.4%)]. 
However, the two datasets differed in the types of procedures included in the analysis 
with all procedures included in the CCAD and a limited number included in the HES 
data analysis. The definition of 30-day mortality differed between data sets, with HES 
recording only those deaths in hospital and the CCAD including all deaths in and out of 
hospital. Thus, the comparison was inhibited by different coding systems and difficulty 
in defining the same procedures and outcomes[61]. 
 
Elaine Burns et al (2011) suggested clinical registries are purpose-built databases for 
prospective data collection. In contrast to the inclusive mandatory administrative data 
sets, clinical registries are mostly voluntary. They will not include all patients with a 





The second systematic review has shown good data accuracy and it provides good 
evidence to accept research performed from HES. The authors in their discussion 
acknowledged the limitations of their findings and the heterogeneity of the data that 
prevented them from performing meta-analysis. They discussed what constitutes a 
reliable data with data accuracy aims for 100% accurate or more realistic 95%. 
However, their findings of median 86.1% (IQR: 73.1–96.1%) for procedure codes and 
96.0% (IQR: 89.3–96.2%) for diagnostic are acceptable for research. They concluded 
Accuracy rates are improving. Current levels of reported accuracy suggest that routinely 
collected data are sufficiently robust to support their use for research and managerial 
decision-making[57]. 
1.8 General Surgery 
As discussed, earlier HES data can be used to measure outcome (mortality) and 
discussed the systematic review of administrative data reliabilities. One can say that 
HES is a good data for measuring outcomes. An evaluation of surgical outcomes in 
general surgery is discussed in the thesis.  
 
Surgery as a branch is very wide, it covers, General Surgery, Orthopaedic Surgery, 
Urology, Otolaryngology, Ophthalmology, Neurosurgery, Cardiac Surgery, Thoracic 
Surgery, Paediatric Surgery and Transplant Surgery. General Surgery used to cover 
many of these specialities until it was decided to make them a speciality by itself such 
as urology and paediatric surgery. General surgery at the moment covers a number of 
sub-specialities like colorectal surgery, upper GI surgery, Hepatopancreatobiliary 
surgery, vascular surgery, and breast and endocrine surgery. All general surgeons are 
able to perform emergency surgery such as appendicectomy and elective surgery such 





This thesis is aimed at developing an approach to evaluate surgical outcomes of general 
surgery using HES data. Because the field of general surgery is very wide, the research 
will be limited to common surgical pathologies, i.e. it should be a pathology treated by 
all general surgeons, and the patient with these diseases should present to the general 
surgeon and not to the specialist surgeon such as stomach cancer. 
A decision was made to choose common surgery from general surgery, lower GI 
surgery and upper GI surgery. 
• General surgery (inguinal hernia repair). Inguinal hernia is very common. Each 
year, over 62,000 patients undergo surgery in England as discussed later in the 
thesis. 
• Upper GI surgery (Gallstone and gallbladder). Gallstone and cholecystectomy is 
very common problem in surgery. Each year there are over 45,000 patients 
undergo surgery in England as discussed later in the thesis. 
• Lower GI surgery (large bowel resection and surgery for rectal prolapse). 
Elective and emergency large bowel resection comprise the majority of lower 
GI surgery and each year there are over 35,000 operation performed in England 
as discussed later in the thesis. 
From the general surgery inguinal hernia was selected for the research. Inguinal hernia 
is the most common surgical operation that all surgeons are able to treat. Inguinal 
hernia can be treated by open surgery or laparoscopic surgery. The outcomes of 
inguinal hernia were defined and a comparison between open and laparoscopic 
approaches was performed. 
 
The most common upper GI surgery condition is Gallstone disease. The gallstone can 





cause symptoms from passing into the bile duct and cause obstructive jaundice and 
gallstone pancreatitis. Patients with gallstone disease offered cholecystectomy 
(gallbladder removal). Patients undergoing cholecystectomy can develop a number of 
complications. Bile duct injury is the most important complication and the research will 
aim at investigating bile duct injury rate and factors that may contribute to it.   
The gallstone may not cause symptoms in the gallbladder and they may pass into the 
bile duct and cause either obstructive jaundice or gallstone pancreatitis. Gallstone is the 
most important cause of pancreatitis and they account around 50% of all cases of 
pancreatitis. Patients should undergo cholecystectomy during index admission or within 
2 weeks of discharge from index admission[62]. The research will investigate 
compliance with this guideline and the outcome if the patients do not receive the 
treatment within this time.  
 
From lower GI surgery, bowel resection surgery was selected. Bowel resection is very 
common and they could be performed as an emergency or elective. Although almost all 
elective surgery is performed by the colorectal surgeons, emergency surgery is 
performed by all General Surgeons. Patients undergoing bowel resection may develop a 
number of complications such anastomosis leak, bleeding, infection etc… one of the 
important complications that is not very well studied is Venous Thromboembolism 
(VTE) following surgery. The research will investigate the rate of VTE following 
bowel resection, timing of the VTE and factors associated with VTE. 
 
The last topic selected for the research is surgery for rectal prolapse. Although this is 
more of colorectal speciality, it is very important. Surgery for rectal prolapse is 





keen to restrict surgery for those patients to only surgeon with special interest in pelvic 
floor surgery. The research will investigate the changing trends in surgery for rectal 
prolapse and look at different types of surgery. The study will also explore the number 
of surgeons performing surgery and whether surgery for rectal prolapse should be 
offered by a specialist surgeon.  
1.9 Surgical outcomes 
Recently the government encouraged the relative royal colleges to publish surgeon 
outcomes. The Royal College of Surgeons of England for example is working toward 
improved methods of ensuring high standards in surgical practice through public 
reporting of operation outcomes. A reliable system of measuring outcomes will have 
many benefits[63]: 
 Greater public transparency and accountability. 
 Enable surgeons a better basis for judging and improving their practice. 
 Offer patients the basis to make informed choices about their care. 
 Evidence for service improvement and quality assurance of operations. 
 Better data for health service commissioners when making funding decisions. 
Surgical outcomes are very broad terms that include many outcomes and these are the 
main ones.  
1.9.1  Mortality 
Perioperative mortality is the most important outcome of surgery. It can be either 
observed (crude) mortality rate or Standardised Mortality Rate (SMR). Crude mortality 
rate where the results represent the true figure without any adjustment whereas SMR is 
defined as the ratio of observed deaths in a study group to expected deaths in the 





for it (sometimes it is called age specific mortality rate). However, in the last 15 years, a 
number of other factors were used to adjust for standardised mortality ratio such as age, 
gender, comorbidity, and social class, and other factors[64]. 
 
Mortality is often reported over a specific period of time. In-hospital mortality is 
defined as death during index admission regardless of the time period. Other method of 
reporting perioperative mortality rate is to specify a specific time period following the 
index surgery. This could be reported after 30 or 90 days postoperatively and called 30-
day postoperative mortality and 90-days postoperative mortality rate.  
 
The benefit of in-hospital mortality it covers the whole patient admission until 
discharge and it often occurs when the patient is well and fully recovered from surgery 
regardless of the time; i.e. patient could remain in hospital for 4 months and die and this 
patient will be missed if we use 30- or 90-days mortality. However, the drawback of 
such measurement it excludes all deaths occur following discharge. 30 days 
postoperative mortality is the preferred method in most literature, however the preferred 
method of describing perioperative mortality following surgery in the UK in colorectal 
cancer surgery is 90 days from date of operation[24]. 
 
The reported 90 days postoperative mortality includes all deaths that occur within this 
time period, even if the death occurs due to natural causes and not related to the actual 
surgery. The argument of the government is this rule applies to every surgeon and 
therefore, it shouldn’t discriminate between surgeons or hospitals[65]. There are some 






1.9.2 Morbidity and Complications 
Morbidity and complications are the second most measured outcomes in surgical 
practice after mortality. In any research that involves surgery morbidity is always 
measured and the figures are very important to inform the readers and patients about the 
complication rate and what they may experience in the perioperative period. Morbidity 
varies from simple surgical site infection or urinary tract infection to multiorgan failure. 
In general, the complications can be divided into surgical complications such as those 
directly related to surgery such as bleeding, collection, anastomotic leak, and injury to 
other organs during surgery; and systematic complications such as chest infection, 
Venous thromboembolism, myocardial infarction, and renal failure. Another 
classification of morbidity is early and late complications. Early complications are the 
ones that occur in the immediate postoperative period. Late complications, on the other 
hand, are the ones that occur many months following surgery such as recurrence of 
hernia operation or venous thromboembolism. 
The Royal College of Surgeon of England has issued guideline that all hospitals should 
run a monthly meeting of morbidity and mortality (M&M) so hospitals monitor their 
practice and constantly improve the quality of care delivered to their patients[67]. 
1.9.3 Length of stay 
Length of hospital stay is often considered a marker for efficiency. The average cost per 
bed day varies between £222 (2015/16 Enhanced Tariff Option)[68] to £400[69]. 
Therefore, hospitals that discharge patients a day earlier than their counterpart will save 
a considerable amount of money by freeing hospital beds. Hospital stay of patients is 
often determined by many factors such as patients’ premorbid conditions, operative 







1.9.4 Readmission rate 
Another parameter that can be used to measure surgical outcome is readmission 
rate[71]. This is often measured over a certain period of time (normally 30 days) and it 
indicates failed discharge. Hospitals in the NHS at the moment are penalised for any 
readmission and they are not paid for the readmission[72]. Recently, some hospitals 
started auditing this practice and all cases discussed in their weekly M&M meetings and 
they discuss whether the readmission was related to surgery or not. If not, they amend 
their results of readmissions[73]. 
 
Readmission rate should always be measured in addition to the length of stay. This is 
because both parameters are related to each other. Early discharge is often associated 
with higher readmission rate and longer hospital stay is associated with lower 
readmission rate. Hospitals who keep their patients longer in the hospital will allow for 
all complications to occur while patients are still hospitalised.  Therefore, their 
readmission rates are often low. On the other hand, hospitals that discharge their 
patients early often have a higher readmission rate in general as some patients will 
develop certain complications a few days later and require readmission[74]. 
1.9.5 Patient satisfaction, reported outcome, and quality of life 
One of the important aspects of measuring surgical outcome is to measure patient 
satisfaction with their treatment; patient reported outcome survey of operations and 
their quality of life. While patients may survive an operation, they may not be happy 
with the outcome of surgery. Their unhappiness may be related to the hospital journey 
or because they had a bad experience with a particular person. These are often 
measured by hospitals locally. Hospitals often record patient feedback (complaints and 
compliments). Hospitals also measure their patients’ satisfaction by sending surveys to 





publishes these data on a monthly basis and each NHS Trust publishes their results on a 
monthly basis for each speciality. These types of patient satisfaction surveys are more 
directed at patient and family experience from the service they received. 
 
Patient Reported Outcome Measures (PROMs) are collected nationally by all NHS 
Trusts[76]. It is designed to assess the quality of care delivered to NHS patients from 
patient perspective. Currently covering four clinical procedures, PROMs calculate 
the health gains after surgical treatment using pre- and post-operative surveys. It is 
delivered for four procedures: hip replacements, knee replacements, groin hernia, and 
varicose veins surgeries. 
 
PROMs have been collected by all providers of NHS-funded care since April 2009. 
PROMs measure a patient’s health status or health-related quality of life at a single 
point in time, and are collected through short, self-completed questionnaires. This 
health status information is collected before and after a procedure and provides an 
indication of the outcomes or quality of care delivered to NHS patients. 
 
Quality of life of patients after certain surgical intervention has been developed for 
years and they represent a significant part of patient’s outcome. There are general 
quality of life survey and disease specific quality of life. General quality of life index is 
a survey sent to patients with a number of qualities of life aspect. There are a number of 
these survey such as 36-item short form survey[77] and the Rand -36[78] where 36 
different aspects of life are measured. They measure quality of life in general and can 
be used following every operation. Another method to measure quality of life following 





pelvic floor surgery. For example, constipation related quality of life[79] and the Faecal 
Incontinence Quality of Life scale (FIQL)[80]. 
1.10 Aim and Objectives 
Most of surgical researches are based on surgical outcomes. The research that can 
inform the risk analysis is normally derived from published prospective clinical trials or 
retrospective analyses of existing datasets. However, restricting the information to only 
the traditional research sources has limitations, however, there are other valuable 
sources of information a surgeon can draw upon. The aim of this thesis is therefore, to 
explore one such source of information. The Hospital Episode Statistics (HES) is a 
national data warehouse of all National Health Service (NHS) patients treated in NHS 
hospitals or private hospitals. The process of extracting data from the HES is not a 
trivial task and within this thesis there is an added aim of developing a methodology to 
convert HES (administrative data) into useful clinical data that can be used to study 
surgical outcome. To develop an algorithm to cover all surgical outcomes will be 
beyond the scope of a PhD and therefore for the purposes of this thesis, the aim is to 
develop and validate a protocol for the following five objectives: 
1. Can HES data be used to identify rare complications when the code is available? 
2. Can HES data be used to identify rare complications when the code is not 
available? 
3. Can HES data be used to compare different types of surgery for the same 
condition? 
4. Can HES data be used to measure changing trends in surgical practice? 





For each of these objectives, A different surgical pathology will be used. This research 
will be limited to common pathologies that are seen by all general surgeons on a regular 
basis. One or two examples from each subspecialty of general surgery is chosen as 
follows. 
• General surgery (inguinal hernia repair) 
• Upper GI surgery (gallstone and gallbladder) 





2 Literature review 
As discussed in the previous chapter the aim of thesis is to evaluate surgical outcomes 
using hospital administrative data and 5 objectives were set to deliver the aim: an 
example was selected for each objective as follow. 
1. Can HES data be used to identify rare complications when the code of this 
complication is available? 
o Example used: Venous Thromboembolism following Bowel resection. 
2. Can HES data be used to identify rare complications when the code is not 
available? 
o Example used: Bile duct injury following laparoscopic cholecystectomy. 
3. Can HES data be used to compare different types of surgery for the same 
condition? 
o Example used: Compare laparoscopic and open inguinal hernia. 
4. Can HES data be used to measure changing trends in surgical practice? 
o Example used: Surgery for rectal prolapse. 
5. Can HES data be used a national audit tool? 





2.1 Literature review 
The aim of the literature review is: 
• Identify if any of the objectives has been investigated in the past from HES data. 
An example from general surgery was chosen for each objective. 
• Is there historical data from other source of data that answer these objectives 
(this will be discussed in the introduction of each study in the relevant chapter). 
A literature review is performed to identify if any research from HES data was studied 
in the past to answer any of these objectives. The literature review is focused on 
inguinal hernia, gall stone and bowel pathology as per objectives. The literature search 
is limited to years between 1990 (The start of HES data in 1989) and 2011 (The start of 
the part time PhD), adult patients, English language, and for studies that used HES data 
only. For each category, the search is divided into anatomy, disease or pathology, types 
of surgery or surgical procedures, and HES data. A thesaurus assessment of all terms 
used is performed and explode term is used if available. For HES data search, Some 
published studies do not use the term HES data or Hospital Episode Statistics in their 
abstracts. Terms such as in England or English database is used instead. Therefore, a 
searched for all studies with the term England was performed to capture all studies and 
then only papers that are relevant was selected. 
 
Healthcare Databases Advanced Search (HDAS) Engine is used for the literature 
search.  HDAS is provided in partnership between National Institute of Clinical 
Excellence (NICE) and Health Education England (HEE). The search is limited to 
Medline database only. The search was performed in July 2019. Due to technical reason 





publication between 1990 and 2011, English language, and adult age group” was 
applied to the last search. 
2.1.1 Inguinal hernia 
The aim of the literature review is to examine if any study from HES data that was 
performed in the past to investigate inguinal hernia repair. The aim of the objective in 
this example is to compare laparoscopic and open inguinal hernia repair. A literature 
search of all studies that used HES data to study outcome of inguinal hernia surgery 
was performed. All terms related to inguinal hernia anatomy was searched and only 
inguinal hernia was found. The second stage is to assess the terms for pathology which 
is inguinal hernia. There are a number of procedures used to repair inguinal hernia 
which are listed in the table below. The search term used for the dataset were HES data, 
England, and Hospital Episode Statistics. A thesaurus term is used if available. 
Anatomy Number  Pathology Number  
Exp “Inguinal hernia” 11231   
Total 11231   
Surgical techniques  HES data  
Open inguinal hernia repair 1484 HES data 1037 




Total extraperitoneal hernia repair 407 Exp “England” 103666 
Transabdominal preperitoneal hernia 
repair 
406   
Lichtenstein inguinal hernia repair 613   
Mesh inguinal hernia repair 1869   
Suture inguinal hernia repair 317   
Shouldice inguinal hernia repair 203   
Total 3787 Total 105055 
 





As of July 2019, a total of 11,231 papers were published in the literature with the term 
inguinal hernia (explode). A total of 3,787 papers were published in the literature 
studying inguinal hernia repair. And finally, for the terms HES, “Hospital Episode 
Statistics” and for England (explode), the literature was searched and a total of 105055 
papers were published during the same period of time as shown in table 1. 
 
Anatomy, pathology and surgical technique results were combined using the term 
“OR”. The results were then combined with HES data results using the term “and”. A 
total of 69 articles were identified. The limits were then applied and only 9 papers were 
found. All abstracts were reviewed and all of them were selected because they mention 
the term England or a place in England rather than because they were derived from 
HES data. Therefore, as of 2011, there was not a single study published in the literature 
from HES data assessing inguinal hernia as shown in figure 1. 
 






As indicated in the objectives, a comparison of different types of inguinal hernia repair 
is to be performed as an example of the objective. The study will identify all inguinal 
hernia which was performed in England. Laparoscopic inguinal hernia can be 
performed using TAPP or TEP. HES data don’t have the codes required to differentiate 
between both types. Therefore, Laparoscopic repair is going to be used for the research. 
Open inguinal hernia repair can be performed by all other types mentioned in table 1. 
HES data again can’t differentiate between these types and therefore, Open inguinal 
hernia repair will be used for the research. The research compares laparoscopic and 
open inguinal hernia as an example of the use of HES data to compare different surgical 
treatment. The comparison of these operation is based on short term outcome (early 
complications such as bleeding, infection, and urinary retention). and long-term 
complications in terms of reoperation which is a surrogate for recurrence. 
2.1.2 Gallbladder 
The aim of the literature review is to identify any study published in the literature from 
HES data investigating gallbladder diseases. Two examples are identified from 
gallbladder disease to represents two objectives of the research. The first objective is 
can HES data be used to identify rare complications when there are no codes for the 
complication. Bile duct injury following laparoscopic cholecystectomy is the example 
used for this objective. 
 
The second objective is can HES data be used as a national audit tool. Definitive 
management of gallstone pancreatitis is the example for this objective. Before these 
examples are performed, A literature review of all studies used HES data to study 






Anatomy  Disease  
Exp. Gallbladder 14,807 Exp “Gallstone”/ or exp 
“cholelithiasis”/ or exp 
“cholecystolithiasis” 
38,803 
  Exp “jaundice Obstructive”/ or 
“exp “cholestasis, 
extrahepatic”/ or exp “mirizzi 
syndrome” 
6,639 
  Gallstone pancreatitis 1,279 
  Biliary colic 962 
  Exp “Gallbladder neoplasms”/ 
or exp “gallbladder diseases” 
35,433 
  Exp “ acalculous 
Cholecystitis”/ or exp 
“cholecystitis”/ or exp 
“gallbladder diseases”/ or exp 
cholecystitis, acute”/ or 
“cholangitis” 
47,320 
  Gallbladder empyema 268 
  Gallbladder mucocele 74 
  Gallbladder perforation 1,001 
Total studies 14,807 Total studies 72,850 
    
Surgical techniques  Dataset  
Exp “cholecystectomy”/ or 
2xp “cholecystectomy, 
laparoscopic”/ or exp “biliary 
tract surgical procedures” 
37,044 Hospital Episode data 1,216 
Exp “Cholecystostomy” 726 Exp “England” 103,666 
Subtotal cholecystectomy 239 HES data 1,037 
Removal of gallbladder 909   
    
Total studies 37,581 Total studies 105,055 
 
Table 2: terms used for gallbladder literature search 
 
The terms used for search strategy is illustrated in table2. Terms related to gallbladder 
anatomy is gallbladder. The second stage was to assess the terms for pathology which is 
gallstone and by using thesaurus terms, explode gallstone, cholelithiasis and 





illustrated in table 2. The procedures used to remove gallbladder are cholecystectomy 
and subtotal cholecystectomy. Other terms used for procedure is cholecystostomy 
which is used to describe radiological drainage of gallbladder. Finally, a search for 
dataset that includes HES data, England, and Hospital Episode Statistics was 
performed. A thesaurus term was used if available. Table 2 shows all terms used and 
the number of studies as of July 2019. If there were thesaurus terms available then 
explode term was used and this is written exp. If there were no thesaurus terms then a 
searched for the term was used. 
 
A total of 14,807 papers were identified with the term Gallbladder (explode) for 
anatomy. 37,581 papers were identified in the surgical technique as of July 2019. A 
search for all the terms used for any disease or pathology related to gallstone such as 
gallstone pancreatitis or biliary colic was performed. All terms are listed in table 2. A 







Figure 2: flowchart of gallbladder literature review 
 
 
A combined search for anatomy, surgical techniques and pathology or disease was 
performed using the term “OR” a total of 99,388 articles were identified. The results 
were combined with HES data and 163 articles were identified. A limit of published 
year 1990 to 2011, adult patient and English literature were applied to the results. The 
number was reduced to 33 study as shown in figure 2. All abstracts were reviewed and 
the majority of articles were related to the England term used and not applicable to 
HES. Only 4 articles were identified. 
2.1.2.1 Review of papers 
The first paper published in the literature from HES data studying gallbladder disease 
was in 2003 and reported on gallstone admission and surgery between 1989 and 
2000[81]. The study investigated admission with gallstone diseases by gender over 
time, the results were adjusted for age and presented per 100,000 population. The study 





male and female. And finally, the study investigated endoscopic surgery for gallstone 
disease over the same period of time. 
The study found Between 1989/1990 and 1999/2000, the age‐standardized hospital 
admission rates for cholelithiasis increased by 30% for males and 64% for females. 
Admission rates for cholelithiasis increased progressively with age from 1.1 per 
100,000 in the 0–14‐year age group to 277.1 per 100,000 in the ≥ 85‐year age group in 
1999/2000. The age‐standardized percentage of hospital admissions for cholelithiasis 
with an operation fell significantly by 16.9% from 1989/1990 to 1999/2000. The male 
operation rate decreased from 54.2% to 44.0% and the female rate from 61.2% to 
50.9%. Females had a higher percentage of admissions for cholelithiasis with an 
operation than males in each year of the study. The frequency of operation was 
approximately 50–60% for most age groups, but decreased progressively with 
advancing age at ≥ 65 years. The proportions of admissions undergoing therapeutic 
endoscopy increased several‐fold, especially amongst older individuals. Case fatality 
rates declined. The male rate fell by 32% from 0.6% to 0.4% and the female rate by 
42% from 0.5% to 0.3%. In general, there was a downward trend in case fatality rates 
for cholelithiasis throughout the study period. Case fatality rates following admission 
for cholelithiasis were highest in the 75–84 year and for patients over 85 year. 
 
The second paper investigated emergency admission with gallbladder pathology and 
investigated the emergency surgery rate and readmission[82]. The study showed there 
were 25,743 patients admitted as an emergency with acute gallbladder disease in 
England between April 2003 and March 2004. Of these, 3,770 patients (14·6%) were 
readmitted as an emergency with acute gallbladder disease during the period April 2003 





of readmissions was 4,770, accounting for 15·65 of all 30,513 admissions. The male: 
female ratio of the 21,973 patients admitted once was 33: 67 and was similar to the ratio 
of 31: 69 in those admitted more than once. The mean (SD) age of those admitted once 
was 57.9 (19.1) years and of those admitted more than once was 54·0 (19.8) years (P < 
0·001). The study showed emergency surgery for acute gallbladder disease was very 
low (14.7%), the attempted laparoscopic approach for those who underwent surgery 
was 70.3% with the national conversion rate for emergency laparoscopic 
cholecystectomy was 10.7%. The study also investigated the length of stay of each 
cohort (no surgery, open surgery, laparoscopic surgery and converted cases). The 
postoperative hospital stay after a successful laparoscopic cholecystectomy was 
significantly lower than that after an open cholecystectomy or a conversion to an open 
cholecystectomy (median (IQR) 2 (1–4) versus 6 (3–10) days; P < 0·001). The 
remaining 21,952 patients who did not have an emergency cholecystectomy had a 
median hospital stay of 5 (IQR 2–8) days. The study investigated emergency 
readmission with gallstone diseases for cohort who did not undergo surgery and they 
found a significant number of patients were readmitted with the same pathology 
(15.6%). The study was a milestone in gallstone disease and showed emergency surgery 
for acute admission with gallstone disease is low in England. 
 
The same group published later another study about conversion rate of (elective and 
emergency) laparoscopic cholecystectomy[83]. The study investigated conversion rate 
of laparoscopic cholecystectomy and its association with patient related factors and 
non-patients related factors. The study showed the conversion rate was 5.2% for the 
study period (elective and emergency). The conversion rate for elective surgery were 





The mortality rate was low at 0.24% for the intervention/whole population. However, 
the mortality rate for open surgery is much higher (1.7%) than conversion cases (0.5%) 
and for laparoscopic surgery (0.06%) (P<0.01). 
 
The study investigated factors associated with conversion and found patients related 
factors such as age, gender mode of admission, and diagnosis are significantly 
associated with higher conversion rare. Age < 40 conversion rate was 2.1% compared 
to10.9% for age >70 (P<0.01). Male conversion rate was 9.8% compared to female 
3.7% (P <0.01). patients with biliary colic are less likely to have conversion 3.6% 
compared to patients with cholecystitis 6.1% (P<0.01). 
 
The study also investigated the non-patients related factors such as consultant caseload 
and hospital volume of surgery. The study showed consultant caseload is inversely 
associated with higher conversion rate (P<0.01). the study showed consultant with 
caseload of less than 10 have a conversion rate of 8.7% compared to 3% for consultant 
who perform over 70 case a year. 
 
The authors calculated the previous year consultant case load and used it for the studied 
year. This provides standardisation across all surgeon. The study showed the conversion 
rate for emergency cholecystectomy decreased from the previous year published in the 
previous article by them. This suggests surgeons’ skills and possibly patient’s selection 
are getting better. The study also suggests surgeon who perform surgery regularly for 







The fourth paper identified in the literature search was about acute pancreatitis rather 
than gallstone. Because gallstone is one of the causes of pancreatitis, the study will be 
included in the literature review.  The study investigated the incidence of acute 
pancreatitis and its mortality and geographical variations and its associated with alcohol 
intake[84]. The study found between1998 and 2003 there were 55,960 cases of acute 
pancreatitis. The calculated incidence was 22.4 per 100,000. The incidence increased 
from 20.9 per 100,000 (95% CI 20.6–21.4) in 1998/99 to 23.5 (95% CI 23.1–23.9) in 
2002/03. The incidence varied between 10.0 per 100,000 in Cambridge and 46.1 in 
Gateshead. At the regional level, the highest rates were in the North East (28.3 per 
100,000 per year) and the North West (27.3 per 100,000) and the lowest rates were in 
the East of England (18.1) and the South East (18.3). They found the majority of 
mortality occurs in the first week of admission and the mortality is significantly 
associated with increasing age P<0.01). Gallstone as a cause is responsible for 27% of 
acute pancreatitis patients. 
 
The literature has investigated mortality rates and rates of conversion in patients 
admitted for gallbladder surgery. However, postsurgical complications of 
cholecystectomy have not been investigated. While the literature has investigated the 
trends of admissions of gallstone to hospitals, it did not study other gallstone diseases 
such as bile duct injury following laparoscopic cholecystectomy, gallstone ileus, 
management of gallstone pancreatitis, management of cholangitis have not been 
investigated. 
 
Bile duct injury is the most important complication of cholecystectomy, bile duct injury 





a need to investigate this complication from HES and investigate all factors that may 
increase the incidence of bile duct injury. There are no codes for bile duct injury in the 
HES data. Therefore, bile duct reconstruction will be investigated as a surrogate for bile 
duct injury and this will be the example of measuring complication following surgery 
when there is no code for that complications. 
 
Another complication of gallstone disease is gallstone pancreatitis. The last study 
reviewed showed the incidence of pancreatitis and it showed gallstone account for only 
27% of the total cases. Patients admitted with gallstone pancreatitis should undergo 
definitive management of gallstone pancreatitis during index admission or within 2 
weeks of discharge[62]. An assessment of all hospital compliance with this guideline is 
required as well as an assessment of what happens to the patients if they didn’t receive 
the definitive treatment in time. This study will be used as an example of using HES 
data as a national audit tool. 
 
Each study is published in a chapter later in the thesis. The need for each study is 
discussed in details in the introduction of each chapter. 
2.1.3 Bowel pathology 
The last two objectives of the research are from bowel pathology. The first is can HES 
data be used to identify rare complication when there is a code? An example of this 
objective is development of Venous Thromboembolism following bowel resection. The 
other objective is can HES data be used to identify changing trends in surgery for rectal 
prolapse? Prior to the studies being performed, literature review of all studies that used 
HES data to investigate outcome for bowel surgery was performed to make sure none of 





Anatomy Number  Disease Number 
Colon 157,485 Rectal prolapse 
 
2,878 





or exp Intestine, Large 
187,427 Faecal incontinence 2,092 
Exp “anal canal” 17,672 Exp “Rectal 
diseases” 
224,658 
Bowel 140,390 Exp “Diverticulitis/ 




  Exp “Inflammatory 





  Exp “Colitis. 
Ischemic”/ or exp 
Colitis, 
microscopic”/ or exp 
“proctocolitis” 
2,384 
  Larger Bowel 
Obstruction 
151 
  Exp “colonic 
disease, Functional” 
11,071 
  Exp “Colonic 
psudo-obstruction” 
680 
  Exp “colorectal 





  Exp “anus 
neoplasm”/ or exp 
“rectal neoplasm” 
45,584 
  Exp “Colonic 
Polyps” 
8,068 
Total 414,451 Total 313,269 







Surgical techniques Number of papers Dataset Number of 
papers 
Exp “colectomy”/ or 
exp “colon”/ or exp 
proctocolectomy, 
restorative” 
83,460 Hospital Episode 
data 
1,216 
Bowel resection 13,671 Exp “England” 103,666 
Anterior resection 14,762 HES data 1,037 
Ileocolic resection 600   
Panproctocolectomy 93   
Exp “colectomy” 19,776   
Hemicolectomy 3,719   
Sigmoid colectomy 997   
Exp “proctectomy” 3,344   
Exp “surgical 
stomas”/ or exp 
“colostomy” 
10,119   
Bowel anastomosis 34   
Rectopexy 802   
Delormes procedure 225   
Altemeier's procedure 37   
Sacral nerve 
stimulation 
1,315   
Total 123,005 Total 105,055 
Table 3B: literature review of all studies for bowel in HES dataset 
 
The terms used for search strategy is illustrated in table 3. Terms used for anatomy are 
bowel, colon, rectum and lower gastrointestinal tract. The second stage in the literature 
search was to assess the terms for pathology. This was divided into functional bowel 





cancer and polyp. Inflammatory bowel disease such as colitis, and benign bowel 
pathology such as diverticulosis. Prior to search any term, Thesaurus search for all 
terms was performed to find any MESH term available for each of the term used. If 
thesaurus term was identified, then a term explode was selected and this is highlighted 
as exp prior to the term. There are a number of surgical procedures for bowel surgery 
and these terms are list in table 3. Finally, a search for HES data, England, and Hospital 
Episode Statistics was performed as explained previously. 
 
A total of 414,451 paper were identified for the anatomy of bowel as of July 2019. 
123,005 studies were identified for surgical techniques for bowel surgery and 313,269 
papers were identified in pathology or diseases section as shown in table 3 (A & B). 
 
 
Figure 3: Flowchart for literature review of studies from HES data on bowel pathology 
 
A combining search for anatomy, pathology, and operations was performed using term 
“OR”. A total of 599,880 articles was identified in the literature up to July 2019. The 
results were combined with HES data results using the term “and”. A total of 1,269 





279 articles were identified. All abstracts were reviewed and the majority of them were 
selected due to the presence of England term in the searching strategy. Only 15 papers 
from HES data studying bowel disease published in the literature up to 2011. 
2.1.3.1 Review of papers 
There are 15 papers published in the literature that covers bowel surgery, pathology and 
anatomy for HES data. The majority of them were published in 2010 and 2011. None of 
the studies were used to assess venous thromboembolism following bowel resection. 
The review also didn’t identify any paper that investigated surgery for rectal prolapse or 
indeed examined changing practice to inform planners. The need for this study is 
discussed in details in the relevant chapter. A review of all published papers is listed 
below. 
 
The first two paper from HES data investigating bowel pathology were published in 
1995 and 1998. Both researches were from the early days of HES data and the 
methodology used were limited to the aim. The aim of the first paper was to investigate 
the incidence of Crohn’s disease in Oxford and England. the study linked Oxford data 
to the National data[86]. Age-standardized admission rates were calculated from the 
Hospital In-patient Enquiry and the Oxford Record Linkage Study. In addition, annual 
hospitalized prevalence, first hospital admission rates (as a proxy for incidence) and 
readmission rates were calculated for the Oxford population. The study showed neither 
episode-based (hospital admission) nor person-based (oxford data) rates increased for 
ulcerative colitis. Relapses resulting in hospital admission were more common for 






The aim of the second paper was to investigate trends in hospital activity, hospital 
admissions, and treatments for colorectal cancer on residents of the South Thames 
regions (population 8 million)[87]. A total of 18,542 patients were admitted between 
1989 and 1993 with colorectal cancer. The number of admissions was doubled (98% 
increase p < 0.0001) in the period studied. The proportion of patients having a day case 
admission rose from 9% in 1989 to 18% in 1993 (p < 0.0001). Overall, 2,894 (16%) 
patients had a day case admission; 1,894 of these (65%) were also admitted as ordinary 
(overnight) admissions. The number of Finished consultant episode (FCEs) and 
admissions per patient rose from 1.37 and 1.28 respectively in 1989 to 2.09 and 1.99 
respectively in 1993. FCEs were between 5% and 8% higher than admissions over the 
five years. Chemotherapy accounted for 50% of the rise in day case admissions; 
colonoscopy and sigmoidoscopy were associated with a further 18%. Fourteen per cent 
of the increase in ordinary admissions was also because of chemotherapy. The study 
describe admission for colorectal cancer in a single area in England. The study is 
designed to give a descriptive statistic for admission whether day case or overnight stay. 
The study also investigated the cause of admission such as Chemotherapy. 
 
Both papers were designed to answer a specific aim and it was conducted in simple 
methodology and the results congruent with the aim. The conclusion of both papers is 
consistent with their results. 
 
In 2007, a study from Imperial College analysing the use of administrative data or 
clinical databases as a predictor of risk of death was published[88]. The study aim was 
to compare risk prediction models for death in hospital based on an administrative 





databases: the national cardiac surgical database, the national vascular database and the 
colorectal cancer study. The study created three models from HES data to predict death 
and compared the results to the best published predictive risk model based on data from 
the clinical databases. For CABG and abdominal aortic aneurysms, they used the most 
recent society reports available. For colorectal resection they used the published model 
in the report on risk adjusted outcomes from the Association of Coloproctology of 
Great Britain and Ireland. they compared models using receiver operating characteristic 
(ROC) curve scores (c statistics). The study found the power of the complex predictive 
model was comparable with that of models based on clinical datasets with ROC curve 
scores of 0.77 (v 0.78 from clinical database) for isolated CABG, 0.66 (v 0.65) and 0.74 
(v 0.70) for repairs of ruptured and unruptured abdominal aortic aneurysm, respectively, 
and 0.80 (v 0.78) for colorectal excision for cancer. 
 
The study showed risk prediction of mortality from HES data is comparable to data 
from national registry in prediction of mortality. They study however, is not designed to 
investigate colorectal cancer, but it is designed to assess reliability of HES data in 
mortality predictions. 
 
HES were used to investigate season of birth and ulcerative colitis (UC) development as 
well as to assess temporal changes in the age distribution in inflammatory bowel 
disease. Each of these aims were published in a separate article by the authors. The 
former paper was published in 2008[89]. The background to the study is the suggestions 
that seasonal variations of individual birth time may increase the risk of UC. Infection 
in the perinatal period was thought to be the cause. The study investigated all 





of birth. The study found there is no correlation between month of birth and UC 
development later in life. 
 
The latter study investigated temporal changes in the age distribution of IBD[90]. This 
study used separate hospital statistics from England and Scotland to follow the changes 
in the age distribution. A cross-sectional study assessed hospitalizations (with Crohn's 
disease or ulcerative colitis listed as primary or primary plus secondary discharge 
diagnosis). The admissions were expressed as age-specific and sex-specific rates per 
10,000 living population. The separate age-specific rates of Crohn's disease and 
ulcerative colitis of consecutive 6-year or 7-year time intervals were plotted against 
their respective age group. The study showed a bimodal age distribution of 
Inflammatory bowel disease. with a prominent first peak occurring in younger patients 
with Crohn's disease and a prominent second peak occurring in older patients with 
ulcerative colitis. 
 
Both studies used the same methodology to study age and inflammatory bowel disease 
and it was consistent with the aim. The conclusions reaffirmed the results and both 
studies confirmed the ability of HES data to investigate age related admission of 
inflammatory bowel disease. 
 
Comorbidity of patients is very well linked to higher mortality rate. Shack et al in 2010  
investigated whether the time of onset of comorbidity is associated with survival of 
colorectal cancer using HES data[91]. HES data were linked to North West cancer 
registry. Charlson comorbidity score were calculated from HES data and linked to 





HES data and diagnosis of cancer was calculated. The impact of Charlson comorbidity 
score on one-year survival was investigated as well as the effect of different time frame 
from the onset of comorbidity and diagnosis on the survival. The study found 
comorbidity recorded 6 to 18 months prior to the diagnosis is associated with lower 
survival than those who has their comorbidity recorded after the diagnosis. The study 
concluded Administrative data provide a good estimate of the prevalence of most 
comorbid conditions but may be biased for patients with severe comorbidity who are 
not fit for surgery. The authors concluded that the time window in which a comorbid 
condition occurs in relation to the cancer diagnosis should be taken into account based 
on their findings. However, recording comorbidity in HES data doesn’t necessarily 
represent the true onset of the disease, but it represents the timing of recording of the 
comorbidity in HES. This confounding factor was not discussed by the author and It 
was not incorporated in their conclusion. 
 
A group from imperial College published 7 studies from HES data on bowel surgery. 
They compared laparoscopic and open surgery for bowel cancer surgery and rectal 
surgery for cancer[92]. Their main end point is a 30 day and 1-year mortality. The 
secondary end point is 28 day readmission and length of stay.  Between the study dates 
3,709 of 192,620 (1.9%) elective colonic and rectal resections were classified as 
laparoscopically assisted procedures. After correction for age, gender, diagnosis, 
operation type, comorbidity, and social deprivation, laparoscopic surgery was a strong 
determinant of reduced 30 day mortality (odds ratio, 0.57; 95% confidence interval, 
0.44-0.74; P < 0.001) and one-year mortality (odds ratio, 0.53; 95% confidence interval, 






The same group repeated their research but for nonelective Excisional Colorectal 
Surgery in English National Health Service Trusts: A Study of Outcomes from HES 
Data between 1996 and 2007[93]. The study investigated the cause for bowel resection 
and types of surgery. The study also investigated the trend over time of right 
hemicolectomy and panprocotcoloectomy and terminal ileostomy. The results were 
calculated per 100,000 population and showed little variations over time.  The study 
investigated the mortality rate for different pathology such as diverticular disease, 
colitis, cancer, and polyps. the study showed only 0.6% of total cases were performed 
laparoscopically. The study used binary logistic regression to assess factor associated 
with 30 days and 365 days mortality rate. The study showed the odds ratio for mortality 
in advanced age >80 is 12.31 (95%CI 11.27-13.45) when compared to those less than 
55 years. Patients with Charlson comorbidity score of >6 is more likely to die compared 
to those that have no comorbidity OR 5.93 (95%CI 5.33-6.60). Patients with diagnosis 
of peritonitis were more likely to die compare to other types of diagnosis OR 9.24 
(8.15-10.47). The study concluded that mortality rate of non-elective colorectal surgery 
was high and they recommend a validation study to compare the mortality rate between 
different healthcare providers. 
 
Another study from the same group demonstrated a new use of HES data to measure 
quality of service by measuring reoperation rate following colorectal surgery[12]. The 
primary end point is Reoperation after colorectal resection, defined as any reoperation 
for an intra-abdominal procedure or wound complication within 28 days of surgery on 
the index or subsequent admission to hospital. The study showed the overall 
postoperative reoperation rate for all patients undergoing colorectal resection 





required a reoperation on their primary admission. The remaining 2,759 patients 
underwent a subsequent admission that included a reoperation. Emergency patients 
experienced slightly higher rates of reoperation than elective patients (7.0% v 6.2% 
with OR = 1.149 95% CI 1.118 to 1.112, P<0.001). A total of 11,536 (4.7%) underwent 
re-laparotomy after colorectal resection, 1,560 (0.6%) experienced a subsequent stoma 
related complication requiring surgery, and 3,861 (1.6%) had a wound complication 
requiring reoperation. The study showed elective and emergency patients who 
experienced a complication requiring reoperation during their initial admission had a 
prolonged median length of stay (for elective patients, length of stay 27 (IQR 17–43) 
days with reoperation (n=7,873) v 11 (9–16) days with no reoperation (n=150,974), 
P<0.001; for emergency patients, length of stay was 34 (21–55) days with reoperation 
(n=5,401) v 17 (11–28) days with no reoperation (n=82,071), P<0.001). They also had a 
higher rate of postoperative mortality (elective patients, 938/7,873 (11.9%) with 
reoperation v 4,399/150,974 (2.9%) with no reoperation, P<0.001; emergency patients, 
1,251/5,346 (23.4%) with reoperation v 12,511/82,126 (15.2%) with no reoperation, 
P<0.001). 
 
The study showed there is significant variations of reoperation rates among consultant 
and trusts. The variation varied between none and 50% for the former and none and 
17% for the latter. The study used funnel plot to compare Trusts and surgeons. To avoid 
errors, the study excluded low volume surgeons and Trusts. They defined low volume 
surgeon as any who performed less than 5 procedures and low volume trusts as any who 






The Study aim was well thought and the methodology was designed to answer such a 
question. However, there is a major confounding factor in the study design. The study 
excluded consultant and Trust with small number, but they didn’t explain where did 
they come up with those definition of small number. Trusts who performed more than 
10 procedures over the study period 2000-2008 means the Trust has performed one or 
two procedure a year. This is a major confounding factor and probably this is the reason 
behind this huge variation among the healthcare providers. 
 
The same group also published a paper about Volume analysis of outcome following 
restorative proctocolectomy[94]. The study aimed to determine national provision and 
outcome following pouch surgery (restorative proctocolectomy, RPC) and to examine 
the effect of institutional and surgeon caseload on outcome. The study identified all 
RPC surgery between 1996 and 2008 performed in England. They assessed the 
association between hospital volume and surgeon caseload over the study period. The 
authors showed the majority of operations are performed by a low volume hospitals and 
surgeons. The study grouped surgeon and hospitals into 3 groups. Low volume, 
intermediate volume and high volume. They study failed to show any difference 
between these groups of surgeons or hospitals for mortality, length of stay, and 
readmission rate. The study, however, showed high volume surgeon have a lower 
failure rate of pouches. The study suggested the number of operations carried out by 
surgeons and hospitals are very low. The study showed the number of operations was 
low for all centres. This methodology and results are valid and the conclusion is 
consistent with the results. This type of studies is important to inform service provision 





later created a national registry[95] trying to increase the focus on these patients and up 
to now no definitive decision has been made to centralize the service. 
 
The same group also published a study in 2011 assessing a colorectal perspective on 
voluntary submission of outcome data to clinical registries[96]. The aim of the study 
was to identify outcome differences amongst patients undergoing resection of colorectal 
cancer at English National Health Service trusts using Hospital Episode Statistics 
(HES). A comparison was undertaken of trusts that submitted and those that did not 
submit, or submitted only poorly, voluntarily to a colorectal clinical registry, the 
National Bowel Cancer Audit Programme (NBOCAP). The study showed Unadjusted 
30 day in‐hospital mortality rates were higher in non‐submitting than in submitting 
trusts (5·2 versus 4·0 per cent; P = 0·005). Submitter status was independently 
associated with reduced 30‐day mortality (OR 0·76, 95%CI (0·61 to 0·96); P = 0·021) 
in regression analysis. The main end point of the study is mortality, length of stay and 
readmission within 28 days were analysed using HES data to compare outcomes 
between submitters and non‐submitters to the NBOCAP data set. The comorbidity score 
of both groups and the social deprivation is significantly different in favour of the 
submitting group. Most healthcare providers (HCP) were submitting data (132) and 
only 20 centres didn’t submit data, the study concluded A higher postoperative 
mortality rate following resection of colorectal cancer was found in trusts that do not 
voluntarily report data to NBOCAP. Implications regarding the voluntary nature of 







The study is well designed and conducted. The study compared only HCP that submit 
data and the one who don’t submit or submit less than 10% of their data. One of the 
confounding factors that may be the cause of the higher mortality, is the fact that HCP 
who submit partial data may not be enthusiastic to submit their poor data. The 
developed system is a good well-designed system, but probably, the authors should 
have compared complete submission and incomplete to give a clearer picture. 
 
The last paper published by this group is failure to rescue value as a marker of the 
standard of care following reoperation for complications after colorectal resection[97]. 
The study used a system described by Silber and colleagues[98] coined the phrase 
‘failure to rescue’ (FTR) to describe patients who died from an acquired complication 
following surgery. The metric they described represents the proportion of deaths among 
patients who experience complications. In a study investigating patients undergoing 
cardiac surgery they ranked hospitals according to their case‐relevant mortality, and 
observed significant differences in FTR rates between the best and worst ranked units 
despite equivalent complication rates[99]. Risk adjusting model was developed using 
comorbidity and social deprivation model. Reoperation rate were calculated within 28 
days of surgery. They assessed hospital structure in terms of CT scan HDU bed, ICU 
bed etc… the study then compared low mortality quintile and failure to rescue with 
other quintiles and they found there is significant difference between low mortality 
quintile and high quintile. The study concluded FTR‐S rates differed significantly 
between English colorectal units, highlighting variability in ability to prevent death in 
this high‐risk group. This variability may represent differences in serious surgical 
complication management. FTR‐S represents a readily collectable marker of surgical 





The study is well designed and conducted based on published work from the 1990s. the 
study however, grouped HCP on their mortality figures in low mortality quintile, 
second, third, fourth, and highest. Then they discovered the failure to rescue is higher in 
the higher mortality. This raise the question whether these data are interfering with each 
other. 
 
Another study assessed the association between Clostridium difficile (C diff) diarrhoea 
in patients with inflammatory bowel disease (IBD) and mortality and length of 
stay[100]. The study identified all patient underwent surgery for IBD. Then they 
identified both patients who developed C diff and compared both groups. They study 
showed patients who developed C diff are more likely to die and have a longer hospital 
stay in the hospital. they concluded patients with inflammatory bowel disease admitted 
to NHS hospitals in England with co‐existent C. difficile infection are at greater risk of 
in‐hospital mortality and morbidity than patients admitted for inflammatory bowel 
disease alone.  
 
The last study in this literature review investigated thirty-day postoperative mortality 
after colorectal cancer surgery in England[101]. The study assessed variations between 
HCP 30 days mortality rate. The study also assessed factors that increase the risk of 
mortality. The study adjusted for these factors. The risk adjusted 30 days mortality were 
plotted in funnel plot to assess variations among HCP. The study showed there is 
significant variation in 30 day postoperative mortality following major colorectal cancer 
surgery existed between NHS hospitals in England throughout the period 1998 & 2006. 





make it possible to identify and spread best practice, improve outcomes and, ultimately, 
reduce 30 day postoperative mortality following colorectal cancer surgery. 
 
To summarise. HES data in bowel surgery were used in three different approaches in 
bowel  
• To assess the incidence of inflammatory bowel disease and seasonal variation 
and the association of C diff and IBD. 
• To assess mortality. This was demonstrated in calculating mortality rate for 
elective and nonelective bowel resection. HES was also used to assess whether 
HES can be used to predict mortality and failure to rescue as well as the cause of 
death and comorbidity impact on death., HES was used to assess mortality rate 
in bowel surgery as the end point for volume outcome association in pouch 
surgery. HES was used to compare between two surgical approaches in bowel 
resection with mortality as the main end point. 
• To assess the reoperation rate following bowel resection as a marker for good 
practice. 
The literature review for bowel showed HES was not used to identify rare 
complications such as VTE following bowel resection. HES was used to identify 
IBD cases and pouch surgery, but HES was not used to assess surgery for rectal 





3 Data and Methodology 
HES data is an administrative data. In order to perform any clinical research, the data 
has to be converted into clinical data. The literature review confirmed that all data are 
converted into clinical data but the studies didn’t discuss in their methodology how this 
process was completed. In this chapter, a description of how HES data can be converted 
into clinically usable data and ideally with no errors. This step should be performed 
before any other method of analysis is performed.  
 
Each objective in the thesis is different and the aim of the studies is different too. Each 
study aim requires different methodology and statistical analysis. Each study 
methodology is discussed in each chapter but all of the studies share the first step which 
will be discussed in this chapter. 
 
In this section, HES data is described. The level of ethical approval needed to access the 
data is discussed. A methodology of how to handle the data and store is discussed. And 
finally, a discussion of how HES data can be converted onto clinical data and how to 
analyse it.  
3.1 Hospital Episode Statistics  
HES data is the national data warehouse for all patients treated by the NHS. The data is 
collected by each NHS Trust, PCT, and Independent Treatment Centre and sent to the 
NHS Information Centre (NHSIC) each month. The data is managed by a private 
company called “Northgate” that stores and cleans the data according to defined 
protocols. The data is then anonymised and provided to end users by Northgate under 





3.1.1 Types of available HES data 
Before 2010, the NHSIC classified HES data into 4 categories based on their sensitivity 
and security. Each category was called Bespoke 1, 2, 3, or 4. Bespoke 1, is freely 
available online and can be accessed by any individual. Bespoke 2 is any extract that 
contains particular information about certain groups often requested by a researcher.  
Bespoke 3 contains all information hosted by the NHS IC about each single admission 
in England and is supplied as episodes, it does not contain any sensitive data. Bespoke 4 
contains sensitive data. 
 
During 2010 the NHSIC made several changes to the classification of data, and as a 
result the application process has been modified. The term Bespoke was abandoned and 
the application process was simplified. A data request is divided into: A) Tabulated data 
that is available free online and can be accessed by any person.  B) Tailored summary 
table that does not require any governance approval. C) Tailored summary table 
including sensitive data: Requires governance approval. D) Episode records: Requires 
governance approval. E) Episode records including sensitive data: Requires governance 
and DSMG (Data Base Monitoring Subgroup) approval. F) Episode records contain 
patient identifiable information: Requires ECC (Ethical and Confidentiality Committee) 
approvals. G) Mortality data: Requires ONS (Office of National Statistics) approval. 
 
Sensitive data is defined as any information that cannot identify a patient but is specific 
to a particular individual - examples include; Hospital Number, Critical Care Number, 
Accident and Emergency Number, and Consultant Code. Patient identifiable data is 
defined as any data that can identify a particular patient - examples include; date of 





3.1.2 Level of approval 
Using patient data for the purpose of research has been controlled by section 60 of the 
Health and Social Care Act 2001. This act regulates those wishing to obtain identifiable 
patient information and Data Controllers who are asked to supply identifiable patient 
information. Section 251 of the NHS Act 2006 allows the common law duty of 
confidentiality to be set aside in specific circumstances where anonymised information 
is not sufficient and where patient consent is not practicable. These requests were 
handed to the newly established ECC (Ethical and Confidentiality Committee) as part 
of the bigger National Information Governance Board for Health and Social Care 
(NIGB).  
3.2 Apply, store and install HES data into a computer 
An application was submitted to the NHSIC and access to the data was granted. There 
are several steps needed to access and store the data to satisfy the NHSIC governance 
body. There are also several technical aspects needed to be met before the data can be 
installed on a computer and make it ready for analysis.  
3.2.1 Applying for HES data 
The research seeks to develop techniques that use HES data set to measure meaningful 
surgical outcomes that will allow the characterisation or assessment of surgical care. 
Therefore, applying for the raw data (episode records) was thought to be the most 
appropriate option. No attempt was made to obtain sensitive or patient identifiable data, 
as it was deemed not necessary for this research. An application for Episodes Records 
without patient identifiable data does not require ethical committee approval, but it does 






The application was submitted by Mid Cheshire Hospitals NHS Foundation Trust 
(MCHFT) to the NHSIC. A request of all inpatient hospital data (365 fields) for the 
financial year 2000/2001 till 2008/2009 was submitted in 2009 and later another request 
for the data up to April2012 was submitted in 2012. The NHSIC was satisfied with the 
application and as a result the data was supplied as a delimited text file.  
3.2.2 Data security 
HES data were transferred by Royal Mail special delivery in the form of text files 
stored on 8 DVDs. The file containing each year’s data set was about 4 Gigabyte in 
size.  The DVDs are stored in a locked locker in the Research and Development 
Department at MCHFT as required by the NHSIC. 
3.2.3 Accessing the data 
The data were supplied in the form of a delimited text file, which was compressed as a 
zip file. Each record (episode) has 365 fields, and each year has at least 13 million 
individual episodes. WinRAR® was used to unzip the files. Each field was separated 
from next one by a delimiter. In this case it was vertical bar or pipe (|) rather than the 
usual comma (,).  
Microsoft Office Access is user friendly and easy to understand. A user does not need 
to learn a programming language such as Structured Query Language (SQL) and most 
data handling is by windows style queries using a graphical user interface. 
Nevertheless, it has some disadvantages, the maximum size of the database is 2 GB and 
the maximum number of fields is only 255 as of Access 2003. Therefore, a different 
relational database management system (RDBMS) was needed to store and interrogate 
the base data set. Microsoft SQL server 2005 is used by the Information Technology 
Department at the MCHFT for managing the hospital data; therefore, it was chosen to 
store and handle the data because of its availability and support from the Hospital 





query to identify the patient needed is performed and the data then transferred to 
ACCESS for further analysis.  
3.3 validation of Clinical codes. 
3.3.1 Pilot audit of general surgery clinical codes. 
 
The audit was designed to assess the accuracy of diagnostic and operative codes. Due to 
the fact that I haven’t had any formal training in clinical coding, I shadowed a clinical 
coding administrator for three days to understand and learn the normal practice of 
clinical coding.  
 
The study was classified as an audit by the hospital. The audit was divided into three 
parts: Data collection, clinical coding analysis of the data, and converting the audit 
results into clinical information. 
3.3.2 Participant: 
The audit was conducted by 3 individuals: the clinical coding manager, the clinical 
coding supervisor, and an experienced research fellow in surgery (registrar level) 
myself.  
The sample 
A sample of 108 patients was selected randomly by the information department at the 
hospital using a computer program from all surgical admissions admitted between 1st of 
January and 1st of July 2010 to Mid Cheshire Hospitals NHS Foundation Trust. These 
patients could be admitted as an emergency or elective. They could also be admitted as 








3.3.3 Methods  
Patients’ case notes were retrieved from the medical record. Each patient admission was 
recoded and inserted into the computer. The codes involve the diagnosis and operation. 
The diagnoses contain the primary diagnosis (the reason patients admitted to the 
hospital) and secondary diagnosis (these includes other diagnosis, comorbidity, and 
complications or misadventures). Whereas operations codes include the primary 
operation (the main operation the patients had) and secondary operation where all other 
procedures and operations such endoscopy, urinary catheter, and other operations are 
coded. 
 
The audit will not only focus on the coding accuracy, but also on the sequence of 
coding. For example, if the primary diagnosis was coded in the secondary diagnosis 
then the code is considered inaccurate. 
3.3.4 Data analysis 
The coding department will calculate their results by percentage of accuracy. For each 
category: primary diagnosis, secondary diagnosis, primary procedure, secondary 
procedure. 
The second part of data analysis was made by converting the result into more clinically 
oriented data. The diagnosis is divided into 4 parts: The primary diagnosis, other 
diagnosis, comorbidity, and complications. If the diagnosis recorded in the audit is 
different from the original one but clinically similar then the data is considered accurate 
even if it is considered inaccurate in the initial analysis. 
3.3.5 Results 
The audit which was performed by the clinical coding manager and her staff showed an 
accuracy of 80% for Operative codes and 85% for the diagnostic codes. Further analysis 





actual codes but in the sequence of the codes. Many of the codes were recorded as 
primary diagnosis or operation and the auditor changed it to be the secondary diagnosis 
or operation. For example, the accuracy of clinical codes increased to 95% for the 
diagnosis and 90% for operation if the  search for the codes in the first three fields was 
performed rather than the first field only. Therefore, to identify patients, it is important 
to search for the first three fields.  
 
There is however, some pitfall when using the above methods which should be 
considered. For simple procedures such as inguinal hernia, performing such analyses 
can lead to certain problems. A patient can be admitted for major surgery and at the 
same time, the surgeon decided to repair the hernia. Therefore, searching for inguinal 
hernia repair in the second or third operative fields will select those patients as well. 
Adding those patients to the analysis will skew the results of length of stay, mortality, 
infections etc.  To overcome such a problem, the researchers should look for those cases 
manually. All patients who were recorded to have an inguinal hernia repair in the 
second and third operative fields should be inspected individually to decide whether to 
include them or exclude them. 
3.4 How to convert HES data into clinical data (inguinal hernia) 
This chapter describes how to convert administrative data into a clinical data. Inguinal 
hernia will be used as an example.  
3.4.1 Background for inguinal hernia 
A hernia is a protrusion of an organ through the wall of the cavity that normally 
contains it. While there are many types of hernia, a groin hernia is the most common. 
This is characterized by a swelling in the groin area that normally disappears when a 





abdominal strain or following lifting of a heavy object. Clinical examination of a patient 
will confirm a hernia. Groin hernia can be either inguinal, which is the most common 
type, or femoral. This study will concentrate on inguinal hernia only. 
 
Inguinal hernias are divided into primary where the hernia has not been repaired before 
and recurrent where the hernia has been repaired previously. These two types are both 
of importance and since they are different the outcomes of surgery should be reported 
separately.   
 
Also, of relevance is the type of repair. Although there are many types of repair, they 
are divided into 2 main categories: Laparoscopic and open inguinal hernia repair. 
Laparoscopic repair can be done by TEP (Total ExtraPeritoneal) repair or TAPP 
(TransAbdominal PrePeritoneal hernia) repair. The open surgery can be repaired by 
suture such as Bassini or Shouldice or mesh repair. In the current practice the majority 
of surgeon use mesh for open inguinal hernia unless there is contraindication for mesh 
such as presence of infection or dead bowel. HES data does not have codes to 
differentiate between different categories of repair other than open (suture or mesh) and 
laparoscopic repair.  
 
The site of a hernia poses another variable, as a hernia could be right sided, left sided, 
or present on both sides. Each group of patients has to be identified separately to 
facilitate the correct follow up of these patients. This step is crucial to identify 
recurrence. As patient may have right inguinal hernia repair then 2 years later, he 
develops a left side and therefore, further repair on the left doesn’t represent a 






Patients undergo inguinal hernia can develop several complications. These 
complications can be divided into early and late. Early complications which occur 
during hospital admission or the patient readmitted to a hospital within 30 days of 
discharge. Infection, bleeding, injury to an organ (bowel or bladder), and urinary 
retention are the most common types of early complications. Late complications are 
often referred to either recurrence of the hernia or chronic pain.  
3.4.2 Aims of this study  
The aim of this study is therefore to investigate early and late complications of inguinal 
hernia repair using HES data. 
3.4.3 Method 
All patients with primary and recurrent inguinal hernia between April 2002 and April 
2009 were identified using SQL server and the results were imported into an ACCESS 
database for analysis. All inguinal hernia repairs performed in England between April 
2002 and April 2009 were identified by searching the first three operative fields of the 
HES dataset using the Office of Population Censuses and Surveys Classification of 
Surgical Operations and Procedures (4th revision) codes (OPCS-4) for T20* (primary 
inguinal hernia) and T21* (recurrent inguinal hernia). Only patients with a matching 
diagnostic code, International Classification Disease 10th Edition (ICD-10) K40* 
(inguinal hernia), in the first three diagnostic fields of the HES dataset were included in 
the final analysis.  
 
Patients were then selected in the operative and diagnostic codes match inguinal hernia. 
Matching the 2 system (diagnostic and operative) will eliminate all possible coding 
error.  In order to assess the number of cases removed by adopting the method of 





underwent repair in 2002 was performed. This trial showed the number of cases which 
was not selected was less than 1.2% of all episodes during that year. Patients 
undergoing laparoscopic repair were identified with the operative code Y50.8 before 
2006 and after 2006 with Y50.8 or Y75.*. Any patients didn’t have these codes were 
considered open repair. 
 
Patients who underwent an inguinal hernia repair between April 2002 and April 2004 
were used as the initial study cohort. Each patient spell (admission) may contain one or 
more episodes. These episodes are patient being transferred from one care to another 
care. These episodes are seen as duplicate in HES data. Duplicate episodes were 
removed, for example in 2002 the total number of episodes identified was 71357 and 
after exclusion of duplicates with the same admission date and HESID, 70293 were 
included in the analysis. The data were divided into primary and recurrent and then into 
unilateral and bilateral. Each of these subgroups were divided into laparoscopic repair 
and open repair. If the side of the original operation was not recorded, or the patient was 
under 18, or was admitted as an emergency, then patients were excluded from further 
analysis. 
Following the initial analysis, a further cohort of patients operated on in the year April 
2006 until April 2007 were analysed in a similar manner to confirm the results and see 
if they had changed following publication of the NICE guidance. 
3.4.3.1 Early outcome criteria 
Early outcome criteria studied were, in-hospital mortality, length of hospital stay, 
complications and readmission. Complications were identified using ICD-10 codes by 
searching the secondary diagnostic fields for infection (T814, T857, and T813), 





was defined as any patient readmitted to a general surgeon with a speciality code 100, 
as an emergency within 30 days of discharge with bleeding or infection, or if a patient 
was readmitted with urinary retention within two days of discharge. 
3.4.3.2 Late outcome criteria 
Patients were followed using HESID, until April 2009, to identify those requiring a 
further inguinal hernia repair on the same side. For example, if a patient had an inguinal 
hernia repair on the left side during 2002, then the dataset was searched to identify the 
need for a subsequent inguinal hernia repair on the left side or a further bilateral repair. 
3.4.4 Technical Points 
Type 1 HES data which we used is anonymised; however, HESID is a unique ID 
generated from a mixture of individual characteristics can be used to link episode 
records across time and place.  
3.4.4.1 Dealing with episodes and spells 
HES data contains information about episodes rather than spells. A patient spell 
represents the time from the date of admission until date of discharge. A spell may 
contain several episodes. This occurs for example when a patient is transferred to 
another department for an investigation under another consultant e.g. for an endoscopy 
or where part of the spell is on an intensive care unit when the episode might be 
generated under an ITU consultant. When we identified patients undergoing inguinal 
hernia repair therefore, the number of episodes was higher than the number of patients. 
Some patients also have more than one admission (spell) in a single year, e.g, a patient 
underwent a right sided hernia repair and was then readmitted with a complication or 
for a left hernia repair few months later or in another example was readmitted for a 






When duplicates exist, this can lead to confusion and complicate matters and under 
some circumstances leads to incorrect results as data interrogation and table linking can 
lead to an apparent increase in patient numbers.  
 
Removal of the duplicate episodes was a challenge. Manual removal of the data is time 
consuming and impractical due to the size of the data set. After several attempts, I 
found the best and most accurate method to remove the duplicate data was to use the 
query wizard in ACCESS. This is a specific Query designed to find duplicates (Find 
Duplicate Query Wizard). Using HESID as a patient identifier I ran the Query with 
HESID alone and in a particular data set could identify all patients with a duplicate ID. 
This will be a mix of duplicate episodes in the same admission as well as patient who 
have been admitted more than once. I need another field to identify admissions and I 
chose the date of admission.  
3.4.4.1.1 Method for the removal of duplicate episodes in one spell 
In Access 
• Click Create and chose Query Wizard. Select Find Duplicate Query Wizard.  
• Click the Table you want to remove duplicates from and click next.  
• In the available fields chose HESID and date of admission and move them to the 
duplicate-value field.   
• Click next and then move all fields into additional query fields and then click 
next. The Query Wizard will eventually identify the duplicated data but will not 
remove them. The Query contains all original and duplicated data e.g. it may 





• To remove the duplicates, sort the table by HESID and for each patient record 
manually delete the duplicated one and leave the original one. This will remove 
this data from the base table.  
3.4.4.1.2 Method for identify the first operation in a single year 
In order to create a cohort for this study, the first admission for an inguinal hernia repair 
must be identified.  
In Access 
• Click Create then click Query Design and choose the Table you want.  
• Select HESID and move to the Table below.  
• Repeat the same method for HESID again and for date of admission.  
• Click Sigma symbol (total). In the table below, in the total row. 
• Click on the group by and changed to count for the second HESID and for the 
date of admission with criterion first admission and run the query. It will show a 
table with three fields. The first will give HESID, the second will give the 
number of counts of HESID, and the third will show the first date of admission.  
 
 
3.4.4.2 Identify complications, surgical approach, age and mode of admission 
Following several attempts at dividing the tables into single categories and linking them 
again, I found this confusing and liable to produce erroneous results. I found the easiest 








3.4.4.2.1 Mode of Admission 
In Access 
• For the mode of admission patient will be classified into elective and 
emergency.  
• A new field is created in the original table with name MOA (Mode of 
Admission). Then an updated query is designed by selecting both the Admission 
Method and the MOA.  
• Insert 11, 12, and 13 in the criteria field for the admission method and insert 1 in 
the update to field for the MOA and run the query. This will update the MOA 
and insert 1 for each elective.  
• Repeat the method and insert 21, 22, 23, 24, and 28 in the criteria field for 
admission method and insert 2 in the update to field for MOA and run the 
criteria.  
3.4.4.2.2 Surgical approach 
In Access 
 Create a new field and call it SA.  
 Using the update query, all operative fields and the SA are selected and moved 
to the table.  
 In the criteria for all operative fields search for Y508* or Y75* and insert 1 in 
the update to field for the SA and run the query. This will enable you to identify 
all patients who underwent laparoscopic repair.  
 All patients with blank means they have been operated by open surgery. This 
can be updated in the same method but select only the SA. Insert “is null” in the 





 Now you can identify the surgical approach in every patient with 1 for 
laparoscopic and 2 for open repair. 
3.4.4.2.3  Complication  
Complications could be identified by creating new fields for infection, bleeding, and 
urinary retention. Then select all diagnostic fields and repeat the method described 
above using the codes as follows: infection (T814, T857, and T813), bleeding (T810), 
injury to an organ (T812), and urinary retention (R33). Because patients undergoing 
repair of an inguinal hernia are almost always a day case or they are discharged the next 
day most complications will not be recorded in the same admission. Patients were 
therefore followed to identify any who were re-admitted with complications over the 
next 30 days of index operations. All patients who were admitted as an emergency 
under a general surgeon (100) who had or were re-admitted with complication that 
suggest infection (T814, T857, and T813), bleeding (T810), injury to an organ (T812), 
and urinary retention (R33) were identified using the original database in SQL server. 
Using HESID both tables are linked together to identify those who were readmitted 
with one of these complications. New tables were then created that contained the 
information with regards to re-admissions under a general surgeon with infection, 
bleeding, injury to an organ and urinary retention.   
In Access 
• Using the query design, select both tables. Drag HESID from table 1 (hernia) 
into HESID table 2 (any of the complications table).  
• Double click the joint line and select number 2 use all data from table 1 and only 
data from table 2 where the joint fields are equal.  





• To identify the time from index admission till readmission, select an empty field 
and then click on expression builder.  
• Select date of admission for table 2 and double click, it will appear at the top 
box and then insert “-“. Select and double click on the date of admission of table 
1 and run. 
• The new table contains all table one data in addition to the selected fields from 
table 2 as well as the time from index admission till readmission.  
• For this study only readmission within 30 days are important. Therefore, sort the 
table by the time. Chose only the time less than 31 and delete the rest.  
• This should be repeated for the other complications and eventually be able to 
create a single table with all complication, SA, MOA. 
3.4.4.2.4  Age 
Children under 18 were then deleted from the dataset with criterion 18 or less. There 
was a problem with the data results because age less than 1 year is coded as 7001 or 
more, therefore, data for patients with age below 18 or above 7000 were deleted. 
Longer term follow-up was assessed by reoperation rate. Hernias can be left or right 
sided or bilateral and it is therefore important to update the tables with this information, 
which is included in the HES operative codes. If this information was missing patients 
were excluded from analysis. I created tables for right, left and bilateral hernia repairs 
to facilitate the follow up of these patients. This was repeated for all the years. 
3.4.4.3 Following patients across time 
Each patient operated on between 2002 and 2004 is followed to discover if any 
underwent repair for a further inguinal hernia on the same side following the index 





for all years to see if they underwent further surgery on the left side or bilateral surgery 
and patients who underwent right sided surgery will be followed to see if they 
underwent a further hernia repair on the right side or bilateral surgery. Whereas for 
bilateral surgery if they underwent any surgery on any side. Time to reoperation is 
calculated from date of the index surgery to the date of reoperation. If there is more 
than one reoperation then the time is calculated till the first reoperation.   
 
The data can be presented in a number of ways, for example the data can be presented 
in terms of hernias or patients, in terms of the type of surgery, laparoscopic versus open 
or the type of hernia, unilateral versus bilateral or recurrent versus primary. This can 
lead to quite complex analyses and this has to be borne in mind when interpreting the 
data. 
In Access 
• Click Create and then query design. Select left side hernia in 2002, 2003, 04, 
05… 2008 data.  
• Link the HESID from 2002 to all other HESID. Select 2002 and drag it to the 
table below. Click on the linking joint and select number 2.  
• Select HESID from 2003 and drag to the table below. Click on the next empty 
field and then click on expression builder. Select 2003 table and double click on 
date of admission until it appears on the top box. Enter “- “.  
• Select 2002 table and double click on date of admission. Repeat this for every 
year and run the query. A new table will be formed with new fields for every 







In order to find the first operation a new table is needed as follows. 
• Now create a new table with query design. Select the table and drag into table 
below. 
•  Click on an empty field and then click on expression builder.  
• Select the time to surgery 2003 and double click. Write & and then double click 
on the time to surgery 2004 and so on then run the query to create a new table.  
• Using “&” is mandatory because it will show results as 1 &6 into 16 rather than 
7 whereas using + will produce 7. Sort the new table by the new time to surgery 
and then remove the 6 and keep then one. This is the best and easiest way to get 
the first time to surgery. 
 
A similar approach was used for all other studies with minimal modifications depends 






4 Can HES data be used to measure rare complications 
when there is a code? 
Bowel resection is a common elective lower GI surgery and a common surgery carried 
out under emergency conditions. All general surgeons are, therefore, trained to perform 
emergency laparotomy and colectomy. One of the rare complications of bowel 
resection, Venous Thromboembolism (VTE) will be used to measure and assess the 
factors that are associated with it. VTE is one of the most important complication of 
bowel resection and all patients should receive prophylactic treatment during their 
hospital admission and for 28 days following discharge[102, 103]. VTE following 
bowel resection will be measured and all factors that increase VTE will be identified. 
Venous Thromboembolism has a specific code in ICD10 codes and it can be measured 
directly. Therefore, VTE following bowel resection is chosen as an exemplar for this 
objective. 
 
The research presents the largest dataset studying such an important and fatal 
complication following surgery and it also study factors that are associated with higher 
incidence of VTE. 
4.1 Venous thromboembolism following colorectal resection 
4.1.1 Abstract 
Aim: The study investigated the rate of significant venous thromboembolism (VTE) 
following colorectal resection during the index admission and over one year following 
discharge. It identifies risk factors associated with VTE and considers the length of 





Method: All adult patients who underwent colorectal resections in England between 
April 2007 and March 2008 were identified using Hospital Episode Statistics (HES) 
data. They were studied during the index admission and followed for a year to identify 
any patients who were readmitted as an emergency with a diagnosis of deep venous 
thrombosis (DVT) or pulmonary embolism (PE).  
 
Results: A total of 35,997 patients underwent colorectal resection during the period of 
study. The VTE rate was 2.3%. Two hundred and one (0.56%) patients developed VTE 
during the index admission and 571 (1.72%) were readmitted with VTE. Following 
discharge from the index admission, the risk of VTE in patients with cancer remained 
elevated for six months compared with two months in patients with benign disease. 
Age, postoperative stay, cancer, emergency admission, and emergency surgery for 
patients with inflammatory bowel disease (IBD) were all independent risk factors 
associated with an increased risk of VTE. Patients with ischaemic heart disease and 
those having elective minimal access surgery (MAS) appear to have lower levels of 
VTE.  
 
Conclusion: This study adds to the benefits of MAS and demonstrates an additional risk 
to patients undergoing emergency surgery for IBD. The majority of VTE occurs 
following discharge from the index admission. Therefore, surgery for cancer, 
emergency surgery for IBD, and those with an extended hospital stay may benefit from 
extended VTE prophylaxis. This study demonstrates that a stratified approach may be 






Venous thromboembolism (VTE) is a major cause of preventable morbidity and 
mortality. Each year around 25000-32000 patients die in the United Kingdom as a result 
of VTE related to hospital admission [104]. The incidence of VTE in general surgical 
patients has been reported to be as high as 25% in patients who did not receive 
prophylaxis[105]. An international consensus statement recommends that all moderate 
and high risk general surgery patients undergoing operation should receive VTE 
prophylaxis.[106] The National Institute for Health and Care Excellence (NICE) in 
England has issued guidelines that recommend VTE prophylaxis for all patients 
undergoing major abdominal surgery.[102, 103] Patients undergoing colorectal surgery 
are considered to be at high risk of VTE.[107-109] 
 
Certain factors such as cancer and major trauma are well known to increase the risk of 
VTE,[110, 111] but it is not clear whether emergency surgery with colonic resection is 
a risk factor. Although hospitalization without surgery is a risk factor for VTE,[112] 
there is little evidence to show that prolonged hospital stay following surgery increases 
the risk of VTE. Minimal access surgery (MAS) has been suggested to increase the risk 
of VTE following surgery [113, 114]. The increased risk of VTE following MAS may 
be due to prolonged operating time, increased intra-abdominal pressure from 
pneumoperitoneum, and reverse Trendelenburg position.[115] Conversely MAS may 
reduce the risk of VTE because it is associated with a shorter hospital stay and early 
mobilization in the setting of enhanced recovery. Recent studies suggest a lower risk of 
VTE following MAS compared to open colorectal surgery, [108, 116, 117] although 






The risk of symptomatic VTE following surgery remains high following discharge. 
[118] In the case of bariatric surgery Steele et al (2011) showed the rate of cumulative 
VTE increases from 0.88% during a hospital admission to 2.99% at 6 months post-
surgery.[119]  Because the risk of VTE extends beyond the index hospital admission, 
recent studies[120] suggest that patients undergoing surgery for cancer should be 
discharged with 28 days of pharmacological VTE prophylaxis. NICE guidelines were 
modified in 2010 to recommend pharmacological VTE prophylaxis for 28 days 
postoperatively for patients having major cancer surgery involving the abdomen or 
pelvis.[103] 
 
The aim of this study was to investigate the rate of VTE following colorectal resection 
by laparoscopic or open technique for benign and malignant disease during the index 
admission and for one year following discharge. The study was also used to identify 






Hospital Episodes Statistics (HES) data were obtained from the National Health Service 
Information Centre (NHSIC) and imported into Microsoft 2005 SQL server for 
analysis. All adult patients who underwent large bowel resection in England between 
April 2007 and March 2008 were identified by searching all operative fields of the HES 
dataset using Office of Population, Censuses and Surveys Classification of Surgical 
Operations and Procedures (4th revision) codes (OPCS-4). 
 
Patients undergoing laparoscopic repair were identified with the operative code Y75*, 
converted cases using Y714 and all other patients were considered open.  Pelvic surgery 
was defined as surgery involving the rectum and included anterior resection, 
abdominoperineal resection, Hartmann’s operation (H33) and panproctocolectomy 
(H04). Abdominal surgery was defined as colectomy (H05 and H11), subtotal 
colectomy (H29), right hemicolectomy (H06 and H07), transverse colectomy (H08), 
left colectomy (H09) and sigmoid colectomy (H10).  
 
Patients with a malignant diagnosis of cancer were identified using the diagnostic codes 
ICD 10 (C18 colon, C19 rectosigmoid, C20 rectum, and C21 anal canal), while all other 
diagnosis were classified as benign. Patients with benign pathology were sub classified 
into inflammatory bowel disease (IBD) using ICD10 codes (K50 for Crohn’s disease 
and K51 for ulcerative colitis) and other benign pathology. Patients were also classified 
according to surgical approach (minimal access surgery (MAS) versus open), mode of 







The mode of method was calculated by searching the admimeth (Admission Method) 
field which identifies how the patient was admitted to hospital (for elective admissions 
number 11, 12, and 13were selected and 21, 22, 23, 24 for emergency admission). 
Comorbidity was identified by searching all secondary diagnostic fields for codes for 
ischaemic heart disease, congestive cardiac failure, hypertension, renal disease, 
metastatic disease, connective tissue diseases, dementia, diabetes mellitus and 
complications, chronic pulmonary disease, paraplegia and hemiplegia, liver disease, 
cerebrovascular accident and peripheral vascular disease. The codes used for 
comorbidity was obtained from the Dr Foster Charlson comorbidity score.[121] 
 
VTE was identified during the index admission i.e. an admission during which a patient 
underwent a large bowel resection using ICD-10 codes (International Classification 
Disease 10th Edition) by searching the HES dataset for the codes for PE (I26*), DVT 
(I80.2) (thrombophelibitis of deep vessels of lower extremities), and I80.1 
(thrombophelibitis of femoral vein) in any diagnostic field except the primary 
diagnosis.  
 
To identify VTE occurring after the index admission, patients were then followed for a 
further year using HESID (The HES Patient ID (HESID) provides a way of tracking 
patients through the HES database without identifying them) to identify any who were 
readmitted to a hospital as emergency with a diagnosis of VTE in any of the first two 
diagnostic fields. Of course, not all patients with VTE required admission, but most 
with a PE and suspected PE did so. Most hospitals also treat patients with extensive 
DVT, ileofemoral, or bilateral DVT, phlagmasia alba dolens, or phlagamsia cerulosa 





a hospital with VTE and required treatment as an inpatient.  A flow chart of the 
methodology is illustrated in Figure 1. 
4.1.3.1 Statistical analysis  
Univariate analysis including Chi square, Mann Whitney, and independent t-test were 
used as appropriate. Multivariate analysis was carried out with binary logistic 
regression.  Only factors that were statistically significant (P<0.05) in univariate 
analysis were included in the multivariate analysis. All analyses were carried out using 
SPSS 13.  
 
 







Thirty-Five thousand and nine hundred and ninety-seven (35 997) adult patients 
underwent colorectal resection between April 2007 and March 2008. The mean age was 
65 years and the male to female ratio was 1:1. The median postoperative stay was 9 
(IQR 6-15) days. Two thirds (66.3%) of the patients were admitted electively and one 
third as an emergency. The majority of patients (86%) underwent open surgery and 
14% underwent MAS. More than half the procedures were performed for colorectal 
cancer (56%) and the rest were for benign pathology. A pelvic operation where surgery 
involved the rectum was performed in 42.7% of the patients and other types of 
colectomy were performed in 57.3% of cases. 2710 patients (7.5%) died during the 
index admission.  
 
 








Factors Total VTE Non VTE p-value VTE 
vs non-VTE 









duration (IQR)  
9 days (8-15) 12.5 day (8-
23) 
9 days (7-15) <0.001 
Table 1A: Univariate analysis of age and postoperative duration for patients who 




who had VTE 
Percentage  P value 
Gender 
Male 367/16989 2.2% 
NS 
Female 405/16330 2.5% 
Surgical approach 
MAS 85/4982 1.7% 
0.003 
Open 687/28391 2.4% 
Diagnosis 
Benign 280/14273 2.0% 
<0.001 
Cancer 492/19046 2.6% 
Site of surgery 
Pelvic 341/14416 2.4% 
NS 
Abdominal 431/18903 2.3% 
Mode of admission 
Elective 458/23172 2.0% 
<0.001 
Emergency 314/10147 3.1% 
Table 1B: Univariate analysis showing factors associated with increasing risk of VTE. 






Two hundred and one (0.56% (95%CI 0.49-0.64%)) patients were coded to have had 
VTE during the index admission, and 571 (1.72% (95%CI 1.47-1.72%)) were 
readmitted with VTE as the primary or secondary diagnosis as an emergency within a 
year of the index admission giving an overall rate of VTE at one year of 2.3% (95%CI 
2.13-2.44%), most occurring in the first six months following surgery (Figure 2). 
















Percentage P value 
Ischaemic heart 
disease 
R 10% 56/3352  1.7% 
0.009 
NR  716/29967 2.4% 
Cerebrovascular 
accident 
R 0.8% 8/263  3% 
NS 
NR  764/33056 2.3% 
Congestive 
Cardiac Failure 
R 1.4% 18/460 3.9% 
0.022 
NR  754/32859 2.3% 
Connective 
Tissue disorder 
R 1.3% 10/423 2.4% 
NS 
NR  762/32869 2.3% 
Dementia 
R 0.4% 4/144 2.8% 
NS 
NR  768/33175 2.3% 
Diabetes 
Mellitus 
R 9.4% 63/3114 2% 
NS 
NR  709/30205 2.3% 
Liver disease 
R 1.4% 7/487 1.4% 
NS 
NR  765/32832 2.3% 
Peripheral 
vascular disease 
R 2.0% 20/675 3.0% 
NS 
NR  752/32644 2.3% 
Pulmonary 
diseases 
R 10.2% 83/3393 2.4% 
NS 
NR  689/29926 2.3% 
Paraplegia 
R 0.4% 5/116 4.3% 
NS 
NR  767/33203 2.3% 
Renal disease 
R 2.2% 26/740 3.5% 
0.029 
NR  746/32579 2.3% 
Metastatic 
disease 
R 9.6% 97/3204 3.0% 
0.005 
NR  675/30115 2.2% 
Hypertension 
R 28.7% 243/9352  2.6% 0.033 





Increasing age, prolonged postoperative stay, open surgery, cancer and emergency 
admission were all associated with an increased rate of VTE, whereas pelvic surgery 
and gender were not associated with higher rate of VTE (Table 1A&B). 
 
Comorbidity including congestive cardiac failure, hypertension, and renal disease were 
associated with an increased risk of VTE. In contrast, patients with ischaemic heart 
disease appeared to have a lower rate of VTE (Table 2).  
 
Table 2 showed the percentage of each comorbidity from the total cohort. the 
proportion and percentage of VTE in each comorbidity and the P value comparing the 
percentage of VTE in each comorbidity to those with no co-morbidity. For example, 
10% of patients were recorded to have ischemic heart disease. Only 1.7% of those 
developed VTE compared to 2.4% of patients who were not recorded to have ischemic 
heart disease but developed VTE (P=0.009).  
 
 
Factors OR (95% CI) P value 
Ischaemic heart disease 0.587 (0.443-0.778) <0.001 
Congestive cardiac disease 1.471 (0.902-2.401) NS 
Hypertension 1.116 (0.949-1.313) NS 
Renal disease 1.081 (0.714-1.636) NS 
Metastatic disease 1.166 (0.932-1.460) NS 
Age 0.994 (0.988-0.999) 0.026 
Postoperative stay 0.990 (0.987-0.993) <0.001 
Surgical approach MAS 1 
1.208 
 NS 
Open  (0.957-1.524) 
Pathology Benign 1  <0.001 
Cancer 1.488 (1.251-1.771) 
Mode of admission Elective 1  <0.001 
Emergency 1.632 1.390-1.971) 
Table 3: Multivariate analysis (binary logistics regression) shows factors associated 






Factors that were significantly associated with VTE on univariate analysis were 
included in the multivariate analysis (binary logistic regression). When the cohort was 
analysed as a whole, prolonged postoperative stay, increased age, emergency 
admission, and cancer were independent factors associated with a higher VTE rate 
whilst patients wi ischaemic heart disease were less likely to develop VTE. All other 
factors including surgical approach were not associated with VTE as shown in Table 3. 
 
The proportion of patients admitted as an emergency that underwent MAS was small 
(10%) compared with open surgery. patient characteristics of MAS vs open surgery are 
listed in table 4 
Factors MAS Open P value 
Age (Mean SD)Years 65.2 (50-80) 65.5 (50-80 NS 
Postoperative duration (Median IQR) 
Days 
7 (4-10) 10 (7-16) <0.001 
Pathology 
Cancer 66.2% 54.3% 
<0.001 
Benign 33.8% 45.7% 
Gender 
Male 50.8% 50.9% 
NS 
Female 49.5% 49.1% 
Site of surgery 
Pelvic 40.9% 43.0% 
0.004 
Abdomen 59.1% 57.0% 
Mode of admission 
Elective 90.0% 62.5% 
<0.001 
Emergency 10.0% 37.5% 
Table 4: Characteristics of MAS versus open patients 
To eliminate any discrepancy between both groups due to the type of admission, the 
analysis was repeated for elective cases only.  This demonstrated that the surgical 
approach was an independent factor associated with increased risk of VTE in patients 
undergoing elective surgery. Open surgery increased the risk of VTE significantly 





The risk of a VTE was high during the index admission and for first few months 
following discharge. The risk of readmission with VTE following surgery for cancer 
remained high for six months following discharge, whereas the risk following surgery 
for benign disease reduced after two months (Figure 3). 
 
Factors OR (95% CI) P value 
Ischaemic heart disease 0.520 0.520 (0.351-
0.769) 
<0.001 
Congestive cardiac disease 0.536 0.536 (1.70-1.698) NS 
Hypertension 1.054 1.054 (0.855-
1.300) 
NS 
Renal disease 1.237 1.237 (0.646-
2.367) 
NS 
Metastatic disease 1.394 1.394 (1.064-
1.827) 
0.016 
Age 0.995 0.995 (0.988-
1.003) 
NS 
Postoperative stay 0.990 0.990 (0.986-
0.994) 
<0.001 
Surgical approach MAS 1 1 0.043 
Open 1.307  (1.008-1.693) 
Pathology Benign 1 1 0.004 
Cancer 1.412 (1.114-1.789) 
Table 5: Multivariate analysis (binary logistics regression) shows factors associated 
with VTE (elective cases only) 
 
 





Patients who underwent surgery for cancer as an emergency had the highest rate of 
readmission for VTE, followed by patients who had elective surgery for cancer 
regardless of the period they spend in hospital following surgery during the index 
admission (Figure 4).  
 
Figure 4: Readmission with VTE and postoperative stay (pathology and mode of 
admission) 
 
The risk of readmission with VTE for patients who underwent surgery for benign 
pathology (whether elective or emergency) was low if the patients spent less than a 
week in the hospital whereas the risk increased significantly if they spent more than a 
week in the hospital.  
When benign pathology was subdivided into IBD and other benign disease, the former 
appeared to be associated with a higher rate of readmission with VTE compared with 
other benign disease (2.1% vs 1.7%). Most VTE in IBD patients occurred in patients 







Figure 5: Readmission with VTE method of admission and pathology ( cancer, IBD, 
and other benign disease). 
 
The length of hospital stays remained a major factor in readmission with VTE 
following discharge for all pathologies (cancer, IBD and benign) as shown in Figure 6. 
Multivariate analysis was performed for patients underwent emergency surgery for 
bowel resection and showed patients with IBD are significantly associated with VTE 






Figure 6: Readmission with VTE postoperative stay and pathology ( cancer, IBD, and 
other benign disease). 
 
 
Factors OR  (95% CI) P value 
Ischaemic heart disease 0.451 (0.257-0.793 0.006 
Congestive cardiac disease 1.424 (0.944-2.147) NS 
Hypertension 0.804 (0.621-1.042) NS 
Renal disease 0.984 (0.572-1.693) NS 
Metastatic disease 1.278 (0.858-1.904) NS 
Age 1.010 (1.002-1.019) 0.018 
Postoperative stay 1.011 (1.005-1.013) <0.001 
Surgical approach MAS 1  NS 
Open 1.245 (0.743-2.088) 
Pathology Benign 1  <0.001 
IBD 1.999  (1.353-2.952) 
Cancer 2.111 (1.608-2.771) 
Table 6: Multivariate analysis (binary logistics regression) shows factors associated 






4.1.5 Discussion  
 
This study showed that with a year’s follow up, the overall VTE rate in England in the 
year 2007 to 2008 following colorectal surgery was 2.3%. The results from this study 
were very similar to those from previous publications.[122]  
 
NICE guidelines for the prophylaxis of DVT were introduced in 2007 and then 
amended in 2010 to recommend prolonged pharmacological prophylaxis in patients 
undergoing resection for malignancy.[123]  As we set out to examine the rates of VTE 
on the index admission and following discharge and since it was likely that the majority 
of colorectal resection patients with both benign and malignant disease had received in 
hospital pharmacological prophylaxis we chose to study the year 2007-2008 because 
prolonged pharmacological treatment in patients undergoing resection for malignancy 
was not yet in routine use. We cannot of course say what VTE prophylaxis this cohort 
of patients had, but we believe that the use of this time facilitated the comparison of the 
malignant and non-malignant groups. 
 
Only a quarter of patients coded as developing a VTE were identified on the index 
admission. Further because there was no facility within HES to identify when a patient 
had suffered a VTE then some of the patients identified as having suffered a VTE on 
the index admission may have suffered this historically.  However, when coders found 
VTE in the past history taken at admission and they included it in the diagnostic code 
for completeness, they tended to use the 'Z (Personal history of...) Code'. Therefore, by 
searching for I codes only, we assumed only those with acute VTE were selected rather 
than those with a previous history of VTE. Another issue of the study was that other 





searching recent preceding years for an admission.  We have therefore chosen to present 
the data in its unabridged form and acknowledge this as a concern, i.e. that the 
incidence of VTE on the index admission may be an overestimate. Two studies were 
recently published investigating the risk of VTE and surgery by linking HES data to 
primary care data. Humes et al[124] investigated the risk of VTE following colectomy 
but not rectal surgery and Bouras et al [125] investigated VTE rate following a number 
of surgery including thyroid, breast and hernia. Both studies found similar results. The 
one year VTE rate was recorded to be 2.5% by the former study and the 90 days VTE 
rate was 2.11% in the latter. Obesity is a known risk factor for VTE. Searching HES 
data for obesity codes is feasible, but we think it is significantly under recorded. 
Therefore, it was not included in the study. 
 
Most VTEs occur in patients who are readmitted during the year after the index 
admission. We have only included readmissions if the VTE code is in the first or second 
field making it much more likely that VTE was the reason for the readmission. Another 
limitation to the present study was it only detected patients readmitted with VTE not 
those who developed it in the community or who were treated in an ambulatory setting 
without admission to hospital. The patients who were admitted to the hospital were, 
however, the high risk group. Patients with significant DVT (e.g. ileofemoral DVT, 
phlagmasia alba dolens, or phlagamsia cerulosa dolens) and most patients with acute PE 
or suspected PE were normally admitted to hospital and would have been be included 






Cancer and its treatment is a well-known risk factor for VTE[110] and it is no surprise 
that this study confirmed this finding. However, in addition, this study demonstrated 
that the risk of VTE remained elevated for at least six months following discharge.   
 
Prolonged post-operative hospital stay and increasing age were also associated with an 
increased risk of VTE which may have been due to poor mobility of patients especially 
in the elderly. Patients admitted as an emergency also had an increased risk of VTE and 
were likely to be sicker with poorer mobility and in a poor nutritional state compared 
with patients undergoing elective surgery. 
 
When the full cohort of patients was analysed, binary logistic regression did not find 
any difference in the rate of VTE between patients undergoing MAS and open surgery. 
Most patients undergoing MAS were admitted electively, however, whereas a third of 
open surgical operations was performed following an emergency admission. The 
analysis was therefore repeated for all patients who were admitted electively. In this 
subgroup those undergoing MAS were shown to have a lower incidence of VTE than 
after open surgery.  This may be an additional benefit of MAS over open surgery 
perhaps due in part to shorter hospital stay and early mobilization due to better pain 
control. 
 
Patients with ischaemic heart disease had a lower incidence of VTE (Odds ratio 0.520 
and 95% CI (0.351-0.769)). These patients are routinely started on antiplatelet 
medication or anticoagulation which may act as a protective factor against developing 






The study has other limitations. It is a retrospective population based cohort study using 
data derived from Hospital Episode Statistics. HES are routinely collected by all 
hospitals in the NHS in England and the validity of the results therefore depends on the 
accuracy and depth of coding.  Nevertheless, previous studies have suggested that the 
accuracy of recording of diagnostic and operative codes in England is high,[56] but 
researchers still have to recognize and account for a degree of coding inaccuracy. HES 
has been shown to be useful for the assessment of effectiveness, comparative audit, and 
equity.[126] A recent systematic review showed that coding accuracy was improving 
and following the introduction of payment by result programme in 2002 the accuracy of 
primary diagnoses had increased from 73.8% (IQR: 59.3-92.1%) to 96.0% (IQR: 89.3-
96.3).[127] Another limitation of this study is that data derived from HES cannot assess 
whether patients received VTE chemoprophylaxis and for how long although by 
choosing the time point studied we have tried to reduce the effect of this confounding 
factor.  
 
In 2010 NICE recommended the use of subcutaneous heparin in patients with 
malignancy for 28 days following discharge after surgical resection.[103] The study 
showed that only a quarter of patients who developed VTE did so during index 
admission and the risk of VTE remained high for six months following surgery. The 
four week period recommended may, therefore, not be adequate. Further studies to 
assess the risk of VTE following the introduction of NICE guideline 2010 may be 







Patients with benign pathology had a lower rate of VTE than those for malignant 
disease; however in those with a prolonged stay, the rate of VTE was similar to those 
seen in patients with a diagnosis of cancer. We would suggest that patients with benign 
disease undergoing resection who have an inpatient stay for more than 15 days 
following surgery should therefore be considered for prolonged thromboprophylaxis 
following discharge.  
 
Patients with IBD were at higher risk of developing VTE compared with healthy 
controls. [128] This study confirmed increased rates of VTE in IBD although elective 
surgery for IBD appeared to have a much lower rate of readmission with VTE 
compared with emergency surgery. This may in part be due to a prolonged hospital 
stay.  
 
VTE is a preventable condition, hence we believe every effort should be taken to reduce 
or eliminate the risk. The present study clearly demonstrated that a stratified approach 
which takes into account hospital stay and pathology may be needed to reduce the 
incidence of postoperative VTE in patients undergoing colorectal resection. Patients 
with a diagnosis of cancer and those undergoing colorectal resections for benign 
condition with extended hospital stay including IBD may benefit from an extended 






5 Can HES data be used to identify rare complications of 
surgery when there is no code available for this 
complication? 
Measuring complications is not difficult if the codes of those complications are 
available, however, there are times when there are no codes available for complications. 
In those situations, either the study is abandoned or a different methodology is needed. 
If the study is deemed to be important and the results of such studies are needed a 
different approach is necessary. In these situations, a surrogate code is necessary to 
identify those complications. 
 
Gallstone disease is very common and the incidence is on the rise. Each year over 
60000 patients are admitted to an NHS hospital to have their gallbladder removed as 
illustrated later in this chapter. Laparoscopic surgery was first used to remove 
gallbladder back in the early 1990 and has since become the standard of care. There are 
several complications that can develop during gallbladder surgery such as bleeding, 
infection, bile leak, VTE, retained stone, collections, and bile duct injury.  
 
Bile duct injury is the most important complication following cholecystectomy. Indeed, 
it is rare but it can cause serious harm to the patient. The average pay-out to patients 
who suffer from bile duct injury is £102,000[129]. Unfortunately, there is no code in 
the ICD10 that identifies bile duct injury. I, therefore, created a new system to measure 
bile duct injury using Bile Duct Reconstruction (BDR) as a surrogate marker for the 
injury. There is potential for this secondary marker to be confounded and there is a need 





5.1 Bile duct reconstruction following laparoscopic 
cholecystectomy in England. 
5.1.1 Abstract 
Objectives: To determine the incidence of bile duct reconstruction (BDR) following 
Laparoscopic Cholecystectomy (LC) and to identify associated risk factors. 
 
Background: Major bile duct injury requiring reconstruction is a serious complication 
of cholecystectomy.  
 
Methods: All LC and attempted LC operations in England between April 2001 and 
March 2013 were identified. Patients with malignancy, a stone in bile duct or those who 
underwent bile duct exploration were excluded. This cohort of patients was followed 
for one year to identify those who underwent BDR as a surrogate marker for major 
BDI. Logistic regression was used to identify factors associated with the need for 
reconstruction. 
 
Results: A total of 572223 LC and attempted LC were performed in England between 
April 2001 and March 2013. 500 (0.09%) of these patients underwent BDR. The risk of 
BDR for Admission with other causes is significantly lower than acute cholecystitis 
(Odds ratio OR0.48 (95%CI 0.30—0.76). The regular use of On Table 
Cholangiography (OTC) (OR 0.69 (0.54—0.88) and high consultant caseload >80 
LC/year (OR 0.56 (0.39—0.54) reduced the risk of BDR. Patients who underwent BDR 
were 10 times more likely to die within a year than those who did not require further 






Conclusions: The rate of BDR following laparoscopic cholecystectomy in England is 
low (0.09%). The study suggests that OTC should be used more widely and provides 
further evidence in support of the provision of LC services by specialised teams with an 






Laparoscopic cholecystectomy (LC) is a common operation, with over 60,000 
operations undertaken each year in England. Based on conversion rate it has been 
suggested that LC should be undertaken by high volume surgeons[130].  
 
Bile duct injury (BDI) is a rare but serious complication of cholecystectomy and the 
reported incidence following LC is between 0.1% and 1.5%[131-137].  Gallrick 
study[135] showed that the overall incidence of BDI was 1.5%; however, they included 
patients with bile leaks, partial duct injury, and non-specific injuries that would not 
have required reconstruction. The rate decreases to 0.1% if only the most serious cases 
of BDI are included[135].  BDI is associated with significant morbidity and mortality. 
Early complications include collections or peritonitis and if not treated sepsis, multi-
organ failure and death[138]. Patients who sustain a BDI are also at risk of long-term 
problems including strictures, cholangitis, and secondary biliary cirrhosis requiring 
multiple hospital admissions, a shortened life expectancy and transplantation[139]. The 
reported peri-operative mortality rate following BDI varies between 0% and 7.2% [134, 
140-142] with a one year mortality of 3.9%[135].  A review of the literature showed 
(602 BDI from 15 studies) that the adjusted hazard ratio of death in the longer term in 
those sustaining BDI compared to those without BDI following LC or attempted LC 
was 2.79 (95% CI 2.77-2.81)[133]. 
 
This study investigates Bile Duct Reconstruction (BDR) following LC or attempted LC 






Hospital Episode Statistics (HES) data were obtained from the National Health Service 
Information Centre (NHSIC) and imported into Microsoft SQL server for analysis. All 
patients who underwent LC or attempted LC between April 2001 and March 2013 were 
identified by searching the operative fields for the OPCS-4 (Office of Population 
Censuses and Surveys 4) codes J18* (cholecystectomy) and the corresponding 
laparoscopic codes.  
 
Using diagnostic codes, International classification of Diseases Version 10 (ICD 10), 
patients undergoing surgery for benign biliary disease of the gallbladder were 
identified.  Those who underwent LC or attempted LC for a stone in the bile duct or for 
a malignant neoplasm of the liver, gall bladder, biliary tree or pancreas were excluded. 
 
There is no specific code for BDI in either ICD-10 or OPCS-4; therefore operative 
codes that are used for BDR were used to identify patients who required biliary 
reconstruction following LC or attempted LC. The cohort of patients was followed 
using HESID (a unique identifier for each patient in HES) to identify patients who 
underwent BDR within a year of the index operation. If a patient underwent more than 
one BDR only the first operation was included in the analysis.  
 







Figure 1: Study design 
 
Factors that may affect the risk of BDR were divided into patient and non-patient 
groups. Patient related factors studied included age, gender, acute pancreatitis, acute 
cholecystitis, comorbidity, and deprivation index score.  The Charlson comorbidity 
score was calculated using methods described by Dr Foster.[121] The deprivation index 
score was used as described in the English indices of deprivation.[143] 
 
Codes used for cholecystectomy 
J181 Total cholecystectomy and surrounding tissue 
J183 Total cholecystectomy 





J188 Other excision of gall bladder 
J189 Unspecified excision of gall bladder 
Codes used for intraoperative cholangiography 
J372 Operative cholangiography through cystic duct 
  
J373 Direct puncture operative cholangiography 
Codes used for laparoscopic surgery and conversion 
Y718 Failed minimal access approach converted to open (before 2006) 
Y714 Failed minimal access approach converted to open (after 2006) 
Y508 Laparoscopic approach to abdominal cavity (before 2006) 
Y75* 
Laparoscopic approach to abdominal cavity (assisted, robotic, hand 
assisted and other approach) (after 2006) 
Codes used for diagnosis 
K800 Calculus of gall bladder with acute cholecystitis 
K801 Calculus of gall bladder with other cholecystitis 
K802 Calculus of gall bladder without cholecystitis 
K808 Other cholelithiasis 
K810 Acute cholecystitis 
K811 Chronic cholecystitis 
K818 Other cholecystitis 
K819 Unspecified cholecystitis 
K82* Other diseases of gall bladder 
K832 Perforation of bile duct 





Codes used for exclusion in the diagnosis fields 
K803 Calculus of bile duct with cholangitis 
K804 Calculus of bile duct with cholecystitis 
K805 Calculus of bile duct without cholecystitis or cholangitis 
K830 Cholangitis 
K823 Fistula of gall bladder  
K831 Obstruction of bile duct 
K833 Fistula of bile duct 
C22* Malignant neoplasm of liver and intrahepatic duct 
C23 Malignant neoplasm of gallbladder 
C24* Malignant neoplasm of other parts biliary tract 
C25* Malignant neoplasm of pancreas 
Codes used for exclusions in the operative fields 
J182 Total cholecystectomy and exploration of common bile duct 
J184 Partial cholecystectomy and exploration of common bile duct 
Codes used to identify bile duct reconstruction 
J27.2 Partial excision of bile duct and anastomosis of bile duct to duodenum 
J27.3 Partial excision of bile duct and anastomosis of bile duct to jejunum 
J27.4 Partial excision of bile duct and end to end anastomosis of bile duct 
J29.1 
Anastomosis of hepatic duct to transposed jejunum and insertion of tubal 
prosthesis HFQ 
J29.2 Anastomosis of hepatic duct to jejunum NEC 
J30.1 Anastomosis of common bile duct to duodenum 





J30.3 Anastomosis of common bile duct to jejunum NEC 
J32.1 Reconstruction of bile duct 
J32.2 Re-anastomosis of bile duct 
Table 1: Operative and diagnostic codes used in this study 
Non-patient related factors included were consultant caseload, hospital volume, 
consultant conversion rate, whether a trust was a regional Hepato-Pancreato-Biliary 
(HPB) centre and consultant rate of use of intraoperative cholangiography (IOC): 
Definitions are summarized in table 2. 
Factors Definitions 
Non-patients related factors 
Consultant caseload Total number of operations performed under the care of a 
consultant in the previous year 
Consultant 
conversion rate 
Number of laparoscopic cholecystectomies converted divided by 
the total number of LC and attempted LC under the care of that 
consultant in the previous year 
Hospital volume Total number of laparoscopic cholecystectomies performed by an 
NHS Trust in the previous year 




Number of OTC's performed by a consultant divided by the total 
number of LC attempted under the care of that consultant in the 
previous year 
Patient related factors 
Acute cholecystitis Patients admitted as an emergency with diagnostic codes  K800 
or K810 who undergo cholecystectomy on that admission 





K85*who undergo cholecystectomy on that admission 
Major bile duct 
injury 
Patient who underwent bile duct reconstruction within a year of 
index admission. i.e hepaticojejunostomy, 
hepaticodeudenostomy, or resection of injured bile duct and 
reanastamosis.  
Table 2 Definitions used in this study 
 
Mortality was assessed for all patients using data derived from the Office of National 
Statistics. One-year mortality was then calculated for patients with or without BDR.  
5.1.3.1 Statistics 
Univariate analysis and multivariate analysis (logistic regression) was used to 
investigate which factors are associated with a risk of bile duct reconstruction.  
 
A funnel plot was used to examine institutional variation and shows the standardised 
ratio of BDRs at 1-year following LC plotted against the number of expected BDRs. 
The expected number of BDRs is derived using a multivariate logistic regression model 
that accounts for patient related factors. The BDR ratio was calculated by dividing 
observed BDR per year over expected BDR per year multiplied by 100. Each hospital is 
represented by a blue dot. The dotted lines show the lower and upper 95% control limit 
and the solid lines the upper and lower 99.8% control limit as described by Eayers[144]. 
If a hospital falls outside the 99.8% control limit, this is considered to be the result of 







572 223 LC or attempted LC were performed in England Between April 2001 and 
March 2013, Table 3. More than half (56%) were undertaken in patients under 55 years 
of age while 7.2% were performed in patients above 75 years. Just over three quarters 
of LC or attempted LC were undertaken in females. The majority of LC was performed 
electively (89%). Almost a third of emergency LC was performed for acute 
cholecystitis and 13.3% for acute pancreatitis. The number of LC performed in the NHS 
in England almost doubled from 32 086 in 2001/02 to 62 020 LC during 2012/13. The 
overall conversion rate of LC in England is 4.3%. One-year mortality rate following LC 
in England is 0.6%. Around half of the patients who underwent LC or attempted LC 
had their surgery under the care of a consultant surgeon who performs between 20 and 
80 cases a year and a quarter of patients underwent surgery under care of consultants 
who perform less than 20 or more than 80 cases a year. 
 
No of cholecystectomies Bile duct reconstruction  % 
Total 572,233 500 0.09% 
Age Group 
   
<55 319,632 220 0.07% 
55-64 119,663 114 0.10% 
65-74 90,700 95 0.10% 
75+ 41,907 71 0.17% 
Not recorded 331 0 0.00% 
Gender 
   
Males 135,478 178 0.13% 
Females 436,606 322 0.07% 
Not recorded 149 0 0.00% 
Ethnicity 
   
White 451,869 405 0.09% 
Asian or Asian British 20,106 25 0.12% 





Other Ethnic Groups 5,657 9 0.16% 
Mixed 2,315 3 0.13% 
Chinese 1,059 0 0.00% 
Unknown 83,099 51 0.06% 
Deprivation (quintile) 
   
1-Most deprived 122,185 100 0.08% 
2 118,715 114 0.10% 
3 116,686 101 0.09% 
4 110,811 96 0.09% 
5-Least deprived 100,190 83 0.08% 
Not recorded 3,646 6 0.16% 
Tertiary Centre 
   
No 461,346 386 0.08% 
Yes 110,887 114 0.10% 
Admission method 
   
elective 510,260 435 0.09% 
emergency 61,406 65 0.11% 
transfer 431 0 0.00% 
other 136 0 0.00% 
Acute cholecystitis (index admission) 
No 551,812 478 0.09% 
Yes 20,421 22 0.11% 
Acute pancreatitis (index admission) 
No 564,077 493 0.09% 
Yes 8,156 7 0.09% 
Year of index admission 
2001/02 32,086 28 0.09% 
2002/03 37,290 36 0.10% 
2003/04 40,824 53 0.13% 
2004/05 39,533 33 0.08% 
2005/06 42,573 35 0.08% 





2007/08 50,702 43 0.08% 
2008/09 50,689 49 0.10% 
2009/10 53,748 32 0.06% 
2010/11 56,254 49 0.09% 
2011/12 61,465 52 0.08% 
2012/13 62,020 40 0.06% 
Converted 
Yes 25,513 254 1.00% 
No 546,720 246 0.04% 
No. Procedures per Institution (previous year, exc.2001/02) 
 
Low volume <200 113,391 82 0.07% 
Middle volume 200-500 286,943 258 0.09% 
High volume >500 139,813 132 0.09% 
No. Procedures per Consultant (previous year, exc.2001/02) 
 
Low volume <20 144,713 149 0.10% 
Middle volume 20-80 254,224 238 0.09% 
High volume >80 141,210 85 0.06% 
Table 3: Demographics of study cohort 
 
Five hundred patients underwent BDR within one year of a LC (0.09%). Patients who 
underwent BDR following LC were 10 times more likely to die within a year of the 
index cholecystectomy (6% vs 0.6%), Table 3. Over the study time period, there is a 







Figure 3: Trend of BDR over the study period 
 
 
5.1.4.1 Patient related factors 
Univariate analysis showed that patient related factors including increasing age, and 
male sex were significantly associated with bile duct reconstruction. However; 
multivariate analysis did not confirm these associations suggesting that other factors 
may be responsible for these findings (Table 4). Only patients with acute cholecystitis 
who undergo LC on the index admission were found by both univariate and 
multivariate analysis to have an increased risk of BDR 
 
Odds Ratio - Bile duct Reconstruction (95% CI) P Value 
Age group <55 1.00   
55-64 0.97 (0.76-1.23) NS 
65-74 0.86 (0.67-1.12) NS 
75+ 1.22 (0.91-1.63) NS 
Gender Females 0.89 (0.73-1.09) NS 
Deprivation    





2 1.24 (0.94-1.64) NS 
3 1.13 (0.85-1.51) NS 
4 1.15 (0.86-1.55) NS 






No acute pancreatitis 0.81 (0.36-1.83) NS 
Charlson score 0.94 (0.80-1.10) NS 
Cholangiography (index admission) 2.73 (2.10-3.56) <0.001 
Converted procedure 22.89 (18.75-27.94) <0.001 




Low volume <20 1.00   
Middle volume 20-80 0.80  NS 
High volume >80 0.56  <0.001 




Low volume <200 1.00   
Middle volume 200-500 1.07  NS 
High volume >500 1.31  NS 
Tertiary Hospital 1.19  NS 
Consultant conversion rate - quartiles 
(previous year, exc.2001/02) 
  
 





2 1.05 (0.72-1.54) NS 
3 1.07 (0.8-1.43) NS 
4- highest 0.95 (0.74-1.24) NS 
Consultant cholangiography rate - tertiles 
(previous year, exc.2001/02) 
  
 
1- lowest tertile 1.00   
2 1.17 (0.86-1.58) NS 
3 0.69 (0.54-0.88) 0.003 
Table 4: Multivariate analysis of factors that may be associated with bile duct 
reconstruction following LC or attempted LC 
 
5.1.4.2 Non patient related factors 
Univariate and multivariate analysis showed that high volume consultant caseload >80 
LC/year is associated with a lower rate of bile duct reconstruction. 
There was a strong association between conversion and BDR OR 22.89 (95%CI 18.75-
27.94)  p<0.001) which may be due to surgeons converting to open surgery when they 
suspect a BDI. Therefore, we used consultant conversion rate in the year before rather 
than conversion in an individual case. There was no association between consultant 
conversion rate in the previous year and BDR following LC or attempted LC. 
 
Similarly, there was a strong association between the use of OTC and BDR in 
individual cases (P<0.001). This may be due to surgeons using OTC when they suspect 
a BDI but when consultants are divided into tertiles on the basis of their use of OTC in 
the year before the index case, those who use it more frequently have a lower rate of 






Trust caseload volume was divided into low volume providers <200 LC/year, 
intermediate volume provider between 200 and 500 LC/year and high volume 
providers, which perform more than 500 LC/year. Univariate and multivariate analysis 
did not show any association between Trust caseload volume and bile duct 
reconstruction. There was no difference in the rate of BDR following LC or attempted 
LC if the index procedure was undertaken in an HPB centre as compared to a non-HPB 
centre.  
 
A funnel plot was used to examine whether some hospitals have a higher rate of BDR 
following LC/attempted LC. As illustrated in figure 2, all hospital results are within the 
95% confidence interval. Most repairs are performed in the hospital in which an injury 




No. bile duct 
reconstructions  
Number performed at 
different hospital 
% Bile duct repairs 
not in same Hospital  
2001/02 28 10 35.7% 
2002/03 36 12 33.3% 
2003/04 53 15 28.3% 
2004/05 33 14 42.4% 
2005/06 35 16 45.7% 
2006/07 50 24 48.0% 
2007/08 43 13 30.2% 
2008/09 49 19 38.8% 
2009/10 32 11 34.4% 
2010/11 49 18 36.7% 
2011/12 52 21 40.4% 
2012/13 40 22 55.0% 













This is the largest study of its kind in the literature that examines BDR following LC or 
attempted LC in England. It investigates all patients who underwent LC surgery in 
England over a 12 year period which represents 1.1% of the total population of 
England. The apparent rate of reconstruction and therefore presumed bile duct injury is 
in keeping with published series (the previous literature for major injuries). Patient 
related factors associated with BDR include cholecystitis on the index admission. Non-
patient related factors associated with a lower reconstruction rate include a high 
consultant cholecystectomy caseload and regular use of OTC. There is a tenfold 
increase in mortality at one year in patients who have undergone a BDR (at one year) 
demonstrating how serious this complication can be. 
 
This study suggests that the incidence of BDR following LC in England is low (0.09%) 
with only 500 cases over a 12-year period. Data from other registries show that  the 
incidence of BDI in Germany is 0.1% (172 368 LC);[131] in Denmark 0.15% (23 672 
LC);[132] in the USA between 0.06%- 0.5%[133, 145]; in Finland 0.82% (6 733 
LC)[134]; and in Sweden 1.5% (51 041 LC)[135] although major BDI in this study 
accounts for only 0.1%. However, researchers have to understand that different 
definitions of what constitutes BDI make comparative analysis difficult. Other reports 
from large single centre studies (over 10 000 LC) showed the incidence of BDI is 
between 0.19%[137] and 0.24%[136]. There was a trend towards a reducing need for 
BDR during the study period, which may represent an increased awareness of methods 






The study has a number of limitations. There are no codes for BDI and we therefore 
used codes for bile duct reconstruction. Other studies using registry data have used 
similar methodology[131-133, 146]. Patients who sustain a BDI and die without 
surgical intervention will not be included in this analysis. This study only identifies 
major duct injuries that require reconstruction, whereas minor injuries that require 
simple repair, drainage or ERCP and stenting are not included. Therefore, the study 
underestimates the incidence of BDI. Nevertheless, most minor injuries are associated 
with a lower rate of complications, and lower long-term morbidity.  However, the study 
does include those patients who fail to respond to ERCP and stenting or who develop 
stenosis of bile duct that requires delayed (within a year) surgical reconstruction.  
 
The study uses HES data which is administrative data that relies on the accuracy of 
clinical coding. A recent systematic review shows coding accuracy is improving and 
following the introduction of payment by results in 2002 the accuracy of coding for 
primary diagnoses has improved from 73.8% (IQR: 59.3-92.1%) to 96.0% (IQR: 89.3-
96.3)[127]. Further studies based on HES are cohort studies; they differ from the usual 
cohort studies in that they represent almost all activity within the area of study in 
England. One also has to consider the context of conclusions that are drawn from 
studies using HES. If findings are of a general nature, then even a relatively high coding 
error rate at some hospitals or even all hospitals will not detract markedly from the 
overall conclusions if significant deviation can be shown[147]. Thus studies based on 
HES data may actually be good at dealing with research questions such as those posed 
in this study but are less good at identifying variations in care between individual trusts 





injuries as the coding issues are complex and we feel that it would be difficult to draw 
valid conclusions from the data. 
 
Cholecystectomy is considered by many surgeons to be more difficult in male as 
compared to female patients and this may lead to a higher complication rates. Our data 
showed male gender is associated with almost double the rate of BDR (0.13%) 
compared to female patients (0.07%). However, this difference is not statistically 
significant when an adjustment is made for other factors.   
 
Age has been shown to be an independent risk factor for BDI[149] and mortality 
following BDI[133]. Associated co-morbidities, frailty, use of anticoagulants, and 
previous abdominal surgeries have been postulated to contribute to the increase risk in 
the elderly [149].  Data from this study showed BDR following LC in elderly patients 
>75 years (0.17%) was more than that in those below 55 years (0.07%). However, 
multivariate analysis did not reveal any significant difference, which is due to other 
factors adjustment. 
 
The calibre of the bile duct increases with age which may make simple repair easier in 
older patients [150, 151]. Whether simple suture repair of the bile duct can be 
accomplished depends on many other factors for example the presence of a clean 
laceration identified at the same time of surgery together with a wide calibre bile duct. 
 
Several studies[152-154] have shown that bile duct injury repaired at an HPB centre is 
associated with a better outcome as compared to those repaired in a general hospital. 





Centralization of HPB services has progressed rapidly in the UK with most major 
resections occurring in HPB centres during the study period. Many of those surgeons 
who used to perform resectional biliary surgery may still practice in their local hospital. 
Further some regions offer an outreach service where a BDI injury may be treated in the 
local hospital by a surgeon from the regional unit. 
 
Most surgeons in the UK perform OTC selectively. Large studies based on registry data 
have produced conflicting results. While some show that the risk of BDI decreases 
when OTC is performed[135, 146, 155-157], others, including a systematic review[158] 
show no benefit[159]. The study showed that surgeons who use OTC more frequently 
have a lower rate of BDR following LC.  
 
The study did not show any difference in BDR following LC between low and high-
volume NHS providers or HPB centres and general hospitals suggesting that all NHS 
providers deliver a satisfactory cholecystectomy service. However, it appears consultant 
caseload is an independent risk factor for BDR following LC. Surgeons who perform 80 
LC/year or more have a lower rate of BDI than low volume surgeons. Further BDI 
appears to be more common in patients who undergo cholecystectomy on an index 
emergency admission with acute cholecystitis.  
 
These results suggest that more widespread use of OTC could also help to reduce the 
incidence of BDI. They do not support centralization of cholecystectomy services; 
however they do suggest that to avoid major bile duct injury the development of 





reduce the incidence of this complication and further suggests that the occasional 





6 Can HES data be used to compare different types of 
surgery for the same condition?  
 
Inguinal hernia is traditionally repaired using open approach. In the last 20 years, 
laparoscopic approach has been used as an alternative method. Laparoscopic approach 
has gradually increased in popularity among surgeon. The literature review did not 
identify research to confirm if the laparoscopic approach is superior to the open 
approach for inguinal hernia.  
 
There are multiple approaches to study superiority such as superiority studies, 
equivalence studies and non-inferiority study. In this study it is proposed that a 
retrospective analysis of HES data with major complication is used as the primary 
outcome. The rationale being patients are consented for a number of complications. 
And they can be used as a good marker to measure outcomes of hernia repair. In hernia 
surgery the main complication is recurrence. However, there is no specific code to say 
which patient has actually recurred, but a surrogate code can be used instead. Hernia 
reoperation is an excellent alternative to recurrence.  
 
Fortunately, reoperation can be measured easily. Patients underwent inguinal hernia 
repair will be followed to identify patients who underwent further surgery on the same 
side of the previous repair. Most recurrence occurs in the first few years following the 
original repair.  Other complications were used as secondary outcomes. These 
complications are infections, injury to an organ and readmission with urinary retention. 
The study will compare both open and laparoscopic techniques and identify factors that 





6.1 Laparoscopic versus open repair of inguinal hernia: a 
longitudinal cohort study.  
6.1.1 Abstract 
BACKGROUND: Traditionally, repair of an inguinal hernia has been by an open 
method, but laparoscopic techniques have recently been introduced and are increasing 
in popularity. This study aimed to compare early and late outcomes following 
laparoscopic and open repair of inguinal hernia. 
 
METHODS: We performed an analysis of inpatient Hospital Episode Statistics. Early-
outcome criteria studied include in-hospital mortality, length of hospital stay, 
complications (infection, bleeding, injury to an organ, and urinary retention), and 
readmission. Late outcome was assessed by the need for a further inguinal hernia repair 
on the same side. 
 
RESULTS: Between April 2002 and April 2004 125,342 patients who underwent 
inguinal hernia repair were included in the analysis and they were followed until April 
2009. There were no differences in postoperative stay between the laparoscopic and 
open groups except for the laparoscopic bilateral hernia repair patients who had a 
shorter stay than the open group. Infection and bleeding were more common following 
open repair, whilst urinary retention and injury to an organ were more frequent after 
laparoscopic repair. Reoperation for another inguinal hernia was more common after 
laparoscopic (4.0 %) than after open repair of primary inguinal hernia (2.1 %), mostly 
in the first year after surgery. There was no difference in reoperation rate following 
repair of a recurrent inguinal hernia. Consultant caseload was strongly inversely 






CONCLUSIONS: Reoperation is more common after laparoscopic than after open 
repair of primary but not recurrent inguinal hernia. Surgeons with a low laparoscopic 
hernia repair caseload have an increased reoperation rate following laparoscopic repair 
of primary inguinal hernia. The increase in reoperation rate following laparoscopic 






Open repair has been the standard surgical approach for the treatment of inguinal hernia 
for over 100 years. Open hernia can be repaired with mesh or with sutures only. There 
are a number of techniques used for suture repair such as Shouldice repair and Bassini 
repair. Tension free mesh hernia repair was first reported by Lichtenstein in 1989[160]. 
The use of mesh reduces recurrence between 50 and 75%[161] and in this regard is 
superior to the Shouldice technique, which is the best non-mesh open inguinal hernia 
repair[162]. The majority of inguinal hernia in the United Kingdom are repaired using 
tension free mesh repair. Open repair of an inguinal hernia with mesh is therefore 
considered the standard with which other techniques should be compared. 
 
Over the last 20 years laparoscopic techniques for the treatment of inguinal hernia have 
been introduced including the transabdominal pre-peritoneal (TAPP) and laparoscopic 
total extraperitoneal (TEP) approaches, which have become increasingly popular[163]. 
 
National Institute for Health and Clinical Excellence (NICE) in the United Kingdom 
issued new guidelines for the treatment of inguinal hernia and suggested that 
laparoscopic surgery should be offered as one of the options for repair[164]. This 
advice was based in part on a meta-analysis of the published randomised trials that were 
available at that time, which showed a recurrence rate of 2·5% following TAPP as 
compared to 2·1% following an open repair and a recurrence rate of 2·3% following a 
TEP as compared to 1·3% with an open technique; these differences were not 
statistically significant[164]. Earlier NICE had not recommended the widespread 





the concern regarding the generalizability of the technique in routine practice rather 
than in individual series.  
 
However, the literature is not all congruent with the findings of NICE metanalysis of 
equivalence between open and laparoscopic repair in 2003 [165]. The relative odds of 
short‐term recurrence were increased by 50 per cent for LIHR compared with OIHR, 
although this result was not statistically significant (odds ratio 1·51 (95% CI 0·81 to 
2·79); P = 0·194). Veterans multicentre randomised controlled study comparing open 
and laparoscopic surgery for the repair of inguinal hernia was published after NICE 
review and demonstrated a higher recurrence (10·1%) rate using laparoscopic as 
compared to an open techniques (4·0%)[166]. A multicentre French study also showed 
higher re-operation rates with the laparoscopic compared to the Shouldice 
approach[167]. Also higher recurrence rates were reported following TEP repair of 
unilateral primary inguinal hernia (3·5%) compared to an open tension free repair with 
mesh (1·2%)[168]. Many other studies have, however, failed to show any difference in 
recurrence rates between the two techniques for recurrent[169] or primary inguinal 
hernia[170-172]. 
 
Early recurrence can be difficult to assess but a significant recurrent hernia will require 
reoperation and therefore reoperation rates have been used as a measure of long term 
outcome.[173, 174] 
 
Due to inconsistency of the findings of published literature, it is suggested a larger 
dataset analysis is needed to compare both techniques. Using data derived from 





patients in England who underwent inguinal hernia surgery over a two-year period, and 
then followed this cohort for a further five years to determine whether any had further 
inguinal hernia repair on the same side. We have sought to identify factors which may 
be associated with  hernia recurrence including patient related factors such as age, sex, 
side of surgery (unilateral or bilateral), type of hernia (primary or recurrent), or 
complications, and non-patient related such as type of surgery, consultant caseload and 
trust caseload.  
6.1.3 Methods 
HES data were obtained from the NHS Information Centre and imported into Microsoft 
2005 SQL server for analysis. All primary and recurrent inguinal hernia repairs 
performed in England between April 2002 and April 2009 were identified by searching 
the first three operative fields of the HES dataset using the Office of Population, 
Censuses and Surveys Classification of Surgical Operations and Procedures (4th 
revision) codes (OPCS-4) for T20 (primary inguinal hernia) and T21 (recurrent inguinal 
hernia). Only patients with a matching diagnostic code, International Classification 
Disease 10th Edition (ICD-10), K45 (inguinal hernia) in the first three diagnostic fields 
of the HES dataset were included in the final analysis.  (In 2002 this technique 
eliminated less than 1·2% of all episodes, and we think this technique increases the 
accuracy of the study by reducing coding errors). 
 
Patients who underwent an inguinal hernia repair between April 2002 and April 2004 
were used as the study cohort. These patients were subdivided into primary/recurrent 
and then into unilateral/bilateral inguinal hernia repairs (Figure 1). If the side of the 
original operation was not recorded or the patient was under 18 or was admitted as an 





later cohort, patients who underwent an inguinal hernia repair between April 2006 and 
April 2007 were identified and followed for two years to identify any undergoing re-
operation for a further inguinal hernia on the same side. 
6.1.3.1 Early outcome criteria 
Early outcome criteria studied were, in-hospital mortality, length of hospital stay, 
complications and readmission. Complications were identified using ICD-10 codes by 
searching the secondary diagnostic fields for infection (T814, T857, and T813), 
bleeding (T810), injury to an organ (T812), and urinary retention (R33). 
Readmission 
A readmission was defined as any patient readmitted to a general surgeon as an 
emergency within 30 days of discharge with bleeding or infection, or if a patient was 
readmitted with urinary retention within two days of discharge. 
6.1.3.2 Late outcome criteria 
Patients were followed using HES ID until April 2009, to identify those requiring a 
further inguinal hernia repair on the same side. For example, if a patient had an inguinal 
hernia repair on the left side during 2002, then the dataset was searched to identify the 
need for a subsequent inguinal hernia repair on the left side or a further bilateral repair. 
 
Consultant and Hospital Caseload 
Consultant caseload, either laparoscopic or open, was defined as the number of patients 
operated on under a consultant’s care in a year. Hospital caseload, either laparoscopic 
or open, was defined as the number of patients treated annually in each NHS trust. Both 






To stratify patients on the basis of patient related factors such as age, sex, side of 
surgery (unilateral or bilateral), type of hernia (primary or recurrent), or complications, 
a model of probability for reoperation was constructed. Predicted probability values for 
patient related factors likely to lead to reoperation were calculated using logistic 
regression. This model was then assessed for discrimination using ROC curve analysis. 
Patients were grouped into three categories low, medium, and high risk of recurrence 
prior to further analysis based on the lower third, middle third and the higher third risk 
group. 
 
For bilateral hernia the number of patients rather than hernias was used for data 
presentation. The reoperation rate was calculated for primary and recurrent hernia then 
for unilateral and bilateral hernia independently.  The time to reoperation is defined as 
the time between the original operation and the first reoperation. 
6.1.4 Statistics 
All data analyses were performed using SPSS version 18·0 (SPSS, Inc., Chicago IL). T-
test, Chi-square, Fisher Exact test, and Mann Whitney test were used for univariate 
analysis. Multivariate analysis was performed using binary logistic regression. Where 






Between April 2002 and April 2004 142,194 patients underwent an inguinal hernia 
repair in English NHS hospitals. 5·1% (7246) were excluded because the side of 
operation was not documented. Of the remaining, 5·0% (6705) were undertaken 
following an emergency admission and 2·1% (2901) were in patients under 18 years 
leaving 125,342 patients for analysis. 
 
The median age of patients undergoing inguinal hernia surgery was 60 years (IQR 47-
71). Patients undergoing a laparoscopic repair of an inguinal hernia were on three years 
younger (median age 57 years IQR 45-67) than those undergoing open repair, (median 
age 60 years IQR 47-72) (P<0.01). 
 
The proportion of female patients undergoing laparoscopic repair of an inguinal hernia 
was lower than in the open group, 4·1% versus 6·6% (Table 1). The majority of 
inguinal hernia repairs were primary (93·5%) and most were unilateral (90·6%) as 
shown in Figure 1. A laparoscopic approach was used in 8108 (6·1%) and laparoscopic 
procedures were converted to open surgery in 111 patients (1·4%).  The use of the 
laparoscopic approach for repair of an inguinal hernia increased from 5·8% of cases in 






Figure 1: Inguinal hernia repair in England April 2002 - April 2004 
Figure 2: Percentage of inguinal hernias repaired laparoscopically together with 
conversion rate 2001-2008 
 
 





Bleeding or haematoma was recorded as a complication in 1242 operations (1·0%); an 
injury to an organ followed 61 operations (0·05%); urinary retention followed 900 
operations (0·7%), and infection followed 396 operations (0·3%). Following an 
inguinal hernia repair 1048 patients were readmitted (0·8%). The in-hospital mortality 
rate was 0·03% (38 patients). 
 
The median length of hospital stay was one day (IQR 0-2). Overall there was no 
difference in the total length of hospital stay (1-day (0-1) versus 1-day (0-2) P=0.23) or 
the post-operative hospital stay (1 day (0-1) versus 0 day (0-1) P=0.15) between 
laparoscopic and open inguinal hernia repair. However, postoperative stay following 
repair of bilateral inguinal hernia was significantly reduced in the laparoscopic group (1 
day (0-2) versus 2 days (1-2)P<0.01). There was no significant difference in the 
readmission rate between open (0·7%) and laparoscopic hernia repair (0·8%). 
Laparoscopic surgery was associated with a lower infection rate (0·2% versus 0·3%), 
and a lower bleeding/haematoma rate (0·8% versus 1·0%). Conversely, the 
laparoscopic technique had a higher incidence of organ injury during surgery (0·2% 






 LAP OPEN P VALUE 
Total patients 8108 117234  
Median age 57 years (45-67) 60 years (47-72) <0·0001^ 
No of females 334 (4·1%) 7690 (6·6%) <0·0001* 
Recurrent hernias 947 (11·7%) 7123 (6·1%) <0·0001* 
Bilateral hernias 3206 (39·5%) 8366 (7·1%) <0·0001* 
Mortality 3 (0·04%) 35 (0·03%) 0·45$ 
Length of stay 1 day (0-1) 1 day (0-2) 0·23£ 
Postoperative stay 1 day (0-1) 0 day (0-1) 0·15£ 
Length of stay 
Unilateral 
0 day(0-1) 0 day (0-1) 0·26£ 
Postoperative stay 
unilateral 
0 day (0-1) 0 day (0-1) 0·06£ 
Length of Stay 
Bilateral 
1 day (0-2) 2 day (1-2) 0·0001£ 
Postoperative stay 
bilateral 
1 day (0-1) 1 day (1-2) 0·0001£ 
Readmission 53 (0·7%) 995 (0·8%) 0·062* 
Bleeding 61 (0·8%) 1181 (1%) 0·025* 
Infection 14 (0·2%) 382 (0·3%) 0·017* 
Injury to an organ 13 (0·2%) 48 (0·04%) <0·0001* 
Urinary retention 121 (1·5%) 779 (0·7%) <0·0001* 
Conversion 111 (1·4%) N/A  
Table 1: Early results of laparoscopic versus open repair of inguinal hernia 





6.1.5.2 Late outcome 
The overall reoperation rate following laparoscopic inguinal hernia repair (4·0%) was 
higher than open repair (2·1%). 
 
The majority of operations were performed for primary inguinal hernia (117,294 
patients, 93·5%). By April 2009 some 2525 (2·2%) of these patients had undergone a 
further inguinal hernia repair on the same side. The reoperation rate following 
laparoscopic as compared to open primary inguinal hernia repair was 4·1% versus 
2·0%, this difference was less marked after unilateral (2·3% versus 1·9%) than bilateral 
primary hernia repair (6·5% versus 4·2%) as demonstrated in Table 2. 
 
Patients who underwent surgery for a recurrent inguinal hernia were more likely to 
require surgery for a further recurrence (3·8%) compared to those who underwent 
surgery for a primary hernia (2·2%), this high reoperation rate is seen with both the 
open and laparoscopic techniques (3·8% versus 3·5%) as shown in Table 2. 
Primary inguinal hernia repair P VALUE (X2) 
 Reoperation Total number  
Laparoscopic 291 (4·1%) 7161 <0·0001 
Open 2234 (2%) 110111  
Unilateral primary inguinal hernia repair  
 Recurrence Total number  
Laparoscopic 97(2·3%) 4159 0·028 
Open 1899 (1·9%) 102116  
Bilateral primary inguinal hernia repair  





Laparoscopic 194 (6·5%) 3002 < 0·0001 
Open 335 (4·2%) 7995  
Recurrent inguinal hernia repair  
 Reoperation Total number  
Laparoscopic 33 (3·5%) 947 0·6 
Open 272 (3·8%) 7123  
Unilateral recurrent inguinal hernia repair  
 Reoperation Total number  
Laparoscopic 19 (2·6%) 743 0·09 
Open 256 (3·8%) 6752  
Bilateral recurrent inguinal hernia repair  
 Reoperation Total number  
Laparoscopic 14 (6·9%) 204 0·19 
Open 16 (4·3%) 371  
Table 2: Reoperation following repair of inguinal hernia April 2002- April 2004 
Factors associated with reoperation 
Following open repair of an inguinal hernia: male sex, bilateral hernia, recurrent hernia, 
and postoperative infection, were all strongly associated with a need for reoperation. 
There was no association between consultant or trust caseload and reoperation (Table 
3). 
 
Factors  Odds Ratio 95% CI P value 
Age for every year 1.001 0.998-1.003 0..45 
Hernia Primary 1   





Gender Female    
Male 1.567 1.282-1.916 <0.001 
Bleeding during index admission 1.000 1.000-1.000 0.12 
Infection during index admission 1.983 1.194-3.291 0.008 
Consultant caseload  1.000 0.999-1.001 0.703 
Trust Caseload  1.000 1.000-1.000 0.740 
Site of 
operation 
Unilateral 1   
Bilateral 1.920 1.686-2.185 <0.001 
 
Table 3: Factors associated with reoperation following open inguinal hernia repair 
(binary logistic regression) 
 
Age, consultant caseload, and presence of bilateral hernias were all factors that 
appeared to be important as regards reoperation following laparoscopic hernia repair 
(Table 4). 
 
Factors  Odds Ratio 95% CI P value 
Age for every year 1.009 1.001-1.017 0.016 
Hernia Primary 1   
Recurrent 0.815 0.557-1.194 0.293 
Gender Female 1   
Male 1.113 0.557-1.194 0.747 
Bleeding during index admission 0.545 0.207-1.432 0.218 
Infection during index admission 1.292 0.151-11.046 0.815 
Consultant caseload  0.987 0.983-0.991 <0.001 
Trust Caseload  1.000 0.999-1.001 0.870 
Site of 
operation 
Unilateral 1   
Bilateral 2.365 1.861-3.007 <0.001 
Table 4: Factors associated with reoperation following laparoscopic repair of inguinal 







The effect of consultant caseload on reoperation rates following laparoscopic and open 
hernia repair is shown in Figure 3. The reoperation rate does not alter with consultant 
caseload following open repair, whereas, with the laparoscopic technique there is an 
inverse relationship. 
 
Figure 3: Consultant caseload versus reoperation rate following inguinal hernia repair 
 
Trust caseload 
There is no difference in reoperation rate following open repair of an inguinal hernia 
between high and low caseload trusts (Figure 4). However, trusts performing high 
numbers of laparoscopic repairs have the lowest reoperation rate (1%), while those with 






Figure 4: Trust caseload versus reoperation rate following inguinal hernia repair 
 
If patients undergoing laparoscopic inguinal hernia repair are stratified into low, 
medium and high risk of reoperation, based on patient related factors and then analysed 
on the basis of consultant and trust caseload as shown in Table 5; patients with similar 
risk can be seen to have up to a fivefold difference in re-operation rate depending on 
where and by whom they are operated on. 
Risk of reoperation CONSULTANT CASELOAD 




<250 3.6% 3.9% 1.8% 0·029 
>250 0 6.3% 0.5 0.018 
Medium risk 
2·42-5·64 
<250 N/A 3.5% 1.3% 0.0001 
>250 N/A 7.7% 1% 0.062 
High risk 
5·64+ 
<250 10.2% 4.7% 5.2% 0·0001 
>250 18.4% 7.7% 2.1% 0·0001 







Time to reoperation 
The reoperation rate following laparoscopic unilateral primary inguinal hernia was 
higher than that following open repair during only the first year of follow up (Figure 5). 
There was no difference in reoperation rates following repair of a recurrent inguinal 
hernia repair by either a laparoscopic or open technique at any time (Figure 7). 
 









To confirm these results with a later cohort, patients undergoing surgery between April 
2006 and April 2007 were analysed in a similar manner to the initial cohort but with 
two further years of follow up. An increased reoperation rate following laparoscopic as 
compared to open repair of inguinal hernia was again seen (Table 6).  
Primary inguinal hernia repair  P VALUE X2 
 Reoperation Total number  
Laparoscopic 200 (2.5%) 8026 <0·0001 
Open 684 (1.4%) 49146  
Unilateral primary inguinal hernia repair  
 Recurrence Total number  
Laparoscopic 101(2·0%) 5067 <0·0001 
Open 593 (1·3%) 45845  
Bilateral primary inguinal hernia repair  
 Recurrence Total number  
Laparoscopic 99 (3·3%) 2959 0.184 
Open 91 (2·8%) 3301  
Recurrent inguinal hernia repair  
 Reoperation Total number  
Laparoscopic 36 (3·2%) 1125 0·688 
Open 102 (3·0%) 3444  
Unilateral recurrent inguinal hernia repair  
 Reoperation Total number  
Laparoscopic 24 (2·9%) 829 0·906 
Open 87(2·8%) 3122  
Bilateral recurrent inguinal hernia repair  
 Reoperation Total number  
Laparoscopic 12 (4·1%) 296 0·844 
Open 15(4·7%) 322  






This study uses national administrative data to report on the early and late outcomes of 
surgery for inguinal hernia in England over a two-year period with a further five years 
of follow-up. A unique identifier HESID has been used to follow individual patients in 
England for up to 7 years postoperatively to detect those who underwent surgery for 
recurrence and this constitutes the biggest study of outcome following surgery for 
inguinal hernia in the literature and reports results as they have actually occurred 
following the introduction of laparoscopic hernia repair in the United Kingdom. 
 
It is, however, a retrospective study using data collected routinely by the NHS. Thus 
there could be differences between the groups that are being compared, causing bias, 
for example it is likely complex hernias will be operated on by an open technique and 
that the laparoscopic approach will often be used preferentially for earlier and less 
technically demanding hernias. 
 
Another criticism of studies of this type is that data may not have been coded or coded 
incorrectly. Previous studies have shown that the accuracy of recording of diagnostic 
codes in England is high (median 91%), but researchers still have to recognize and 
account for a degree of coding inaccuracy[56]. HES data can, however, be used usefully 
for assessment of effectiveness, comparative audit, and equity[126]. 
 
The consultant code identifies only the consultant in charge of a patient’s care. It does 
not necessarily identify the operating surgeon. Teams in English NHS hospitals are 
consultant led rather than consultant delivered. Some operations, such as inguinal 





consultant’s direct or indirect supervision. High-caseload consultants are, however, 
likely to be undertaking or directly supervising a large number of hernia operations. 
Paradoxically, assessing the results of the consultant firm rather than those of individual 
consultant surgeons may thus be advantageous because the former fully reflects real 
practice. 
 
Increased infection and haematoma rates are seen following open as compared to 
laparoscopic repair, a difference which is consistent with other published studies[169, 
175, 176]. Rates in this study are, however, lower and may be a result of under coding. 
 
Urinary retention following open inguinal hernia repair reported rates  vary  between 
0·37% and 3·0%[177]. Urinary retention rates have been shown to be higher following 
laparoscopic repair, 2·3% versus 1·1%[178] and up to 22·0% in a single retrospective 
study[179]. In this study the rate of urinary retention is increased following 
laparoscopic as compared to open repair (1·5% versus 0·7%). 
 
There was no overall difference in the post-operative stay following laparoscopic and 
open unilateral hernia repair, but following bilateral hernia repair discharge was quicker 
with the laparoscopic technique suggesting an advantage for the laparoscopic technique 
in this regard. 
 
Injury to an organ is rare during a hernia repair but has been reported to be higher with 
a laparoscopic technique[180], our study confirms this. It also shows there was no 





early outcome laparoscopic and open inguinal hernia repair would seem to be broadly 
comparable, with minor advantages for each technique. 
 
Multivariate analysis shows that undergoing surgery for bilateral hernia increases the 
risk of reoperation with both techniques, but this is obvious as a patient with two 
hernias will have an increased risk of recurrence in comparison to a patient undergoing 
repair for a unilateral hernia. Post-operative infection may increases the chance of 
recurrence following open repair, but not after laparoscopic repair. This may be because 
infection following laparoscopic repair usually occurs at the port site of operation which 
is far away from the mesh. 
 
Non-patient related factors such as technique, open versus laparoscopic, consultant 
caseload and trust volume also appear to be important as regards failure of an inguinal 
hernia repair. Specifically reoperation rates are higher following laparoscopic as 
compared to open repair of primary inguinal hernia. Following open repair consultant 
caseload appear to have no influence on reoperation rate; however, consultants who 
perform a large number of laparoscopic inguinal hernias have lower reoperation rates 
than surgeons with a low laparoscopic caseload. 
 
Further reoperation rates are higher with the laparoscopic technique in the early 
postoperative years, but return to the rates seen with open repair after this. This suggests 
that technical failure (poor placement of mesh, fixation of mesh, small mesh, or small 
pocket to place the mesh) at the time of laparoscopic inguinal hernia repair may be the 





surgeons that laparoscopic repair is technically more demanding than the open 
technique. 
 
Studies have suggested that surgeon experience is related to hernia recurrence following 
laparoscopic repair,[168, 181]  and it may be argued that the results of laparoscopic 
repair have improved with increasing laparoscopic experience. However, when a cohort 
of patients undergoing repair of an inguinal hernia in 2006 were analysed, the re-
operation rate following laparoscopic repair (2·5%) was still significantly higher than 
open (1·3%) repair (Table 6). 
 
It is interesting that no differences were seen in reoperation rate following repair of a 
recurrent hernia by the open or the laparoscopic route. It is therefore clear that open 
surgery is as effective as laparoscopic surgery for the treatment of recurrent inguinal 
hernia and this is consistent with the latest meta-analysis[169]. 
 
This study demonstrates that reoperation rates are higher following laparoscopic as 
compared to open repair of primary inguinal hernia, but we would suggest that they do 
not show laparoscopic technique is inferior to the open procedure, as reoperation rates 
from high caseload surgeons undertaking laparoscopic repair of inguinal hernia are 
similar to those seen following open surgery. Similarly, results from units undertake a 
large number of laparoscopic hernia repairs are as good as and possibly better than 
those seen following open surgery. Further we have not been able to assess other 
advantages of laparoscopic repair such as early return to work[182-185] and a reduced 





results provide powerful evidence for specialisation of surgeons undertaking 
laparoscopic repair of inguinal hernia together with the development of dedicated units. 
  
Early outcome following open and laparoscopic repair of inguinal hernia is broadly 
similar. Reoperation is, however, more common with the laparoscopic approach and 
may be due to early failure in patients operated on by low caseload surgeons. These 
results provide evidence for increased specialisation of surgeons undertaking 





7 Can HES data be used to measure changing trends in 
surgical practice? 
 
Over the last 30 years surgical practice has changed considerably and continued to 
evolve. New surgical techniques are always under development. Some procedures get 
popular and become the standard of care such as laparoscopic cholecystectomy and 
other techniques become popular for a period of time then loose its momentum and 
eventually fades away when other procedures developed. In order to plan for future 
service and train future surgeons, it is always important to know the current practice 
and predict the future changes. This will help health care providers to identify specific 
skills needed when they appoint new surgeons. 
 
HES data is available and not expensive. It can be used to assess the practice and 
measure the changing trends in surgery. This will help develop future service and 
advice planner about the results of surgery and the need to train future surgeon and the 
skills required when appointing new surgeons by health care providers. 
 
Rectal prolapse is a common surgical problem but the exact incidence is not known. 
While some patients may benefit from conservative management, surgical repair is the 
only definitive treatment. Surgery for rectal prolapse is divided into abdominal and 
perineal repair. The former is subdivided into open and laparoscopic approach. All 
surgical techniques can be divided into resection and fixation. The study will illustrate 





7.1 Epidemiological trends in surgery for rectal prolapse in 
England 2001-2012 
 
This paper was submitted for publication during thesis writing. The reviewers requested 
a number of changes which lead to minor amendment to this version. The published 
paper is attached as appendix 1. 
7.1.1 Abstract 
Background: 
The UK incidence of rectal prolapse is uncertain and there is little international 
consensus about best surgical management. This study analysed trends in admission and 
surgery for rectal prolapse in adults in England between 2001 and 2012 as well as 
prolapse reoperation rates. 
Methods:  
Analysis of data derived from a comparative longitudinal population-based cohort study 
using Hospital Episode Statistics.   
Results:  
During the study period, a total of 25,238 adults underwent a total of 29,379 operations 
for rectal prolapse (mean 2,670 per annum) [median age 73 years (IQE 58-83) years; 
female to male ratio: 7:1]. Median LOS was 3 days (IQR 1-7) with an overall in-
hospital mortality rate of 0.9%. Numbers of total admissions (2001: 4,950 vs. 2012: 
8,927) and of patients undergoing prolapse surgery (2001: 2,230 vs. 2012: 2,808) 
significantly increased (P < 0.001 for trends) throughout the study period. The overall 
increase in surgery (up about 1/3rd overall and 44% for elective) was dwarfed by an 
increase in popularity of laparoscopic surgery (increased 15-fold during the period). 
Overall prolapse reoperation rate (as a surrogate of recurrence) was 12.7%. The lowest 





mortality (1.9%) Laparoscopic and perineal fixations were also associated with low 
reoperation rates (<11%) but lower mortality rates of approx. 0.3% for elective surgery. 
The data refute a trend toward subspecialisation (by surgeon or hospital) during the 
study period. 
Conclusions:  
Admissions for rectal prolapse increased in England between 2001-2012 with parallel 
increases in surgery. Surgical decision making has changed over the period and may be 






Rectal prolapse is an uncommon but highly morbid condition in which a full-thickness 
intussusception of the rectal wall extrudes through the anal canal[188-190]. The only 
potentially curative treatment is surgery with exceptions being patients considered 
medically unfit for surgery and those with minor degrees of prolapse. Over 100 
operations for rectal prolapse repair have been described and none has achieved 
primacy following attempts to provide high quality evidence[20]. Rectal prolapse can 
be repaired via the abdomen or perineum with several alternatives for each described. 
Abdominally, posterior rectopexy (sacral fixation of the rectum) is generally considered 
to have a low recurrence rate but may result in poor function especially 
constipation[191]. Alternatively, the rectum may be fixed with concomitant segmental 
colonic resection (resection rectopexy) but there is a risk of anastomotic leak 1-
5.9%[192, 193]  even though some data suggest it has the lowest recurrence rate[20]. 
Perineal approaches (principally Delormes and Altemeier’s) are less invasive and are 
considered a better option for elderly and medically unfit patients. However these may 
have higher recurrence rates 10 -30% compared to 0-11% for rectopexy[194].  
 
Laparoscopic rectopexy was first reported in 1992 by Berman and has re-popularised 
the abdominal approach[195]. Laparoscopic ventral mesh rectopexy (LVMR) uses an 
anterior rectal dissection with fixation of the anterior rectal wall to a mesh, which is 
then anchored to the sacrum. The operation theoretically preserves pelvic nerves 
avoiding the ‘rectal inertia’ caused by posterior dissection and reportedly better 
functional outcome [196]. Several large series have now been published suggesting low 





recently become the subject of media scrutiny in relation to long-term complications 
from the use of pelvic mesh in general[200, 201]. 
 
The current study evaluated trends in surgery for rectal prolapse in England from 2001 
to 2012 with a focus on type of operation performed and estimates of recurrence based 








7.1.3.1 Data sources 
Hospital Episode Statistics (HES) data were obtained from the National Health Service 
Information Centre (NHSIC) and imported into Microsoft SQL server. All patients 
admitted with rectal prolapse over an 11-year period (April 2001 and March 2012) were 
identified by searching the primary diagnostic codes (K622 for anal prolapse and K623 
for rectal prolapse) using the International classification of Diseases Version 10 (ICD 
10). Data were then imported into Microsoft Access [Microsoft Corp. USA] for 
analysis. Patients who underwent surgery for rectal prolapse were then selected by 
searching the Office of Population, Censuses and Surveys Classification of Surgical 
Operations and Procedures (4th revision) codes (OPCS-4). Codes used are listed in 
table 1. Patients under the age of 16 were excluded from analysis. 
 
Open fixation H35 or H36  
Open resection H04, H05, H09, H10, H33, 
H29  
except H337 
Laparoscopic surgery Y75 or Y508  
Conversion codes Y714 or Y718  
Perineal fixation H421, H422, H423, H425, 
H426, H428, H429, H414 
 
Perineal resection H337, H411, H415  
Table 1: Operative codes for surgery (OPCS4) 
 
Patients were subdivided by type of surgical repair into 6 categories using OPCS codes. 
Open fixation, open resection, laparoscopic fixation (laparoscopic codes plus open 
fixation), laparoscopic resection (laparoscopic codes plus open resection), perineal 
fixation, and perineal resection. Codes for each group are described in suppl. table 1. 
Laparoscopic repair was identified by searching all operative codes for Y75* or Y508* 
using the OPCS code 4. Converted cases were included with the laparoscopic approach 





and emergency repair by mode of admission using the “admimeth” field to identify how 
the patient was admitted to hospital (for elective admissions: numbers 11, 12, and 13; 
and for emergency admission: numbers 21, 22, 23, 24).  
 
Patients identified as having surgery within the 11 year period were followed up until 
March 2012 using HESID to investigate any who underwent further rectal prolapse 
procedures (as a surrogate for recurrence). The HES ID is a unique identifier for every 
patient that is calculated using NHS number, local hospital number and date of birth. 
Using HESID permitted follow-up of patients across time and place and was used to 
calculate reoperation rate for each surgical procedure type. In addition, Consultant 
caseload was identified by searching all patients who underwent surgery by a specific 
consultant per year. The “Pconsult” code is a pseudo-anonymised code for each 
consultant based on their GMC number that permitted identification of individual 
caseloads. Similarly, hospital surgical volumes were calculated by searching the 
“SiteTreat” field. 
7.1.3.2 Data analysis 
Data have been presented descriptively with summary statistics based on data 
distribution. Population statistics were derived from Office of National Statistics census 
2011 [202] to allow incidence rates per 100,000 population to be calculated for both 
rectal prolapse admission and rectal prolapse surgery. Limited statistical analyses were 
performed for time trends using regression of moving averages. All analyses were 






Tables 2 and 3 [Figure 1] show the main results by year from 2001 to 2012 with 25,238 
adult patients undergoing a total of 29,379 operations for rectal prolapse over this 
period (mean 2,662 per annum). There were obvious upward trends (P<0.001 for both) 
in total numbers of patients admitted and of those undergoing surgery of any type for 
rectal prolapse over this time.  
 
Figure 1: Trend of total number of admissions of rectal prolapse and patients underwent 
surgery and total number of procedures per year. 
 
The number of patients admitted to hospital with rectal prolapse in 2011 was 8,927 
providing an annual incidence rate of 18.5 per 100,000 for this year; 2,808 underwent 
rectal prolapse surgery providing a statistic of 6.1 per 100,000 per year. For patients 
over the age of 75, these rates were much higher (106 per 100,000 and 31 per 100,000 
per year respectively). Over the same time period, population statistics showed the 
English population increased by about 3.9 million (8.0%) from around 49.1 million in 





increased by 851,000 (10.9%) for England over the same period. Nevertheless, patient 










































































































The number of operations performed per year increased by approximately one third 
from 2,320 in 2001 to 3,253 in 2011. The number of surgeons providing rectal surgery 
for prolapse increased from 384 in 2001 to 533 surgeons in 2011/2012 keeping the 
median number of operations performed by individual consultants relatively static at 
only 4 (IQR 2-7) per year. The number of hospitals providing rectal prolapse surgery 
increased marginally from 195 in 2001 to 222 in 2011 with a median increase in 
number of surgeries/hospital/per year from 8 (IQR 5-13) to 11 (IQR 5-17) in the final 
year of data analysis. Females were seven times more likely to undergo surgery for 
rectal prolapse compared to males. Median length of stay (LOS) was 3 days (IQR 1-7). 
Overall in-hospital mortality rate was 0.9%. Just over 10% of the operations 
(2,692/25,238 patients, 3,063/29,379 procedures) were performed as an emergency.  
 
Figure 2: Trend of surgical procedures for rectal prolapse 
 
Over the 11-year study period, perineal fixation remained the most popular surgical 





However, the number of patients undergoing laparoscopic surgery (repair/resection) 
increased more than 15-fold from only 48 (2.1% of total cases) in 2001/02 to 725 
operations (22.3% of total) in 2011/12. Over the whole time period, patients selected for 
laparoscopic surgery were significantly younger than patients selected for other types of 
surgery with a mean age of 67 years (IQR 52-79) [Figure 3]. In contrast, older patients 
were more likely to be offered perineal resection: median age 81 years (IQR 73-86). In 
the final year of data analysis, the mean age for laparoscopic surgery was 65 years (IQR 
50-78). 
Figure 3: Mean age and 95% CI range for surgical repair 
 
Elective surgery for rectal prolapse was associated with a significant shorter hospital 
LOS as compared to emergency surgery for all types of surgical repair [table 2]. 
Laparoscopic and perineal fixations were associated with the shortest hospital stay. 





compared to emergency surgery (2.5%). Patients who underwent open resection were at 
higher risk of death compared to other types of surgical repair with a mortality of 14.7% 
in the emergency setting and 3.4% in the elective setting. Elective laparoscopic and 





















































































































Table 3: Data by type of procedure for whole time period 
A: Elective procedures 
 
Using HESID-derived data, 3,241 (12.8%) patient underwent reoperation for rectal 
prolapse. The majority (2622; 80.9%) underwent one further surgery; 489 (15.1%) 
underwent two further surgeries and a small proportion (n = 99; 3.1%) underwent three 
or more further procedures. Procedure type influenced reoperation rate [Table 3] with 
open resection rectopexy having the lowest reoperation rate (9.1% elective and 4.3% 





emergency) and open fixation (16.3% elective and 14.3% emergency). Laparoscopic 























































































































Table 3: Data by type of procedure for whole time period 







To our knowledge, we present the largest dataset to date of patients undergoing surgery 
for rectal prolapse with over 25,000 patients included. Several findings merit 
discussion: (1) the incidence of rectal prolapse and surgical repair increased year on 
year between 2001 to 2012 at a rate greater than that anticipated by population growth 
alone; (2) there appears to be little evidence of subspecialisation for rectal prolapse 
surgery with unchanged and low numbers of procedures per surgeon per annum; (3) 
laparoscopic fixation has increased dramatically in popularity over the period and this 
procedure has favourable outcomes in terms of LOS, mortality and reoperation 
compared to several other procedures; (4) there is no compelling evidence of superiority 
of abdominal procedures over perineal in general; and (5) data confirm the previous 
assertion of higher risk but lower reoperation (recurrence) rate after resection 
rectopexy[204].   
 
The reported incidence of rectal prolapse in our study was 18.5 per 100,000 per year 
which is much higher than a previous report of only 2.5 per 100,000 in a Finnish 
population [205]. The overall in-hospital mortality rate for all types of surgery was less 
than 1% which is comparable to the reported mortality in the literature 0 – 6.5%[206-
209]. Reported recurrence rates in the literature vary from 3- 33%[209-212] depending 
on type of surgical repair and length of follow up. Our overall reoperation rate was 
approximately 12% for both elective and emergency cases. 
 
There are several limitations to this study. The study used the HES database which 
contains administrative data reliant on the accuracy of clinical coding. A recent 





of payment by results in 2002 the accuracy of coding for primary diagnoses has 
improved from 73.8% (IQR: 59.3-92.1%) to 96.0% (IQR: 89.3-96.3)[127]. It has been 
suggested that researchers should consider the context of conclusions that are drawn 
from HES data. If findings are of a general nature, then even a relatively high coding 
error rate at some hospitals or even all hospitals will not detract markedly from the 
overall conclusions if significant deviation can be shown[147, 148]. Thus, studies based 
on HES data may actually be good at dealing with research questions such as those 
posed in this study but are less good at identifying variations in care between individual 
trusts or clinicians[148]. Another limitation of this study was the use of reoperation rate 
rather than actual recurrence rate. Thus some patients who had recurrence but declined 
(or were unfit) for further repair will not have been included in the analysis. This 
indicates that recurrence rates might be underestimated in this study. Finally, we 
acknowledge the time expiration on the data presented (only up to 2012). While, 
sometimes it is normal for HES data to be presented several years after initial 
entry[213, 214], our data are now 7 years old.  We do however feel that these still have 
value in understanding trends in surgical strategy, lack of subspecialisation / 
centralisation to at least this point in time and in providing surrogate outcomes on much 
larger numbers of patients than for instance widely cited single centre cohort studies 
and an under-recruited trial from the same time period[20]. 
 
In summary, this population-based cohort study demonstrates an increasing trend in 
both numbers of admissions and operations for rectal prolapse over the studied decade. 
Despite there being little or no evidence of service centralisation, there has been a 
significant change to laparoscopic fixation during this period and this operation appears 





8 Can HES data be used to measure adherence to national 
guidelines? 
National guidelines are written by national bodies to advice health care providers about 
the effective model of care. They are very important to keep a consistent and safe 
standard of care provided to patients. It also helps managers at health care providers to 
bench mark their service and costs.  
 
In this chapter HES data is to be examined to assess the feasibility of using HES data as 
a national tool to monitor adherence to national guidelines. HES will be used to monitor 
the national adherence to the national guideline for definitive management of acute 
gallstone pancreatitis. The study will also assess the benefit of the national guideline if 
they were adhered to. 
 
Acute gallstone pancreatitis is a common surgical emergency. These patients are at risk 
of readmission with the same problem if they didn’t undergo definitive management. 
The British Society of Gastroenterology guideline recommends that these patients 
should undergo definitive management within acute admission or within 14 days of 
discharge[62]. The definitive management of gallstone pancreatitis is defined as the 
removal of gallbladder in terms of Cholecystectomy or if the patient is not fit for 
surgery to undergo endoscopic sphincterotomy of the ampulla of Vater. In order to 
investigate whether hospitals are following this guideline or not, a national audit has to 







8.1 Definitive management of Gallstone pancreatitis in England 
8.1.1 ABSTRACT 
Aim:  
The aim of this study was to investigate whether definitive treatment of gallstone 
pancreatitis (GSP) by either cholecystectomy or endoscopic sphincterotomy in England 
conforms with British Society of Gastroenterology (BSG) guidelines and to validate 
these guidelines.  
 
METHODS:  
Hospital Episode Statistics data were used to identify patients admitted for the first time 
with GSP between April 2007 and April 2008. These patients were followed until April 
2009 to identify any who underwent definitive treatment or were readmitted with a 
further bout of GSP as an emergency.  
 
RESULTS:  
A total of 5,454 patients were admitted with GSP between April 2007 and April 2008, 
of whom 1,866 (34.2%) underwent definitive treatment according to BSG guidelines, 
1,471 on the index admission. Patients who underwent a cholecystectomy during the 
index admission were less likely to be readmitted with a further bout of GSP (1.7%) 
than those who underwent endoscopic sphincterotomy alone (5.3%) or those who did 
not undergo any form of definitive treatment (13.2%). Of those patients who did not 
undergo definitive treatment before discharge, 2,239 received definitive treatment 
following discharge but only 395 (17.6%) of these had this within 2 weeks. Of the 505 
patients who did not undergo definitive treatment on the index admission and who were 
readmitted as an emergency with GSP, 154 (30.5%) were admitted during the 2 weeks 






Following an attack of mild GSP, cholecystectomy should be offered to all patients 
prior to discharge. If patients are not fit for surgery, an endoscopic sphincterotomy 






Acute pancreatitis is associated with considerable morbidity and mortality[215-217]. 
Gall stones are the aetiological factor in 30 to 50% of cases[216, 218, 219]. Stones less 
than 5 mm in diameter, a wide cystic duct, and a longer common channel between the 
bile and pancreatic duct are predisposing factors[220].  
 
United Kingdom guidelines for the management of GSP were first published by the 
British Society of Gastroenterology (BSG) in 1998[221] and then amended in 
2005[222]. These guidelines suggest that all patients with mild GSP should be offered 
the following programme: 
 On index admission if the condition is not severe (necrotising pancreatitis) and 
the patient is clinically fit for surgery cholecystectomy should be performed 
 On index admission if the condition is not severe (necrotising pancreatitis) and 
the patient is not fit for surgery, then endoscopic sphincterotomy (ES) should be 
performed. 
 If the above two condition are met and the patient is discharged then the 
appropriate treatment should be carried out within 2 weeks of discharge. 
 Following severe GSP, the guidelines suggests cholecystectomy should be 
delayed until a patient is fully recovered.  
 Patients with predicted severe GSP or with cholangitis should have an early ES 
as part of their initial management[223-225] in addition to the routine treatment of GSP. 
 
Published studies suggest that adherence to the BSG guidelines in the UK is variable, 
and compliance with the guideline varies from 6.6% to 89%[226-229]. While in the US 





stones following an attack of GSP or on readmission/mortality rates amongst patients in 
whom there was a delay in definitive management.  
 
The evidence of the appropriate timing of definitive treatment following discharge is 
not well established, one study found that 31% of recurrent GSP occurred in the first 2 
weeks following discharge[231], but another suggests that this figure is 6.5%. A further 
study suggests that performing definitive treatment during the index admission 
increases the length of hospital stay. 
 
Our study investigated current practice and compared this against the definitive 
treatment of GSP in England as recommended by the BSG guidelines[62]. It also 
investigated the effectiveness of cholecystectomy and ES in preventing a further attack 
of GSP and the consequences of delayed treatment.  
8.1.3 Method 
Hospital Episode Statistics (HES) data for the financial year April 2007 to March 2008 
were imported into Microsoft SQL server for analysis. HES contain information on all 
patients treated in England in National Health Service (NHS) hospitals and those NHS 
patients treated in the private sector. Patients admitted with gallstones and acute 
pancreatitis as an emergency was identified by searching the admission method, 
diagnostic and operative fields. 
 
To identify an emergency admission the method of admission was searched for codes 
21, 22, 23, 24 and 28. The International Classification of Diseases (ICD-10) codes 
K85* and K80* were used to identify acute pancreatitis and cholelithiasis respectively. 





Surveys (OPCS-4) codes: J18* was used to identify cholecystectomy and J38* to 
identify ES. Individual patients were followed across time and place using ‘HESID’, a 
unique number generated by combination of the patient’s NHS number, local patient 
identifier, postcode, sex and date of birth. 
 
The index cohort consisted of patients admitted as an emergency for the first time with 
GSP between April 2007 and April 2008. Any patients admitted with GSP or who had 
an intervention (ES or cholecystectomy) between April 2005 and April 2007 were 
excluded from this cohort. The cohort was followed until April 2009 (median duration: 
18 months, range: 12–24 months) to identify those who underwent cholecystectomy or 
ES or those who were readmitted with GSP as an emergency. 
 
If the patients didn’t undergo definitive treatment during index admission, then the time 
to definitive treatment was defined as the time from discharge until ES or 
cholecystectomy was performed. If a patient underwent ES and cholecystectomy, the 
date of the first treatment was used. If a patient was readmitted with a further bout of 
GSP as an emergency, the time from initial discharge until the first emergency 
readmission was used as the time until the second attack. Patients were stratified into 
four groups based on LOS. All statistical analyses were performed using SPSS® 
version 18.0 (SPSS, Chicago, IL, US).  
8.1.4 Results 
A total of 5,878 patients were admitted as an emergency with acute GSP between April 
2007 and April 2008. After excluding patients who had been admitted with GSP or who 
had undergone a cholecystectomy/ES during the period April 2005 to April 2007, 5,454 






Figure 2 Study flowchart  
The median age of the cohort was 63 years. Women were nearly twice as likely to be 
admitted with GSP as men and the median LOS was one week. During the index 
admission, 190 patients (3.5%) died. Of these, 25 had already undergone an ES, 6 a 
cholecystectomy and 159 no definitive treatment. The median number of patients 
admitted with GSP to each NHS trust was 35 patients per year (interquartile range 
[IQR]: 25–51) (Table 1).  
The majority (4,105 patients) underwent definitive treatment either within BSG 
guidelines (n=1,866) or at a later date outside the guideline(n=2,239). Two-thirds 
(n=2,706, 65.9%) underwent a cholecystectomy while 713 patients (17.3%) had an ES 
and 686 (16.7%) underwent both procedures. Patients who underwent a 
cholecystectomy (median age: 56 years, IQR: 39–68 years) were significantly younger 





those who did not undergo definitive treatment (median age: 72 years, IQR 56–83 
years). On the index admission, 1,471 patients underwent definitive treatment. Of those 
who were discharged, 811 underwent an ES alone and 629 a cholecystectomy (28 of 
these underwent both an ES and a cholecystectomy). 
 
Number of patients 5454  
Age, median (IQR) 63 years (45-76)  
Gender M: F 1:1.73 
Length of stay, median (IQR)) 7 days (4-12) 
In-hospital mortality 190 patients (3.5%) 
Admissions per Trust, median (IQR) 34 patients (24—51) 
Number receiving definitive treatment on the index 
admission 
1471 
Number receiving definitive treatment during study period 4105 
Readmission as an emergency with GSP 559  
Deaths following readmission 22  
Readmissions with GSP, median (range) 1 (1-3) 
Table 3 Demographics of patients admitted with GSP during the year April 2007 until 
April 2008 and followed until April 2009. 
 
 
A total of 559 patients, 505 of whom had not undergone definitive treatment on the 
index admission, were readmitted 655 times with a further attack of GSP by April 2009 
(median number of readmissions: 1, range: 1–3 readmissions) and 22 patients (3.9%) 
died following a readmission with GSP (Table 1). Patients who underwent a 
cholecystectomy during the index admission had a significantly lower readmission rate 





have any form of definitive treatment during the index admission (13.2%)  as shown in 
Fig 2. 
.   
 
Figure 2 Re-admission rate following definitive treatment mean and confidence 
interval. 
 
Approximately a third of patients (n=1,866, 34.2%) underwent definitive treatment 
according to BSG guidelines (ie on the index admission or within two weeks of 
discharge). The majority of these patients (n=1,471) had definitive treatment during the 
index admission. Of the 3,824 patients discharged without definitive treatment, only 
10.3% underwent definitive treatment within the next two weeks and only 32.4% had 






Figure 3: Cumulative percentages of patients who undergo definitive treatment in those 
who did not receive definitive treatment on the index admission 
 
Of the 505 patients who did not undergo definitive treatment and who were readmitted 
with a further diagnosis of GSP, about a third of these (n=154, 30.5%) were readmitted 
during the first two weeks following discharge and seven died during this readmission. 
By eight weeks, the cumulative readmission rate in patients who did not undergo 
definitive treatment on the index admission was 8.5% (Fig 4). 
 
Figure 4: Cumulative readmission rates for gallstone pancreatitis and number of deaths 






In Figure 5 patients are stratified into four groups according to their LOS. Only 9.3% of 
those who stayed four days or less underwent definitive treatment on the index 
admission compared with 41.2% of those who stayed more than twelve days. 
 
Figure 5: The proportion of patients who underwent definitive treatment during the 






8.1.5 Discussion and Conclusion 
Data derived from HES are used increasingly to investigate delivery of care in England. 
The validity of studies using these data depends on the accuracy and depth of coding, 
and this has been questioned. Campbell et al showed in a systematic review that there is 
generally a high level of accuracy (91%) for diagnosis although the accuracy for coding 
of operations or procedures was only 69.5%[56]. There may have been an improvement 
in the accuracy of coding in the NHS in England in the ten years since this study due to 
the introduction of the payment by results scheme, which relies on data derived from 
OPCS-4 codes. 
 
Since 2007–2008, the Audit Commission has conducted an annual audit of clinical 
coding in England. Results from the first of these audits suggest that 10.5% of primary 
procedures are coded incorrectly although there was wide variation between different 
trusts and the inaccuracies did not necessarily mean that patients were categorised 
incorrectly [232, 233]. Another study looking at aortic aneurysm surgery found that 
coding accuracy appeared to be high if diagnostic, operative and administrative codes 
were compared, and accuracy could be improved further if they were combined[234] 
similar to our study. 
 
Despite improvements, HES data need careful interpretation. Variations in coding are 
usually ignored when large aggregations of data are used, for example at national level 
as in this study. In this situation, the variations in coding are likely to occur randomly 
and therefore to cancel each other out. Conversely, if comparisons were made between 
individual providers, then variation in coding could not be ignored in this way[126, 





This national audit shows that current practice in England with regard to the definitive 
management of patients with GSP falls well short of that suggested by the BSG[222]. In 
fact, only a third of patients received definitive treatment on the index admission or 
within two weeks of discharge. 
 
HES data lack many clinical details that have been used in other comparative studies of 
acute pancreatitis to stratify patient populations into predicted severe and mild disease, 
and this is a limitation of our study. 
 
This study demonstrates that patients who had definitive treatment during the index 
admission are less likely to be readmitted with GSP than those who did not. When the 
issue of timing is addressed, the study also reveals that a third of readmissions with 
GSP occur in the two weeks following discharge and that some of these patients died. 
Furthermore, only 10% of the patients discharged following an index admission with 
GSP who did not undergo definitive treatment on this admission underwent definitive 
treatment in the two weeks following discharge (Fig 2). This suggests that clinicians are 
not making proper use of the facility provided by the BSG guidelines to undertake a 
cholecystectomy within two weeks of discharge on a routine list. 
 
Although there was a general consensus among clinicians who prepared the BSG 
guidelines that definitive treatment was best performed during the index admission or 
within two weeks of discharge, this recommendation was based on expert opinion and 
not objective data. It may be that definitive treatment during the index admission is 





cholecystectomy or ES before discharge. Subsequent guidelines in acute pancreatitis 
should possibly take this into account. 
 
In addition, it appears that once patients were discharged without definitive treatment, 
only a third had undergone definitive treatment within two months of discharge. This 
may reflect the lack of available operating time on routine lists together with poor 
prioritisation. On the other hand, this and other observational studies[235, 236] have 
shown that the LOS during the index admission increases if patients undergo definitive 
treatment during that admission. It may be necessary to book patients with mild GSP 
for a cholecystectomy once the diagnosis has been made, even if they are still settling, 
as this has been shown to be safe and reduce LOS[237, 238]. In severe pancreatitis 
early cholecystectomy should be avoided while the patient is recovering; there may, 
however, be a role for initial treatment of these patients with an ES to modify this attack 
and to prevent further attacks with interval cholecystectomy at a later date[239-241]. 
 
There is still considerable debate as to whether an ES reduces the risk of a further bout 
of GSP to the same level as a cholecystectomy[242-246]. This study has shown that 
cholecystectomy is superior to ES with regard to the prevention of further attacks of 
GSP. Furthermore, cholecystectomy is a lower risk procedure and the later biliary 
complications attributable to gallstones in the gallbladder such as cholecystitis are 
avoided[236]. There is therefore general agreement that all patients with acute GSP 
who are fit enough should undergo a cholecystectomy. Delaying surgery will not save 
treatment costs although it may decrease LOS on the index admission. Delaying 





readmission with GSP with the associated costs, morbidity and mortality, and this will 
increase the burden on emergency services. 
 
The median number of patients admitted as an emergency with GSP per NHS trust is 35 
(IQR: 25–51). Therefore, for the majority of NHS trusts, the extra theatre time required 
is less than one operation per week, which in most cases should be managed easily if 
treatment of GSP were given the appropriate clinical priority[247]. 
 
Following an attack of mild GSP, cholecystectomy should be offered to all patients 
prior to discharge and these should be prioritised appropriately on emergency or 
elective lists. If a patient is not fit for surgery, endoscopic sphincterotomy should be 







This thesis set out to evaluate the use of HES data to measure surgical outcomes. 5 
objectives were identified to answer such a question. 
The first objective was to identify rare complications when the code of such 
complication is available. Venous thromboembolism was used as an example of rare 
complications following bowel resection. The study showed that rare complications can 
be easily identified whether during index admission or subsequent admissions.  
 
The second objectives showed the ability of HES data to lend itself to measure rare 
complications when the codes for such complications are not available. Bile duct 
reconstruction was used as a surrogate for bile duct injury following laparoscopic 
cholecystectomy. The study showed the feasibility and benefit of such techniques. 
 
The third objective was to compare different types of surgery for the same conditions. 
Laparoscopic versus open inguinal hernia was used as an example. Early and late 
complications following inguinal hernia repair were used to compare both techniques. 
Direct codes for complications were used for early complications and reoperation rate 
was used as a surrogate for recurrence.  
 
 The fourth objective was to measure changing trends in surgical practice. Surgery for 
rectal practice was used as an example. The study showed the ability of HES data to 







Finally, HES data was used as a national tool to identify adherence to national 
guidelines. HES was used to monitor the national adherence to the national guideline 
for definitive management of acute gallstone pancreatitis. The study showed the benefit 
of adherence to the national guideline as well the number of patients who are being 
treated within those guidelines. 
 
9.1 Can meaningful clinical recommendations be made from 
research using HES data? 
HES was used to identify Venous Thromboembolism VTE following bowel resection 
as an example of this objective. It was feasible to calculate the incidence of VTE at one 
year follow up. The study showed a VTE rate of 2.3% at one year follow up which was 
comparable to findings of other research[248]. The risk of developing VTE during 
index admission represents only a quarter of the total number of VTE the patients may 
develop at one year. These findings were first to be reported in colorectal surgery and it 
is comparable to the risk of VTE shown previously from bariatric surgery[119]. Two 
further researches were published from different institutions investigating the risk of 
VTE and surgery by linking HES data to primary care data. Humes et al[124] 
investigated the risk of VTE following colectomy but not rectal surgery and Bouras et 
al[125] investigated VTE rate following a number of surgery including thyroid, breast, 
hernia, and bowel surgery. Both studies found similar results to our findings which 
credence to our methods. The study confirmed what was little known before that the 
risk of VTE following prolonged hospital stay is increased for cancer patients, 
Inflammatory Bowel Disease (IBD) patients, and for benign patients. Policy to reduce 
length of stay is not only important to save money but to speed up recovery and reduce 





Surgery (ERAS) was first introduced by Henrick Kehlet in 1995[249] and since it has 
evolved and become the standard of care across different specialities[250]. NHS Trusts 
should further enhance the use of ERAS and reduce hospital stay. 
 
Laparoscopic surgery is well-known approach to reduce hospital stay[251]. Study for 
HES data showed a new benefit of laparoscopic approach compared to open surgery by 
reducing the incidence of VTE. Training in laparoscopic surgery is very important and 
the NHS commissioned LAPCO training in 2009[252] which was directed at training 
colorectal surgeon the laparoscopic approach. The majority of colorectal surgery can be 
performed by laparoscopic approach and it should become the standard of care to all 
patients. 
 
Studying each comorbidity individually to assess their association with VTE was 
essential to identify factors associated with VTE. The risk of VTE was found lower 
among patients with ischaemic heart disease. This is most likely due to the fact that 
these patients tend to be on antiplatelets agents which act as prophylactic measure. 
Aspirin is the most common antiplatelet and Aspirin was found to reduce the recurrence 
of cancer[253]. It may be a good idea to start all patients on date of diagnosis on 
Aspirin but further studies are warranted.   
 
The rate of Bile Duct Reconstruction (BDR) and therefore presumed bile duct injury is 
in keeping with published series. This study suggests that the incidence of BDR 
following LC in England is low (0.09%) with only 500 cases over a 12-year period. 
Data from other registries show that the incidence of Bile Duct Injury (BDI) in 





between 0.06%- 0.5%[133, 145]; in Finland 0.82% (6 733 LC)[134]; and in Sweden 
1.5% (51 041 LC)[135] although major BDI in this study accounts for only 0.1%. 
However, researchers have to understand that different definitions of what constitutes 
BDI make comparative analysis difficult. Other reports from large single centre studies 
(over 10 000 LC) showed the incidence of BDI is between 0.19%[137] and 0.24%[136]. 
 
The study confirmed what was known before about the importance of Bile Duct Injury 
following laparoscopic cholecystectomy[254]. The study showed that there is a tenfold 
increase in mortality at one year in patients who have undergone a BDR  
 
A similar methodology was used in this study to the one that was used previously by 
Ballal et al 2009 of reporting patients related factors and non-patients related factors for 
risk of conversion following laparoscopic cholecystectomy[83]. Patient related factors 
associated with BDR include cholecystitis on the index admission. Non-patient related 
factors associated with a lower reconstruction rate include a high consultant 
cholecystectomy caseload and regular use of OTC.  
 
The study was able to compare incidence of BDI between different centres and after 
adjustment to all factors, all hospitals in England were within the 99 percentiles during 
the study period. This finding confirms the ability to of HES to compare hospital 
performance in complications of surgery. Several studies[152-154] have shown that 
BDI repaired at an Hepato-Pancreatico-Biliary (HPB) centre is associated with a better 
outcome as compared to those repaired in a general hospital. Data from this study 
showed more than half of the injuries were repaired locally. Centralization of HPB 





centres during the study period. The policy planners should draw up from these findings 
and all patients should be transferred to HPB unit when bile duct injury is diagnosed. 
 
Most surgeons in the UK perform On Table Cholangiogram (OTC) selectively. Large 
studies based on registry data have produced conflicting results. While some show that 
the risk of BDI decreases when OTC is performed[135, 146, 155-157], others, including 
a systematic review[158] show no benefit[159]. The study showed that surgeons who 
use OTC more frequently have a lower rate of BDR following Laparoscopic 
Cholecystectomy (LC). On Table Cholangiogram should be used more widely and all 
surgeons should be trained to use it. Training is needed to understand the anatomy of 
the biliary tree and the OTC procedure during Registrar's training and regional courses 
for the Consultants. Hospital system should encourage the use of OTC by providing the 
necessary equipment.  
 
The study confirms the ability to record rare complications of surgery from HES data 
when there are no codes for such complications. The Study also confirms the ability of 
HES data to compare hospitals across the country and study factors associated with 
such a complication. The study confirmed the importance of Bile Duct Injury in terms 
of risk of death to patients. The study was able to add to the evidence of 
subspecialisation of laparoscopic cholecystectomy is needed and that occasional 
surgeon should consider their practice. The study was able to add to the growing 
evidence that on table cholangiogram is associated with a lower risk of BDI. 
 
Inguinal hernia was used as an example of comparing two different surgical approaches 
for surgery. The reoperation rate was used as a surrogate for recurrence as the primary 





as early complications such as bleeding, injury and urinary retention. Because of the 
complexity of inguinal hernia, a different approach in methodology was needed. 
Inguinal hernia was divided into primary and recurrent and then each of them was 
subdivided into unilateral and bilateral. Each group was then followed across time and 
place to identify if any patient was re-operated on and it appeared in any of the other 
group later in life. The study showed that laparoscopic repair was associated with 
higher incidence of reoperation compared to open repair for the overall group and for 
the primary group. HES also showed that laparoscopic repair has a similar reoperation 
rate to open surgery for recurrent inguinal hernia.  
The results were revalidated by repeating the same methodology for a different timing 
period and the outcome was similar to the original cohort of patients. 
 
HES data analysis was able to monitor infection, hematoma formation, urinary 
incontinence, and injury to an organ. Injury to an organ is rare during a hernia repair but 
has been reported to be higher with a laparoscopic technique[180]. Increased infection 
and haematoma rates are seen following open as compared to laparoscopic repair, a 
difference which is consistent with other published studies[169, 175, 176].The rate 
reported in HES were lower than published literature and it is probably due to under 
reporting.  
 
The study showed that consultant caseload of laparoscopic approach is inversely 
associated with recurrence of hernia. This result informs surgical society about the 
importance of volume of their cases and their results in benign pathology. 
Subspecializing appears to be important not only in cancer surgery but even in common 





account with the current policy of NHS Improvement and Getting It Right First Time 
(GIRFT). 
 
The study from HES was able to identify factors associated with recurrence. Non 
patients related factors in terms of consultant caseload was significantly inversely 
associated with higher reoperation rate in the laparoscopic group but not in the open 
group. These findings reaffirms other Studies which suggested that surgeon experience 
is related to hernia recurrence following laparoscopic repair,[168, 181]. 
 
Research from HES can compare different types of surgery for the hernia and it can 
also be used to identify factors associated with poor outcome of hernia. HES can also be 
used to monitor outcomes of inguinal hernia in the country. 
 
HES data was used to measure changing trends in prolapse surgery. The study showed 
rectal prolapse surgery is increasing year on year at a rate faster than the increase in 
population. HES also showed new techniques in terms of laparoscopic surgery 
increased exponentially during the study period. The study showed that there is little 
evidence of subspecialisation for rectal prolapse surgery with unchanged and low 
numbers of procedures per surgeon per annum. 
 
Data from HES allowed us to measure the incidence of rectal prolapse. The incidence 
was 18.5 per 100,000 per year which is much higher than a previous report of only 2.5 
per 100,000 in a Finnish population [205]. The overall in-hospital mortality rate for all 
types of surgery was less than 1% which is comparable to the reported mortality in the 






Similar to the methodology used in the inguinal hernia repair, It was feasible to measure 
the reoperation rate of different surgical approach for rectal prolapse. The overall 
reoperation rate was approximately 12% for both elective and emergency cases which is 
similar with the reported recurrence rates in the literature 3-33%[209-212]  
 
Limitation of this study was the use of reoperation rate rather than actual recurrence 
rate. Therefore, some patients who had recurrence but declined (or were unfit) for 
further repair will not have been included in the analysis. This indicates that recurrence 
rates might be higher than the data provided.  
 
Studies from HES data have value in understanding trends in surgical strategy, lack of 
subspecialisation and/or centralisation and in providing surrogate outcomes on much 
larger numbers of patients than for instance widely cited single centre cohort studies 
and an under-recruited trial from the same time period[20]. 
 
HES data was used as a National Audit Tool to investigate the national adherence to the 
British Society of Gastroenterologists (BSG) guideline of definitive management of 
gallstone pancreatitis[62]. This national audit shows that current practice in England 
with regard to the definitive management of patients with GSP falls well short of that 
suggested by the BSG. In fact, only a third of patients received definitive treatment on 
the index admission or within two weeks of discharge. 
 
Although there was a general consensus among clinicians who prepared the BSG 
guidelines that definitive treatment was best performed during the index admission or 





not based on objective data. It may be that definitive treatment during the index 
admission is advisable and that patients suffering an attack of mild GSP should have a 
cholecystectomy or endoscopic sphincterotomy (ES) before discharge. Subsequent 
guidelines in acute pancreatitis should possibly take this into account. This is the first 
study to provide the evidence to support the BSG guideline.  
 
In addition, it appears that once patients were discharged without definitive treatment, 
only a third had undergone definitive treatment within two months of discharge. This 
may reflect the lack of available operating time on routine lists together with poor 
prioritisation. On the other hand, this and other observational studies[235, 236] have 
shown that the length of stay during the index admission increases if patients undergo 
definitive treatment during that admission. It may be necessary to book patients with 
mild GSP for a cholecystectomy once the diagnosis has been made, even if they are still 
settling, as this has been shown to be safe and reduce LOS[237, 238]. 
 
There is still considerable debate as to whether an ES reduces the risk of a further bout 
of GSP to the same level as a cholecystectomy[242-246]. This study has shown that 
cholecystectomy is superior to ES with regard to the prevention of further attacks of 
GSP. Furthermore, cholecystectomy is a lower risk procedure and the later biliary 
complications attributable to gallstones in the gallbladder such as cholecystitis are 
avoided[236]. There is therefore general agreement that all patients with acute GSP 
who are fit enough should undergo a cholecystectomy. Delaying surgery will not save 
treatment costs although it may decrease LOS on the index admission. Delaying 





readmission with GSP with the associated costs, morbidity and mortality, and this will 
increase the burden on emergency services. 
 
The study was also able to calculate the workload to each trust and this will help the 
management to make the necessary arrangement to provide such service. The median 
number of patients admitted as an emergency with GSP per NHS trust is 35 (IQR: 25–
51). Therefore, for the majority of NHS trusts, the extra theatre time required is less 
than one operation per week, which in most cases should be managed easily if treatment 
of GSP were given the appropriate clinical priority[247]. 
 
HES data lack many clinical details that have been used in other comparative studies of 
acute pancreatitis to stratify patient populations into predicted severe and mild disease, 
and this is a limitation of our study 
9.2 Strength and weaknesses of HES data. 
There are many benefits of using HES data in measuring surgical outcome compared to 
other types of data. However, HES does have weaknesses and limitations which are 
summarised below. 
9.2.1 Strength of HES data 
9.2.1.1 Overview of practice and changing trends 
HES is one of the best tools readily available to evaluate the changing trend in practice 
and to give a clear overview of current practice. It is reliable and accurate in measuring 
the primary diagnosis and primary procedure.  The degree of error from coding 
inaccuracy is likely to be diluted due to the large number of practices. HES compared to 
other databases are readily available and free. Whereas any other attempt to perform 





Emergency Laparotomy AUDIT (NELA) [255]. HES will help planners to predict the 
future resources needed. For example, the rising use of laparoscopic surgery 10 years 
ago in inguinal hernia surgery has shown the need for more training and resources by 
hospitals to keep up with the demand. Hospitals who did not plan for changing trends 
will always find themselves in a difficult position in the future if they did not assess the 
changes and did not make a plan. For example, in my department, there was a limited 
attempt to introduce laparoscopic surgery in the last 10 years. Therefore, up to 2015 
only 30% of all colorectal resections were performed laparoscopically. When this 
became evident, their aim was to recruit a laparoscopic colorectal surgeon to boost the 
number of laparoscopic cases.  
 
In surgery for rectal prolapse paper, the laparoscopic ventral mesh rectopexy (VMR) 
surgery is rising exponentially. This will again help the heath authorities to start training 
surgeons to perform the surgery so patients will benefit from this kind of surgery 
without post code lottery.  
9.2.2 Weaknesses of HES data 
9.2.2.1 Coding accuracy 
The previous systematic reviews and the current one in my study showed coding 
accuracy of about 85% for both primary diagnosis and primary procedures. These 
figures are good and researchers can conclude researches from HES data are reliable. 
Most coding inaccuracy appears to occur in the fourth character codes and for complex 
diagnosis such as self-harm or non-specific abdominal pain. When studying an 
overview or changing trends, inaccuracy tends to be homogenous and its effect tends to 
be negligible due to the high number of cases studied. However, when assessing 





potentially play a significant role in skewing the data. Research from HES is a good 
tool to study the overall practice rather than investigate a particular case because the 
error margin is high in those circumstances. 
9.2.2.2 Codes insufficiency 
Some procedures and diagnoses lack the relevant codes. There are very few new 
procedures that a code can be found for it. This is clearly evident in Patrick and 
colleagues paper which was published in 2013[256]. They published their findings of 
assessing the HES data to measure the activity of new procedures and devices as per 
NICE guideline. They looked at 12 new technologies and compared only 9. They 
contacted relevant registries, hospitals, and manufacturers to compare the data. They 
found HES have the potential to provide evidence about new devices and procedures. 
However, achieving this potential requires improvement in the simplicity and 
specificity of coding procedures (particularly when they are being used for particular 
indications). A higher priority should be given to the development of a reactive coding 
system with improved specificity of its codes. The study has confounding factors as it 
compare HES data to non-approved databases. Some comparisons of HES data were 
made with the sale figures of manufacturers, which is probably not the best indicator. 
Others compare HES to local hospital database. It is not clear how accurate these local 
hospital databases are and whether they are validated. The final comparison was made 
with national Central Cardiac Audit Database (CCAD). They looked at 5 procedures. 
When they compared HES with CCAD they found high sensitivity of 83.3 (35.9–99.6) 
to 100.0 (75.3–100.0). However, they found HES to be significantly under reporting 
these procedures. When they compared HES to registry, they found a much lower 





on how they calculated their results and what they are comparing to in order to 
complete their findings.  
 
The bile duct injury paper in chapter 5 is another example of coding insufficiency. In 
order to measure the bile duct injury, surrogate code was used instead.  Bile duct 
reconstruction codes were used as a surrogate marker for the bile duct injury. This is a 
very good and reliable method to measure major bile duct injury. However, it has 
several drawbacks, it doesn’t include minor bile duct injury when the surgeon simply 
sutures the repair at time of surgery. It doesn’t include patients who underwent 
conservative management for bile duct injury with ERCP. This can be measured but it 
is very difficult to distinguish between injury and stone. It doesn’t include patients who 
died prior to the repair. However, other studies using registry data have used similar 
methodology[131-133, 146] and our result are consistent with their findings.  
Nevertheless, most minor injuries are associated with a lower rate of complications, and 
lower long-term morbidity.  However, the study does include those patients who fail to 
respond to ERCP and stenting or who develop stenosis of bile duct that requires delayed 
(within a year) surgical reconstruction. 
9.2.2.3 Codes overlapping 
HES depend on clinical codes. Clinical codes are mainly derived from OPCS and ICD 
10 codes. Unfortunately, these codes are not designed by clinicians and they are 
completely out of date. For example, there are over 10 codes for ERCP. Many of these 
codes are not valid and no one uses them. The OPCS codes are not based on operation 
but they are based on IT protocols. Codes should be simplified and mimics true surgery. 
Laparoscopic reversal of Hartmann’s for example is complex procedure where clinical 





different NHS trusts. Sometimes there are more than one code for the same conditions. 
For example, when searching for Delorme procedure for rectal prolapse, there are many 
codes in the OPCS system that can be used. For example, excision of mucosal prolapse 
of rectum NEC, Perineal repair of prolapse of rectum NEC, Other specified perineal 
operations for prolapse of rectum, and Preanal mucosal proctectomy and endoanal 
anastomosis. All these codes should be used when searching for Delorme procedure.  
 
Multiple and duplicate codes can increase the error and mess the data. However, if the 
right steps are taken this can be minimised. Anyone attempting to search HES should 
undergo extensive training in clinical coding, statistics and database management 
before embarking on any research on HES. 
9.2.2.4 Data structure such as comorbidity and events 
One of the main problems of HES data structures are the secondary diagnosis and 
secondary operations fields. These fields combine the primary diagnosis, comorbidities, 
and complications. Some patients have a single diagnosis but many others have 
multiple primary diagnoses. This is evident when a patient is admitted with multiple 
conditions such as diabetic ketoacidosis due to sepsis or exacerbation of heart failure 
due to sepsis or anaemia. The coders may find it very difficult to code the primary 
diagnosis. This is often recorded as inaccurate diagnosis because the original coders 
decide it is the heart failure which is the main cause and the reviewers disagree and 
think it is the sepsis.  
 
In the procedure codes, it is even more evident. If the patient undergoes a laparoscopic 
gastric bypass with laparoscopic cholecystectomy, the coders may code either as the 





and small bowel resection or other procedure. Again, the coders may choose 
laparotomy as the main codes, but the auditor may think it is the adhesiolysis or the 
small bowel resection. That is why when searching for a particular procedure, the 
researcher should look at the first three codes and then search manually for the ones 
where the procedure coded on the second diagnostic fields to decide whether this is 
correct or not.  
 
Another problem is the comorbidity and complications. There is no way of knowing if 
the heart failure recorded in the secondary fields occurred during admission or it is one 
of the comorbidities. Similarly, patients who develop myocardial infarction during 
admission will be recorded in the secondary diagnostic fields, however, it is impossible 
to distinguish this from patients admitted to the hospital with a history of myocardial 
infarction as both events will be recorded in the secondary diagnostic fields. 
9.2.3 Suggestions for HES data analysis 
Understanding the data and codes are one of the most important aspects of any analysis. 
Different methodology can lead to different results. One of the main problems of HES 
is the methodology used to identify patients. The first step is to understand the subject 
very carefully. A lot of work has to be undertaken to analyse the broad subject, the aim, 
expected results and outcome. Some subjects are difficult to be undertaken from HES 
and their results are probably misleading. 
 
Once the subject is accepted and deemed to be feasible to be analysed through HES 
data, the method should be written. The first decision is to decide whether one should 
search by diagnostic codes or operative codes or both of them. Should the researcher 





clinical codes in 108 surgical patients at Leighton hospital in 2010. The audit was 
performed by the clinical coding manager and she found the operative codes accuracy 
was 80% and 85% for diagnostic codes. However, I found the majority of inaccuracy 
was not in the actual codes but in the sequence of the codes. For example, the accuracy 
of clinical codes increased to 90% and 95% respectively, if we search for codes in the 
first three fields rather than simply the first field.  
 
For simple procedures such as inguinal hernia, performing such analyses can lead to 
certain problems. A patient can be admitted for major surgery and at the same time, the 
surgeon decided to repair the hernia. Therefore, searching for inguinal hernia repair in 
the second or third operative fields will select those patients as well. Adding those 
patients to the analysis will skew the results of length of stay, mortality, infections etc.  
To overcome such a problem, researchers should probably assess these cases manually. 
All patients who were recorded to have an inguinal hernia repair in the second and third 
operative fields should be inspected individually to decide whether to include them or 
exclude them. 
 
The second step once the original cohort is identified is to compare the diagnostic fields 
for the relevant diagnosis. For example, searching the inguinal hernia in the diagnosis 
should be performed on the original cohort. This will eliminate any coding inaccuracy 
in the final cohort.  It will however, eliminate some patients who did undergo surgery, 
but I believe it is an excellent method to make sure our cohort is almost 100% accurate 
by searching and linking both diagnostic and operative fields. In the inguinal hernia 





study resulted in almost 100% accuracy. Because it is extremely unlikely for coders to 
give the wrong clinical codes twice. 
 
Identify certain factors in each episode such as method of admission (emergency or 
elective). The best method is to create a new field and use the update table query. 
Searching the “admimethod” field for 11, 12, and 13 should be performed, and then use 
the update table to update the new field to elective. The same method should be 
repeated for every field required for the study.  
 
Charlson comorbidity score can be calculated in the same update query table by 
searching the secondary diagnostic fields for each item such as heart failure. Then a 
new field should be formed in the update table query and is used again to add all scores 
to form the final Charlson comorbidity score by using express builder in Access.  
 
One of the main problems of HES data analysis is the spells and episodes. Each spell 
composes of one or more episodes. For some reason hospitals may record the same 
clinical codes for each episode and others do not. By searching for duplicates (multiple 
episodes) to remove them and keep only one record for that surgery. I described the 
methods in full in the methodology chapter, but it worth noting that certain steps should 
be considered.  
 
 Researchers should use the find duplicate query by using the query 
wizard in Access. 





 Fields of interest should be selected for example, Charlson comorbidity 
score and type of surgery. This will create a query where all duplicate records 
are listed.  
 Once HESID are listed ascending or descending, duplicate cases can be 
deleted manually. If there is discrepancy in the Charlson comorbidity fields or 
surgical fields between different episodes (duplicate), then the correct number 
can be chosen manually and the unwanted ones deleted.   
 
9.3 Proposed changes to HES data 
There are many changes to HES data that can be implemented very easily, but can 
results in ground breaking improvement. Many of the criticisms of HES can be resolved 
in few easy steps.  
 
The first is to divide the diagnostic fields into three categories. The first is the 
presenting diagnosis or symptoms (three fields). This will tell any future researcher that 
a patient presented with right iliac fossa pain and vomiting for example. The second 
part of diagnosis is the main diagnosis. This part represents the main diagnosis of the 
patient such as Appendicitis or ovarian cyst. A combination of both presenting 
diagnostic fields and the main diagnosis can help future researchers that a patient was 
admitted with right iliac fossa pain and a diagnosis was made of appendicitis.  
 
The third diagnostic fields are the comorbidity. There has been a great deal of emphasis 
on the Charlson comorbidity score in HES data. The current strategy is searching the 
secondary diagnostic fields, but it is very difficult to know whether those diagnoses 





coded comorbidity and a set of particular comorbidities should be used. For example, 
any patient with a history of VTE, COPD, Asthma, Heart failure etc should be coded 
under this section. Therefore, the researchers can identify that this patient presented 
with right iliac fossa pain and the main diagnosis was appendicitis and the patient had a 
history of COPD.  
 
The next fields should be labelled as further diagnoses. For example, this patient 
developed myocardial infarction and DVT during his stay in the hospital. Therefore, a 
researcher can identify those as conditions developed during the patient stay, rather than 
the patient having a history of them. 
 
Currently, some coders in some hospitals use the operative codes to record 
investigations. These are not measured and highly unreliable. If HES introduce 
investigation fields to HES data, HES data users can monitor the use of investigations 
by each hospital. Researchers can understand how the current practice is changing and 
what can be done to improve it. HES data team should however, identify what type of 
investigations should be recorded. For example, HES should probably record all 
ultrasound, CT scan, MRI scan, and PET scan. The radiology department can be 
connected directly to the codes by sending what scan was performed, without the need 
for the coders.  
 
Back to our example of appendicitis patient, if this patient underwent CT scan, future 
research can quantify the use of CT scan in diagnosing appendicitis. This is a very 
important question as CT scan involves a large dose of radiations. Policy makers should 





Such practice is widely used in the NHS and can result in unnecessary exposure to 
radiation and potentially those patients may be at higher risk of cancer development in 
the future.  
 
Finally, the operative codes. The current practice is highly misleading and ambiguous. 
The use of multiple codes to represent an operation is probably not ideal. The OPCS 
codes are very primitive and complex, that is very difficult to master by both coders and 
clinicians. It is probably a good idea if clinicians play a significant part in the new 
codes. BUPA codes for example is a better code system than OPCS codes. For 
example, BUPA use H3390 to represents reversal of Hartmann’s procedure, whereas 
the OPCS coders have to use H15.4 + Y16.2 + Z29.1. This is highly complicated and 
often junior coders get them wrong. If researchers and planner are to continue using 
HES data to measure NHS practice, a new system is needed. Each OPCS code comes 
with several other operation or non-specific operation. For example, in rectal prolapse 
surgery H35 codes are one of the codes for this procedure. H358 and H359 represent 
other specific fixation of rectum for prolapse and unspecific fixation of rectum for 
prolapse. Many coders and clinicians do not understand the difference between both of 
them and what they actually mean. Are they meant to be used for Delorme procedure, 
Altemeier’s procedure, abdominal fixation or laparoscopic rectopexy? Of course, 
experienced clinical coders will know which one to use, but a busy or inexperienced 
coder will use any of them. Therefore OPCS codes should be changed, simplified and 
become clinically oriented based on actual surgery rather than Information technology 
(IT).  
Another suggestion is to divide the operative fields in several categories. For example, 





that specific day. Category three represents second or subsequent operation/procedures 
performed in another day. Category four represents any interventional radiology.  
 
To put this into context of our original example of appendicitis, the proposed procedure 
was appendectomy, but the surgeon performed right hemicolectomy instead of 
appendicectomy. Therefore, the researcher will understand and be able to identify that 
from the HES data. The patient was then taken back to theatre because of anastomotic 
leak and exteriorisation of bowel was carried out. Therefore, this should be categorised 
into the third fields rather than into the current system which is very difficult to identify 
and measure. This patient later developed a collection and a radiological drainage was 
carried out. Therefore, researcher should be able to measure this from the fourth 
category in the future.  
 
The fifth category should be kept for complications of surgery. For example, 
anastomotic leak, bowel injury, bladder injury etc. The current system does not allow 
this to be recorded in detail. But there is a very primitive codes for misadventure. By 
forming category 5 for operative complication, both planners and researchers can 
identify those complications and will be able to measure outcome in a much better way 
than the current system. 
 
By making those simple changes to just how the fields are grouped can transform the 
HES from the current style data to the 21st century. Researchers will be able to identify 
the patient pathway and story in a very easy systematic method that cannot be measured 
with the current data. Government can use the data to monitor hospital performance like 






Hospital Episode Statistics can be used to measure surgical outcome in a number of 
useful and reproducible ways. HES can be used to measure mortality, complications, 
compare different surgical approaches, assess the effect of changes in practice, and 
assess caseload outcome association. Those metrics can be used to inform health care 
planners, develop guidelines, and inform patients. The use of HES, however, has 
weaknesses which to a certain extent could be overcome easily with minor alteration in 
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Background: This study analysed trends in admission and surgery for rectal prolapse in 
adults in England between 2001 and 2012 as well as prolapse reoperation rates. 
Methods: Analysis of data derived from a comparative longitudinal population-based 
cohort study using Hospital Episode Statistics (HES).   
Results: During the study period, a total of 25,238 adults underwent a total of 29,379 
operations for rectal prolapse (mean 2,662 per annum) [median age 73 years (IQE 58-
83) years; female to male ratio: 7:1]. Median length-of-stay was 3 days (IQR 1-7) with 
an overall in-hospital mortality rate of 0.9%. Total number of  admissions (2001: 4,950 
vs. 2012: 8,927) and of patients undergoing prolapse surgery (2001: 2,230 vs. 2012: 
2,808) significantly increased over the study period (P < 0.001 for trends). The overall 
increase in prolapse surgery (up by 1/3rd overall and 44% for elective) was dwarfed by 
an increase in popularity of laparoscopic surgery (increasing 15-fold). Overall prolapse 
reoperation rate was 12.7%. The lowest recurrence rate was observed for elective open 
resection (9.1%) but this had the highest mortality (1.9%).  Laparoscopic and perineal 
fixations were also associated with low reoperation rates (<11%) but lower mortality 
rates, in the order of 0.3% for elective surgery. These data refute a trend toward 
subspecialisation (by surgeon or hospital) during the study period. 
Conclusions: Admissions for rectal prolapse increased in England between 2001-2012 
together with increases in surgery. Surgical decision making has changed over the 






What does this paper add to the existing literature? 
 
This is the largest dataset of patients undergoing surgery for rectal prolapse, studying 
over 25,000 patients. The incidence of rectal prolapse and surgical repair in England 
has increased between 2001 and 2012. Laparoscopic fixation has increased dramatically 








Rectal prolapse is an uncommon but highly morbid condition in which a full-thickness 
intussusception of the rectal wall extrudes through the anal canal [1-3]. The only 
potentially curative treatment is surgery with exceptions being patients considered 
medically unfit for surgery and those with minor degrees of prolapse. Over 100 
operations for rectal prolapse repair have been described and none has achieved 
primacy following attempts to provide high quality evidence[4]. Rectal prolapse can be 
repaired via the abdomen or perineum with several alternatives for each described. 
Abdominally, posterior rectopexy (sacral fixation of the rectum) is generally considered 
to have a low recurrence rate but may result in poor function especially constipation [5]. 
Alternatively, the rectum may be fixed with concomitant segmental colonic resection 
(resection rectopexy) but there is a risk of anastomotic leak 1-5.9% [6, 7] even though 
some data suggest it has the lowest recurrence rate[4]. Perineal approaches (principally 
Delormes and Altemeier’s) are less invasive and are considered a better option for 
elderly and medically unfit patients. However these may have higher recurrence rates 
10 -30% compared to 0-11% for rectopexy[8].  
 
Laparoscopic rectopexy was first reported in 1992 by Berman and has re-popularised 
the abdominal approach[9]. Laparoscopic ventral mesh rectopexy (LVMR) uses an 
anterior rectal dissection with fixation of the anterior rectal wall to a mesh, which is 
then anchored to the sacrum. The operation theoretically preserves pelvic nerves 
avoiding the ‘rectal inertia’ caused by posterior dissection and reportedly better 
functional outcome [10]. Several large series have now been published suggesting low 
recurrence rates and lower short-term morbidity[11-13], however this operation has 
recently become the subject of media scrutiny in relation to long-term complications 
from the use of pelvic mesh in general[14, 15]. 
 
The current study evaluated trends in surgery for rectal prolapse in England from 2001 
to 2012 with a focus on type of operation performed and estimates of recurrence based 









The study examined a national dataset (below) to obtain data pertaining to trends in 
incidence of rectal prolapse diagnosis and operations performed for prolapse by year. 
Patients undergoing an index prolapse procedure were followed up longitudinally to 
determine if they underwent further operations for rectal prolapse. As such, the study 
had elements of a multiple cross-sectional and retrospective cohort design.  
Data sources 
Hospital Episode Statistics (HES) data were obtained from the National Health Service 
Information Centre (NHSIC) and imported into Microsoft SQL server. All patients 
admitted with rectal prolapse over an 11-year period (April 2001 and March 2012) were 
identified by searching the primary diagnostic codes (K622 for anal prolapse and K623 
for rectal prolapse) using the International Classification of Diseases Version 10 (ICD 
10). Data were then imported into Microsoft Access [Microsoft Corp. USA] for 
analysis. Patients who underwent surgery for rectal prolapse were then selected by 
searching the Office of Population, Censuses and Surveys Classification of Surgical 
Operations and Procedures (4th revision) codes (OPCS-4). Codes used are listed in 
suppl. table 1. Patients under the age of 16 were excluded from analysis. It is noted that 
there are no HES diagnostic codes for internal prolapse (intussusception) and the cohort 
will almost certainly have included some patients undergoing procedures for this 
diagnosis e.g. those undergoing stapled rectal resection (STARR) procedures. These 
patients represented less than 1% of the whole cohort (n=201). 
 
Patients were subdivided by type of surgical repair into 6 categories using OPCS codes. 
Open fixation, open resection, laparoscopic fixation (laparoscopic codes plus open 
fixation), laparoscopic resection (laparoscopic codes plus open resection), perineal 
fixation, and perineal resection. Codes for each group are described in suppl. table 1. 
Laparoscopic repair was identified by searching all operative codes for Y75* or Y508* 
using the OPCS code 4. Converted cases were included with the laparoscopic approach 
by searching for the codes Y714* or Y718*. Patients were then subdivided into elective 
and emergency repair by mode of admission using the “admimeth” field to identify how 
the patient was admitted to hospital (for elective admissions: numbers 11, 12, and 13; 
















Anterior fixation of rectum 
Posterior fixation of rectum using prosthetic material 
Posterior fixation of rectum NEC 
Fixation of rectum using fascia lata 
Other specified fixation of rectum for prolapse 
Unspecified fixation of rectum for prolapse 
Abdominal repair of levator ani muscles 
Other specified abdominal operations for prolapse of rectum 
Unspecified other abdominal operations for prolapse of rectum 













Anterior resection or proctectomy or Hartmann’s 
 





Laparoscopic or robotic approach to abdominal cavity 





Failed minimal access surgery 











Insertion of encircling suture around perianal sphincter 
Perineal plication of levator ani muscles and anal sphincters 
Insertion of supralevator sling 
Excision of mucosal prolapse of rectum NEC 
Perineal repair of prolapse of rectum NEC 
Other specified perineal operations for prolapse of rectum 
Unspecified perineal operations for prolapse of rectum 








Perineal resection of rectum 
Rectosigmoidectomy and peranal anastomosis 
Peranal resection of rectum using staples 
Supplementary table 1: Operative codes for surgery (OPCS4) 
Patients identified as having surgery within the 11-year period were followed up until 
March 2012 using HES patient ID (HESID) to investigate any who had undergone 
further rectal prolapse operations (as a surrogate for recurrence). The HESID is a 
unique identifier for every patient that is calculated using NHS number, local hospital 
number and date of birth. Using HESID permitted follow-up of patients across time and 
place and was used to calculate reoperation rates for each surgical operation type. In 
addition, Consultant caseload was identified by searching all patients who underwent 
surgery by a specific consultant per year. The “Pconsult” code is a pseudo-anonymised 





individual caseloads. Similarly, hospital surgical volumes were calculated by searching 




Data have been presented descriptively with summary statistics based on data 
distribution. Population statistics were derived from Office of National Statistics census 
2011 [16] to allow incidence rates per 100,000 population to be calculated for both 
rectal prolapse admission and rectal prolapse surgery. Limited statistical analyses were 
performed for time trends using regression of moving averages. All analyses were 








Table 1: Trends in numbers of admissions and operations for rectal prolapse 2001-2012 
 
Tables 1 and 2 [Figure 1] show the main results by year from 2001 to 2012 with 25,238 
adult patients undergoing a total of 29,379 operations for rectal prolapse over this time 
period (mean 2,662 per annum). There were obvious upward trends (P<0.001 for both) 
in total numbers of patients admitted and of those undergoing surgery of any type for 

























01/02 4,950 2,230 2,320 384 4 (3-7) 195 8 (5-13) 73 
 (58-82) 
02/03 5,135 2,085 2,352 391 4 (2-6) 185 8 (4-13) 73 
(57-82) 
03/04 5,322 2,102 2,404 408 4 (3-6) 200 8 (5-12) 73 
(58-82) 
04/05 5,389 1,988 2,321 417 4 (2-6) 197 9 (5-14) 73 
(59-81) 
05/06 5,763 2,060 2,451 432 4 (3-6) 212 10 (6-13) 73 
(59-82) 
06/07 6,058 2,162 2,543 461 4 (3-6) 186 9 (5-14) 74 
(61-84) 
07/08 6,411 2,251 2,612 487 4 (2-6) 192 10 (6-15) 73 
(59-82) 
08/09 6,838 2,404 2,798 483 4 (2-6) 191 10 (5-15) 73 
(59-81) 
09/10 7,685 2,532 3,031 518 4 (3-6) 200 11 (6-17) 73 
(58-83) 
10/11 8,371 2,616 3,159 521 4 (2-7) 222 11 (5-16) 73 
(58-83) 







Figure 1: Trend of total number of admission of rectal prolapse and patients 
underwent surgery and total number of procedure per year. 
 
 
The number of patients admitted to hospital with rectal prolapse in 2011 was 8,927 
providing an annual incidence rate of 18.5 per 100,000 for this year; 2,808 underwent 
rectal prolapse surgery providing a statistic of 6.1 per 100,000 per year. For patients 
over the age of 75, these rates were much higher (106 per 100,000 and 31 per 100,000 
per year respectively). Over the same time period, population statistics showed the 
English population increased by about 3.9 million (8.0%) from around 49.1 million in 
2001 to 53 million in 2011[17]. The number of people over the age of 65 years 
increased by 851,000 (10.9%) for England over the same period. Nevertheless, patient 















































































































Table 2: Data by type of operation for whole time period 
a. elective operations 
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The number of operations performed per year increased by approximately one third 
from 2,320 in 2001 to 3,253 in 2011. The number of surgeons providing rectal surgery 
for prolapse increased from 384 in 2001 to 533 surgeons in 2011/2012 keeping the 
median number of operations performed by individual consultants relatively static at 
only 4 (IQR 2-7) per year. The number of hospitals providing rectal prolapse surgery 
increased marginally from 195 in 2001 to 222 in 2011 with a median increase in 
number of operations/hospital/per year from 8 (IQR 5-13) to 11 (IQR 5-17) in the final 
year of data analysis. Females were more than six times more likely to undergo surgery 
for rectal prolapse compared with males, with some operations having a very high 
female predominance compared to others (Table 2). Median length of stay (LOS) was 3 
days (IQR 1-7). Overall, in-hospital mortality rate was 0.9%. Just over 10% of the 





Figure 2: Trend of surgical procedures for rectal prolapse 
 
Over the 11-year study period, perineal fixation remained the most popular surgical 





However, the number of patients undergoing laparoscopic surgery (repair/resection) 
increased more than 15-fold from only 48 (2.1% of total cases) in 2001/02 to 725 
operations (22.3% of total) in 2011/12. Over the whole time period, patients selected for 
laparoscopic surgery were significantly younger than patients selected for other types of 
surgery with a median age of 67 years (IQR 52-79) [Figure 3]. In contrast, older 
patients were more likely to be offered perineal resection: median age 81 years (IQR 
73-86). In the final year of data analysis, the median age for laparoscopic surgery was 
65 years (IQR 50-78). 
 
 
Figure 3: Mean and 95%CI for surgical repair age 
 
Elective surgery for rectal prolapse was associated with a significant shorter hospital 
LOS as compared with emergency surgery for all types of surgical repair [table 2]. 
Laparoscopic and perineal fixations were associated with the shortest hospital stay. 
Elective surgery was also associated with a significantly lower mortality rate (0.5%) 
compared with emergency surgery (2.5%). Patients who underwent open resection were 





of 14.7% in the emergency setting and 3.4% in the elective setting. Elective 
laparoscopic and perineal fixations were associated with the lowest mortality of just 
0.3%. 
 
Using HESID-derived data, 3,241 (12.8%) patient underwent reoperation for rectal 
prolapse. The majority (2622; 80.9%) underwent one further surgical procedure; 489 
(15.1%) underwent two further operations and a small proportion (n = 99; 3.1%) 
underwent three or more further operations. Operation type influenced reoperation rate 
[Table 2] with open resection rectopexy having the lowest reoperation rate (9.1% 
elective and 4.3% emergency) compared with higher rates for perineal resection (16.9% 
elective and 13.7% emergency) and open fixation (16.3% elective and 14.3% 
emergency). Laparoscopic fixation had an intermediate outcome in terms of re-








To our knowledge we present the largest dataset to date of patients undergoing surgery 
for rectal prolapse, with over 25,000 patients included. Several of the findings merit 
discussion: (1) the incidence of rectal prolapse and surgical repair increased year on 
year between 2001 and 2012 at a rate greater than that anticipated by population growth 
alone; (2) there appears to be little evidence of subspecialisation for rectal prolapse 
surgery with unchanged and low numbers of operations per surgeon per annum; (3) 
laparoscopic fixation has increased dramatically in popularity over the period and this 
operation has favourable outcomes in terms of LOS, mortality and reoperation 
compared with several other operations; (4) there is no compelling evidence of 
superiority of abdominal operations over perineal in general; and (5) data confirm the 
previous assertion of higher risk but lower reoperation (recurrence) rate after resection 
rectopexy[18].   
 
The reported incidence of rectal prolapse in our study was 18.5 per 100,000 per year 
which is much higher than a previous report of only 2.5 per 100,000 in a Finnish 
population[19]. The overall in-hospital mortality rate for all types of surgery was less 
than 1% which is comparable to the reported mortality in the literature 0 – 6.5% [20-
23]. Reported recurrence rates in the literature vary from 3- 33% [23-26] depending on 
the type of surgical repair and length of follow up. Our overall reoperation rate was 
approximately 12% for both elective and emergency cases. 
 
There are several limitations to this study. The study used the HES database which 
contains administrative data reliant on the accuracy of clinical coding. A recent 
systematic review shows coding accuracy is improving and following the introduction 
of payment by results in 2002 the accuracy of coding for primary diagnoses has 
improved from 73.8% (IQR: 59.3-92.1%) to 96.0% (IQR: 89.3-96.3)[27]. It has been 
suggested that researchers should consider the context of conclusions that are drawn 
from HES data. If findings are of a general nature, then even a relatively high coding 
error rate at some, or all, hospitals will not detract markedly from the overall 
conclusions, particularly if significant deviation can be shown[28, 29]. Thus, studies 





as those posed in this study although less good at identifying variations in care between 
individual trusts or clinicians[29]. Notably, we were unable to distinguish between 
patients with external and internal prolapse. There is no HES diagnostic code for 
internal prolapse and thus a minority of the cohort would be expected to represent 
patients with obstructed defection syndrome and high grade internal prolapse. Some 
specific procedure codes may point to such patients in the current cohort e.g. Per-anal 
resection of rectum using staples (H412) but only 201 patients (<1% cohort) underwent 
this procedure. Others, e.g. laparoscopic mesh fixation, have been applied to internal 
and external prolapse [30, 31] but it was not possible in the current cohort to determine 
how many patients had internal prolapse (hindered further by there being no code for 
anterior fixation with mesh). We elected to avoid any attempt to dissect data on this 
basis (hence we describe ‘rectal prolapse’ rather than ‘external rectal prolapse’ 
throughout). Another limitation of this study was the use of reoperation rate rather than 
actual recurrence rate. Thus, some patients who had a recurrence, but declined (or were 
unfit) for further repair, will not have been included in the analysis. This indicates that 
recurrence rates might be higher than the figures provided by these data.  Finally, we 
acknowledge the time expiration on the data presented (only up to 2012). While 
sometimes it is normal for HES data to be presented several years after initial entry[32, 
33], our data are now 7 years old.  We do however feel that these still have value in 
understanding trends in surgical strategy, lack of subspecialisation / centralisation to at 
least this point in time. It provides surrogate outcomes on much larger numbers of 
patients than for instance widely cited single centre cohort studies and an under-
recruited trial from the same time period[4]. 
 
In summary, this population-based cohort study demonstrates an increasing trend in 
both numbers of admissions and operations for rectal prolapse over the studied decade. 
Despite there being little or no evidence of service centralisation, there has been a 
significant change to laparoscopic fixation during this period and this operation appears 
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